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ABSTRACT 
 Locomotion is an innate behaviour that is controlled by different areas of the 
central nervous system, which allow for effectiveness of movement. The spinal cord is 
an important centre involved in the generation and maintenance of rhythmic patterns of 
locomotor activity such as walking and running. Interneurons throughout the ventral 
horn of the spinal cord form the locomotor central pattern generator (CPG) circuit, 
which produces rhythmic activity responsible for hindlimb movement. Motoneurons 
within the lumbar region of the spinal cord innervate the leg muscles to convey 
rhythmic CPG output to drive appropriate muscle contractions. Intrinsic modulators, 
such as acetylcholine acting via M2 and M3 muscarinic receptors, regulate CPG 
circuitry to allow for flexibility of motor output. Using electrophysiology and genetic 
techniques, this work characterized the receptors involved in cholinergic modulation of 
locomotor networks and the role and mechanism of action of a subpopulation of 
genetically identified cholinergic interneurons in the lumbar region of the neonatal 
mouse spinal cord. 
 Firstly, the effects of M2 and M3 muscarinic receptors on the output of the 
lumbar locomotor network were characterised. Experiments in which fictive locomotor 
output was recorded from the ventral roots of isolated spinal cord preparations revealed 
that M3 muscarinic receptors are important in stabilizing the locomotor rhythm while 
M2 muscarinic receptor activation seems to increase the irregularity of the locomotor 
frequency whilst increasing the strength of the motor output. This work then explored 
the cellular mechanisms through which M2 and M3 muscarinic receptors modulate 
motoneuron output. M2 and M3 receptor activation exhibited contrasting effects on 
motoneuron function suggesting that there is a fine balance between the activation of 
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these two receptor subtypes. M2 receptor activation induces an outward current and 
decreases synaptic drive to motoneurons while M3 receptors are responsible for an 
inward current and increase in synaptic inputs to motoneurons. Despite the different 
effects of M2 and M3 receptor activation on synaptic drive and subthreshold properties 
of MNs, both M2 and M3 receptors are required for muscarine-induced increase in 
motoneuron output. CPG networks therefore appear to be subject to balanced 
cholinergic modulation mediated by M2 and M3 receptors, with the M2 subtype also 
being important for regulating the intensity of motor output.  
 Next, using Designer Receptor Exclusively Activated by Designer Drug 
(DREADD) technology, the impact of the activation or inhibition of a genetically 
identified group of cholinergic spinal interneurons that express the Paired-like 
homeodomain 2 (Pitx2) transcription factor was explored. Stimulation of these 
interneurons increased motoneuron output through the activation of M2 muscarinic 
receptors and subsequent modulation of Kv2.1 channels. Inhibition of Pitx2+ 
interneurons during fictive locomotion decreased the amplitude of locomotor bursting. 
Genetic ablation of these cells confirmed that Pitx2+ interneurons increase the strength 
of locomotor output by activating M2 muscarinic receptors.  
 Overall, this work provides new insights into the receptors and mechanisms 
involved in intraspinal cholinergic modulation. Furthermore, this study provides direct 
evidence of the mechanism through which Pitx2+ interneurons regulate motor output. 
This work is not only important for advancing understanding of locomotor networks 
that control hindlimb locomotion, but also for dysfunction and diseases where the 
cholinergic system is impaired such as Spinal Cord Injury and Amyotrophic Lateral 
Sclerosis. 
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1. INTRODUCTION 
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1.1. Spinal Control of Movement 
Movement is a mechanical feature that allows an individual to change their 
position or orientation towards a reference point. A variety of different movements are 
necessary for survival such as grasping and reaching for food and escaping from 
predators. Movements are complex behaviours that require a range of neuronal outputs 
from different regions of the nervous system. A hierarchy of diverse centres for control 
of movement exist within the nervous system that can adapt, program and differently 
execute a plurality of actions. Understanding how these networks function will 
ultimately contribute to our knowledge of how the central nervous system controls 
movement in health and disease. 
The motor cortex is involved in the initiation and control of voluntary movements. 
The motor cortex integrates sensory information from peripheral afferents and is 
responsible for muscle activation, setting command for adequate muscle force and 
direction of movement. This brain area is also involved in the organization and 
programming of motor sequences. Neurons projecting through the corticospinal tract 
affect, directly or indirectly through descending brainstem pathways, neurons involved 
in the generation of muscle contraction thus controlling movement (Scott, 2004; 
Guertin, 2013). 
The brainstem is involved in the control of posture and several autonomic 
functions. It also integrates sensory information originating from visual, somatosensory 
and vestibular inputs which can be translated into changes in the modulation of motor 
output (Kim et al., 2017; Mathews et al., 2017). The Mesencephalic Locomotor Region 
(MLR) is located in the brainstem and is involved in the initiation of motor drive 
(Jordan et al., 2008). Several neurotransmitters can be released after MLR activation, 
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such as the classical excitatory amino acid glutamate that can trigger functional changes 
in spinal circuits sufficient to produce locomotor activity (Hochman et al. 1994; Kim et 
al. 2017; Jordan et al. 2008; Cazalets et al. 1992). 
The spinal cord is an important centre for the control of movement, being able to 
provide enough output for rhythmic movements without the need for information from 
higher brain areas. This was first suggested more than 100 years ago in experiments 
performed in the spinalised cat. After cutting the communication between the brain and 
the spinal cord and dorsal roots to remove sensory input, Brown (1911) was able to 
detect muscle contraction followed by relaxation along with alternation between 
respective extensor and flexor muscles in the cat hindlimb (Brown, 1911). This idea, 
which was highly discussed during the beginning of the 20th century (see Stuart & 
Hultborn 2008), became the first evidence that central circuits can produce rhythmic 
behaviours, these networks being known today as Central Pattern Generators (CPGs).  
Different CPGs have been described in a variety of systems and animals, differing 
in their properties for the generation of rhythmic activity. In systems such as the lobster 
pyloric and leach rhythm generating networks, intrinsically oscillating pacemaker 
neurons can generate rhythmic activity. In more complex networks such as mammalian 
spinal locomotor networks, the generation of rhythmic patterns is dependent on the 
interaction between different types of neurons. Reciprocal inhibition underlies 
oscillatory-type firing where inhibitory interneurons project to contralateral excitatory 
neurons, thus acting as “half centre oscillators” where one half centre inhibits its 
contralateral counterpart (Marder and Bucher, 2001). 
These CPG networks can be modulated by either descending or by local 
modulators that can affect the rhythm generating properties of neurons allowing for a 
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variety of adaptable behaviours (Miles and Sillar, 2011). The work presented in this 
thesis focussed on CPG networks in the spinal cord responsible for mammalian 
hindlimb locomotion and their fine-tuning by local modulators. 
 
1.2. Mammalian spinal locomotor Central Pattern Generator 
 The exact organization and function of the neurons responsible for the 
generation of rhythmicity in the mammalian spinal cord remain unclear. Different in 
vivo and in vitro preparations have been used to study locomotor circuits. In vivo 
insights from the adult mammalian CPG were drawn from experiments using 
decerebrated animals in which electrical activation of brainstem locomotor regions or 
pharmacological excitation elicited fictive locomotion that was recorded from hindlimbs 
through electroneurograms. Fictive locomotion is considered the output measured from 
muscle or ventral roots in the absence of muscle contraction (e.g. muscles removed or 
paralyzed) but that would ultimately lead to limb movement. Early studies were 
performed in the cat (Orlovskiĭ et al., 1966; Jankowska et al., 1967; Grillner and 
Zangger, 1979) and later utilised rabbit (Viala and Buser, 1971), rat (Kinjo et al., 1990; 
Bem et al., 1993), mice (Meehan et al., 2012) and also marmoset monkey (Fedirchuk et 
al., 1998). In vitro spinal cord preparations from neonatal rodents, which allow 
pharmacological activation and manipulation of the locomotor CPG and recording of 
neuronal activity, have been used extensively to study network organisation (Kudo and 
Yamada, 1987; Smith and Feldman, 1987). In isolated spinal cord preparations from 
neonatal mice it is possible to evoke rhythmic activity, which when recorded from 
ventral nerve roots resembles the pattern of walking or running in the intact animal, 
with alternation between bursts of activity recorded from nerves that innervate 
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functional antagonist (right/left and flexor/extensor) muscle groups (Jiang et al., 1999). 
Both in vivo and in vitro preparations have proven to be important tools for advancing 
the understanding of the roles of different types of neurons that are part of the spinal 
locomotor circuitry.  
 
1.2.1. Genetic diversity in spinal neurons 
 To better understand how mammalian spinal circuits generate rhythmicity, 
genetic tools have been used to elucidate the diversity of populations of neurons within 
the spinal cord that contribute to the generation and appropriate assembling of motor 
output. Spinal neurons can be traced based on the restricted expression of specific 
developmental transcription factors. This approach has proven useful to better 
understand the different genetically identifiable neurons that comprise the motor 
networks and are responsible for shaping rhythmic outputs.  
It is during development that different groups of neurons start to arise with 
interneurons (INs) responsible for sensory input being differentiated dorsally while 
motoneurons (MNs) and INs involved in the generation of motor output being aligned 
ventrally. The differentiation of each neuronal subtype in the spinal cord is based on 
signalling gradients that establish a grid-like set of positional cues (Jessell, 2000) 
allowing a spatial division and distinction of 11 neuronal progenitor domains. From 
these, 6 progenitor domains (dl6, V0, V1, V2, V3 and MNs) are thought to produce 
neurons that are part of the locomotor circuitry while the other 5 (dl1, dl2, dl3, dl4 and 
dl5) contribute to sensory networks. Specific transcription factors involved in the 
differentiation of neurons from progenitor domains are used to identify distinct 
populations that may be divided further, into more specific subpopulations (Goulding, 
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2009). Locomotor networks require a high-level of organisation that will produce 
coordination between right and left sides as well as between antagonistic muscles (i.e. 
extensor vs flexor). The interplay between the different genetically identifiable 
populations of CPG INs allows for effectiveness and flexibility of locomotor pattern. 
The developing brain homeobox protein 1 (Dbx-1) is the transcription factor that 
controls the fate of the V0 population of INs that displays a critical role in right-left 
burst alternation (Lanuza et al., 2004). This population can be subdivided into V0V 
(ventral) and V0D (dorsal) INs according to their migration pattern during development. 
The V0v INs are glutamatergic and their identity is consolidated by the expression of 
Even-Skipped Homeobox 1 (Evx1), whereas the V0D population release γ-aminobutyric 
acid (GABA) or glycine (Moran-Rivard et al., 2001; Pierani et al., 2001). Less than 
10% of the V0 neurons give rise to a subpopulation of INs identified by the expression 
of the Paired-like homeodomain 2 transcription factor (Pitx2). These can be subdivided 
into cholinergic and glutamatergic subgroups with the former being recruited during 
locomotion in a task-dependent manner (Zagoraiou et al., 2009).   
The V1 IN population can be identified by the expression of the transcription 
factor Engrailed-1 (En1). V1 INs include Ia inhibitory INs and Renshaw cells (Alvarez 
et al., 2005). Ia inhibitory INs are mostly innervated by sensory afferents and are 
responsible for reciprocal inhibition to antagonistic MN pools whereas Renshaw cells 
are excited by MN axon collaterals and inhibit MN firing thus being involved in 
recurrent inhibition of synergistic MN pools (Renshaw, 1946; Eccles et al., 1954). The 
V1 population can be further fractionated into more specific subsets based on a 
combinatory expression of different transcription factors which give rise to groups of 
INs with distinctive physiology and anatomical properties (Bikoff et al., 2016). V1  INs 
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project to ipsilateral INs as well as MNs and seem to be involved in controlling the 
duration of the locomotor step cycle, thus being essential for fast locomotor output 
(Gosgnach et al., 2006). 
V2 INs project intersegmentally and ipsilaterally in the mammalian spinal cord. 
They express the transcription factor LIM homeobox 3 (Lhx3) and can give rise to 3 
distinct subpopulations (V2a, V2b and V2c). Each subgroup can be traced with a 
specific genetic marker. The identity of the excitatory V2a INs is consolidated by the 
Chx10 transcription factor and this subpopulation is involved in the control of right-left 
alternation (Crone et al., 2008; Clovis et al., 2016). Ablation of inhibitory V2b INs, that 
express GATA binding protein 2/2 (Gata2/3), compromises alternation between 
reciprocal extensor and flexor muscles (Zhang et al., 2014). V2c interneurons are 
known to derive from the same progenitor domain as V2a and V2b subpopulations but 
their exact role in CPG networks is still unclear (Panayi et al., 2010).  
The V3 IN subgroup is involved in fine-tuning the robustness of movement. V3 
INs can be genetically traced by the single-minded homolog 1 (Sim1) transcription 
factor (Zhang et al., 2008). These INs can be further divided into ventral and dorsal 
subpopulations, according to their distribution pattern, which exhibit different 
functional properties. Ventral V3 INs have a more spatially restricted branching and 
generate intense tonic firing, whereas dorsal V3 INs have a more complex arborization 
and fire at low frequencies (Borowska et al., 2013). 
The dI6 interneurons settle in the ventral region of the spinal cord close to the 
central canal of the spinal cord and can display two different functional phenotypes that 
were shown to be rhythmically active, highlighting a possible role in rhythm generation 
(Dyck et al., 2012).  
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Hb9 INs are a group of mostly glutamatergic spinal neurons whose embryonic 
origin is not fully understood. These interneurons do not affect pattern generation since 
they do not seem to be necessary for adequate right-left or extensor-flexor phasing, 
however, they do seem to be involved in controlling the frequency of locomotor activity 
(Caldeira et al., 2017).  
Spinal MNs are the ‘final common pathway’ (Sherrington, 1906) in the spinal 
cord for initiation of movement. MNs originate from the motoneuron progenitor domain 
(pMN) and are located in the ventral horn, most specifically in lamina IX. They release 
acetylcholine (ACh) at the neuromuscular junction (NMJ) which ultimately leads to 
muscle fibre contraction. Neurons responsible for the innervation of visceral muscles 
(e.g. cardiac muscle, gut) will not be addressed in this work and thus the term “MN” 
will only refer to spinal neurons that project from the ventral horn and synapse onto 
skeletal muscle fibres. MNs receive a variety of motor and sensory-motor inputs from 
INs that contribute to the refinement of movement. There are 3 subtypes of MNs: (i) 
alpha (ii) beta and (iii) gamma MNs. Gamma MNs are important in adjusting the 
sensitivity of muscle spindles, which are sensory organs within the body of a muscle 
that detect changes in muscle length and control stretch responsiveness to prevent 
overstretching and maintain muscle tone. Alpha and beta MNs are responsible for the 
generation and maintenance of muscle contraction. Alpha MNs have large cell bodies 
and form synapses with extrafusal muscle fibres thus initiating skeletal muscle 
contraction. Beta MNs are smaller than alpha MNs and innervate both extrafusal and 
intrafusal fibres thus also adjusting the stretch responsiveness at the muscle spindle 
(Stifani, 2014).  
18 
 
Despite its complexity, the mammalian CPG exhibits some degree of 
conservation of the organisation that is present in other systems. The generation of 
rhythmicity by the crustacean stomastogastric ganglion (Marder and Bucher, 2001), 
lamprey (Ekeberg and Grillner, 1999) and Xenopus tadpole swimming networks 
(Ekeberg and Grillner, 1999), Drosophila larvae crawling circuit (Wystrach et al., 2016) 
and leech heartbeat network (Weaver et al., 2010) involves reciprocal inhibition that 
secures coordination and adequate oscillatory patterns. In the mammalian spinal cord, 
reciprocal inhibition is important for the generation of right-left as well as extensor-
flexor alternation, which sets the stage for appropriate locomotor pattern. Besides the 
diversity in neuronal subtypes (figure 1.1), modulation of spinal networks can account 
for adaptable changes to network output, which are required to suit varying 
biomechanical and behavioural demands.  
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Figure 1.1 – schematic of the functional organization of the different subtypes of INs 
that comprise the mammalian CPG. Locomotor networks comprise a bilateral network 
with extensor and flexor, pattern and rhythm generating modules. Populations of 
genetically identified INs (blue circles) interact with each other through excitation 
(arrows) or inhibition (bars) to generate and sustain adequate locomotor behaviour. 
Adapted from Acton & Miles 2017.  
 
 
 
 
 
 
 
20 
 
1.3. Neuromodulation of spinal locomotor networks 
Different locomotor behaviours are necessary for survival in mammals. Change 
in speed is required for a prey to escape from a predator, climbing a tree might be 
crucial to search for food and crawling might be necessary to shelter from adverse 
environmental conditions. In order to respond to these variable locomotor demands, the 
CPG needs to adapt and change motor output. Neuromodulation can alter synaptic 
function and the intrinsic properties of spinal neurons leading to changes in the speed, 
coordination or strength of rhythmic motor output. Modulators can arise from higher 
brain areas (extrinsic modulators) or from sources within the spinal cord (intrinsic or 
local modulators) (Miles and Sillar, 2011).  
 
1.3.1. Extrinsic neuromodulators  
Projections from the brainstem, cortex and other supraspinal nuclei can affect 
spinal locomotor output. The sources and roles of three of the most studied extrinsic 
modulators: 5-hidroxitriptamine or serotonin (5-HT), noradrenalin (NA) and dopamine 
(DA), are discussed below.  
 
1.3.1.1. Serotonin 
The first insights into the role of 5-HT in CPG networks came from studies in 
the lamprey spinal cord (Harris-Warrick and Cohen, 1985) and the stomatogastric 
ganglion of the lobster (Marder and Eisen, 1984), which showed that 5-HT affected 
rhythmic motor behaviours. In mammals, 5-HT originates from descending pathways 
that project from the raphei nuclei in the brainstem (Lakke, 1997). Stimulation of 
serotonergic neurons from the parapyramidal region of the mid-medulla can elicit 
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rhythmic locomotor-like activity in the isolated spinal cord of the rat (Liu and Jordan, 
2005). In the rat it has been shown that 5-HT can initiate and modulate locomotor 
output since 5-HT-containing descending INs were activated after MLR stimulation and 
were able to produce locomotor rhythm through the activation of 5-HT7 receptors 
(Cabaj et al., 2017). In comparison, in isolated spinal cords, 5-HT2 antagonists were 
shown to be able to block 5-HT induced patterns of activity (Cazalets et al., 1992). On 
the other hand, in N-Methyl-D-aspartic acid (NMDA)-induced fictive locomotion, 
activation of the 5-HT1 receptor can have an inhibitory effect (Beato and Nistri, 1998). 
Therefore 5-HT might have both excitatory and inhibitory actions through the activation 
of 5-HT7/5-HT2 and 5-HT1 receptors, respectively. At the single cell level 5-HT 
depolarizes spinal INs and MNs reducing action potential threshold (Elliott and Wallis, 
1992; Fedirchuk and Dai, 2004). In commissural INs, 5-HT increases N-, P/Q and L-
type Ca2+ currents (Abbinanti & Harris-Warrick 2012; Abbinanti et al. 2012). The 
variety of mechanisms by which 5-HT shapes locomotor network excitability suggests 
that this transmitter system has a powerful modulatory influence on spinal circuits 
involved in the control of movement. 
 
1.3.1.2. Noradrenalin 
Neurons projecting from the locus ceruleus of the brainstem to the spinal cord 
are the main sources of NA (Nygren and Olson, 1977). NA can induce episodes of 
hindlimb locomotion in spinalised cats (Barbeau and Rossignol, 1991). In neonatal rat 
in vitro spinal cord preparations, NA can elicit slow patterns of right-left alternating 
motor activity, which were dependent on α1-adrenoreceptors. During NMDA-induced 
locomotion, activation of α2 and β adrenoreceptors slows down the rhythm while the α1 
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subtype increases the frequency (Sqalli-Houssain and Cazalets, 2000). In the neonatal 
mouse, electrical stimulation of the cauda-equina can evoke a regular alternating rhythm 
that can be slowed down by α1 agonists, which increase burst duration, or silenced by 
α2 agonists (Gordon and Whelan, 2006). These effects might reflect the variety of 
different cellular mechanisms that can be triggered by activation of adrenergic 
receptors, which have a widespread distribution in the spinal cord (Noga et al., 2009). 
Activation of α1-adrenoreceptors decreases the medium afterhyperpolarization phase 
(mAHP), increases the total persistent inward current and depolarizes cat MNs (Lee and 
Heckman, 1999). Meanwhile, exogenous NA decreases inward rectifying K+ currents 
(IKIR) in neonatal rat MNs (Maylis Tartas et al., 2010). In ventral horn INs, activation of 
the noradrenergic system through brainstem stimulation can hyperpolarize the voltage 
threshold, which was suggested to contribute to a monoaminergic mechanism for 
initiation of locomotion and facilitation of spinal reflexes (Fedirchuk and Dai, 2004). 
The actions of NA on the locomotor network are variable and underlie a strong 
modulation of the mammalian spinal motor circuitry.    
 
1.3.1.3. Dopamine 
 The first studies on the role of dopaminergic modulation of locomotor circuits 
came from experiments in the spinalised cat where application of L-DOPA could 
modulate reflex circuits and promote locomotor activity (Jankowska et al., 1967). The 
main sources of spinal DA in mammals were later shown to derive from projections 
originating from the A11 nuclei of the posterior hypothalamus (Skagerberg and 
Lindvall, 1985). These descending projections act on the excitatory D1-like (D1 and D5) 
and inhibitory D2-like (D2, D3 and D4) families of DA receptors, which are known to 
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be widely distributed throughout the lumbar spinal cord (Zhu et al., 2007). D1-like 
receptors are mostly expressed in the ventral horn where CPG neurons are located while 
D2-like receptors are present in the dorsal horn and might be involved in nociception 
(Zhu et al., 2007). DA is released during locomotion (Gerin and Privat, 1998) and can 
elicit fictive locomotor-like rhythmic bursts in the cat (Kiehn and Kjaerulff, 1996), rat 
(Kiehn and Kjaerulff, 1996) but not in mice (Sharples and Whelan, 2017). In the 
neonatal mouse spinal cord, DA seems to play a role in shaping drug-induced locomotor 
output by reducing the frequency, increasing the amplitude and contributing to burst 
regularity. This action is dependent on the excitation state of the network (Sharples et 
al., 2014; Sharples and Whelan, 2017). The robust modulatory actions of DA reflect a 
variety of cellular mechanisms triggered by the activation of dopamine receptors on 
CPG neurons and MNs. In the neonatal mouse spinal cord, DA has been shown to 
increase MN excitability by decreasing first spike latency and the mAHP. These effects 
were attributed to the negative regulation of A-type K+current (Ia) and the small 
conductance Ca2+-activated K+channel (SK) along with an increase in glutamatergic 
inputs to MNs (Han et al., 2007). The increase in glutamatergic inputs through AMPA 
receptor activation in MNs is mediated by D1 receptors (Han and Whelan, 2009). On a 
particular population of CPG neurons - Hb9 INs – DA increased their oscillatory 
activity which resulted in increased excitation (Han et al., 2007). DA has been recently 
described as a positive modulator of the Na+/ K+ ATPase, which underlies an ultra-slow 
AHP (usAHP) in mouse MNs and is responsible for activity-dependent changes in 
active locomotor networks (Picton et al., 2017). DA is therefore an important extrinsic 
modulator that contributes to the shaping of rhythmic motor output by acting on both 
MNs and CPG INs. 
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1.3.2. Intrinsic modulators 
 Local or intrinsic modulators arise from within the spinal cord and contribute to 
functional changes in CPG networks. They can help to adjust the speed, duration, 
coordination and strength of the motor output depending on the type of neuromodulator 
that is being released (Miles and Sillar, 2011).  
Classic neurotransmitters that convey motor commands via activation of fast, 
ionotropic receptors can also act as modulators of spinal function. Glutamatergic INs 
are present in the spinal cord and are part of an important excitatory drive within the 
CPG network (Goulding, 2009). Intrinsic glutamate can act on group 1 metabotropic 
glutamate receptors which results in a decrease in motor output by reducing fast 
inactivating Na+ currents in mouse MNs (Iwagaki and Miles, 2011). GABA that arises 
from a variety of inhibitory INs in the spinal cord has been shown to decrease excitatory 
synaptic drive to MNs ultimately resulting in reduced firing and reduced burst 
amplitude (Bertrand, 1999). ACh can be released from dorsal and ventral horn INs 
(Oguz Kayaalp and Neff, 1980; Gillberg et al., 1988) and can increase neuronal 
excitability to affect locomotor output in rats (Kiehn et al., 1996; Jordan et al., 2008).  
Other molecules are also known to fine-tune CPG function. Adenosine, derived 
from astrocytes, acts on inhibitory A1 adenosine receptors located on CPG INs to 
modulate the frequency of drug-induced locomotor activity (Witts et al., 2012, 2015; 
Acton and Miles, 2017). Nitric oxide, which is presumably released by both dorsal and 
lamina X INs, has been shown to modulate the timing and intensity of fictive motor 
output (Foster et al., 2014). Peptides and peptide receptors are present in both dorsal 
and ventral horns of the spinal cord indicating the presence of an endogenous 
25 
 
peptidergic modulation of spinal circuits (Heuer et al., 2000; X. Liu et al., 2003). 
Different neuropeptides have been shown to promote modulation of rhythmic output in 
the neonatal mouse spinal locomotor network (Barriere et al., 2005).  
An important factor to consider when studying neuromodulation is that one 
modulator may change the role of another modulatory system. This second-order effect, 
known as metamodulation, can allow one modulator to have an excitatory or inhibitory 
effect on the modulation exerted by another modulatory system (Miles and Sillar, 
2011). For example, glial-derived adenosine exerts its actions on the locomotor CPG 
through the modulation of DA signalling within the mouse spinal cord. Adenosine, 
acting via A1 receptors, inhibits the intracellular pathway downstream of D1 receptor 
activation, thus affecting dopaminergic modulation during drug-induced locomotion 
(Acevedo et al., 2016; Acton and Miles, 2017). Another example of metamodulation is 
present in the swimming networks of Xenopus larvae tadpoles where nitric oxide 
modulates the release of NA in the spinal cord (McLean and Sillar, 2004). These 
examples demonstrate that metamodulation is an important mechanism in the regulation 
of the function of spinal motor networks (Miles and Sillar, 2011). 
The experiments described in this thesis aimed to increase our understanding of 
one of the major intrinsic modulators of the mammalian locomotor CPG, ACh, for 
which many questions remain regarding its exact sources, roles and mechanisms of 
modulation. The sections below will address current knowledge of cholinergic 
modulation of spinal circuits. 
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1.4. Cholinergic modulation of locomotor circuits 
 Early studies highlighted ACh and its analogues as being responsible for the 
generation of muscle contraction (Bacq and Brown, 1936, 1937; Mcdowall and Watson, 
1951). Groups of large cholinergic neurons, later referred to as MN pools (Romanes, 
1951), were identified in the ventral horn of the spinal cord and it was shown that these 
cholinergic neurons innervated specific muscles according to their position in the 
periphery (Hollyday et al., 1977; Landmesser, 1978).  
The role of ACh within spinal locomotor networks initially attracted less 
attention. The concentrations of ACh and activity of ACh-esterase were shown to be 
lower in the spinal cord compared to the neuromuscular junction (Eccles et al., 1956; 
Mitchell and Phillis, 1962). Early studies showed that exogenous ACh has both 
excitatory and inhibitory actions during ventral or dorsal root stimulation, with the 
opposing roles hypothesised to depend upon ACh concentration and the state of activity 
of the spinal cord (Eccles, 1947; Eccles et al., 1956; Fernandez-de-Molina et al., 1957; 
Mitchell and Phillis, 1962). Injection of ACh into the spinal cord was first shown to 
increase the electrical activity recorded from cervical rootlets in the cat (Feldberg et al., 
1953). Renshaw cells, a major population of glycinergic INs located close to MN pools, 
were first found to be activated through antidromic stimulation of motor nerves and 
were thought to account for the early descriptions of the effects of ACh and ACh-
esterase inhibitors on the spinal cord (Eccles et al., 1954, 1956). Ventral root discharges 
in response to ACh and depressant actions on spinal reflexes were later found on the cat 
lumbrosacral cord (Fernandez-de-Molina et al., 1957). These early descriptions of ACh 
were the first evidence of cholinergic neuromodulatory effects in the spinal cord.  
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ACh can act on both ionotropic nicotinic (nAChR) and metabotropic muscarinic 
(mAChR) receptors. Early studies of the distribution of ACh receptors in the spinal cord 
suggested greater expression of mAChRs compared to nAChRs, with the former being 
mostly present in the ventral horn whereas ionotropic nAChRs are generally localized in 
the dorsal horn (Oguz Kayaalp and Neff, 1980; Gillberg et al., 1988). Besides having 
different patterns of expression throughout the spinal cord, both nAChRs and mAChRs 
are involved in the control of both sensory and motor outputs within spinal circuits. 
 
1.4.1. Spinal sources of acetylcholine 
Most of the knowledge on the ACh receptors derives from insights obtained 
from functional approaches with very limited evidence available on the precise receptor 
distribution in the spinal cord. A slowing step has been the poor description of the 
different populations of cholinergic INs in the spinal cord. There are different, discrete 
groups of cholinergic INs both in the dorsal and ventral horns of the spinal cord. The 
cholinergic INs located dorsally are found in laminae II-IV and are involved in 
nociception and inhibition of cutaneous afferent input by modulating GABA and 
glycine release. These cholinergic dorsal INs do not seem to affect locomotor circuitry 
involved in the generation of rhythmic motor patterns (Todd, 1991; Kurihara et al., 
1993; Bordey et al., 1996; Garraway and Hochman, 2001; Olave et al., 2002; Stewart 
and Maxwell, 2003; Genzen and McGehee, 2005; Seddik et al., 2006, 2007; Wang et 
al., 2006; Takeda et al., 2007; H. M. Zhang, Zhou, et al., 2007; H. Zhang et al., 2007; 
Cai et al., 2009; Shelukhina et al., 2009; Zhang et al., 2009; Mesnage et al., 2011; Liu 
et al., 2011; Pawlowski et al., 2013; Jeong et al., 2013; Chen et al., 2014). The 
remaining non-dorsal INs that release ACh in lumbar sections of the mammalian spinal 
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cord seem to be restricted to laminas VII and X (Gillberg et al., 1988, 1990; Sherriff 
and Henderson, 1994; Bertrand and Cazalets, 2011). These include a group of 
bilaterally projecting cholinergic INs known as partition cells present in lamina VII 
close to the central canal (Sherriff and Henderson, 1994; Bertrand and Cazalets, 2011), 
Pitx2+ INs (Miles et al., 2007; Zagoraiou et al., 2009), GABAergic and cholinergic 
cluster cells (Gotts et al., 2016), and other unidentified groups of cholinergic INs 
scattered around this area (Oguz Kayaalp and Neff, 1980; Gillberg et al., 1988, 1990; 
DenbSchäfera and Eidenb, 1998; Kobayashi et al., 2002; Carlin, 2005; Liu et al., 2009; 
Bertrand and Cazalets, 2011). From all these studies, Pitx2+ INs remain the only group 
of cholinergic INs that can be genetically traced thus providing a reliable tool to study 
muscarinic modulation of spinal locomotor networks. Using Cre-lox recombination it 
has been possible to visualize Pitx2+ INs and perform anatomical and functional studies 
of this subpopulation (Zagoraiou et al., 2009). 
 
1.4.2. Nicotinic acetylcholine receptors 
In the Central Nervous System nAChRs are made up of 5 different subunits that 
can be divided into two distinct classes, either α (α2-α9) or β subunits (β2-β4). The 
assembly of specific subunits structurally and functionally defines the type of nAChR 
and its ionic conductance. Binding studies have suggested the presence of different 
types of subunits of nAChRs in the spinal cord (Khan et al., 2003). However, the 
heteromeric α4β2 nAChR that is permeable to both Na+ and K+, and the homomeric α7-
subunit containing receptor that is highly permeable to Ca2+, are the two subtypes of 
nAChRs that have been functionally described in the spinal cord (Alvarez et al., 1999; 
A. Bradaïa and Trouslard, 2002). Despite not having a pronounced role in the 
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cholinergic modulation of CPG networks involved in hindlimb locomotion (Jordan et al. 
2014), nAChRs do seem to be important for the activation of Renshaw Cells (Alvarez et 
al., 1999; Mentis et al., 2005; Nishimaru et al., 2005; Lamotte d’Incamps and Ascher, 
2008; Shelukhina et al., 2009; O’Donovan et al., 2010), the regulation of GABA and 
glycine release in the dorsal horn and near the central canal (Ren and Greer, 2003; 
Seddik et al., 2006; Gonzalez-Islas et al., 2016), nociceptive signalling (Garraway and 
Hochman, 2001; Bradaïa et al., 2005; Takeda et al., 2007; Shelukhina et al., 2009), 
viscerosensory transmission (Bordey et al., 1996; A Bradaïa and Trouslard, 2002; 
Bradaïa et al., 2005; Seddik et al., 2006; Ogier et al., 2008) and embryonic 
development of locomotor networks  (Milner and Landmesser, 1999; Ren and Greer, 
2003; Myers et al., 2005).  
In the dorsal horn, nAChRs are thought to be involved in the inhibition of 
nociceptive signalling via facilitation of inhibitory transmission to dorsal INs, mainly 
through α4β2 and α7-subunit containing nAChRs (Garraway and Hochman, 2001; 
Bradaïa et al., 2005; Takeda et al., 2007; Shelukhina et al., 2009). Activation of 
nAChRs has also been implicated in the control of GABA and glycine release in the 
dorsal horn and near the central canal (A. Bradaïa and Trouslard, 2002; Ren and Greer, 
2003; Bradaïa et al., 2005; Seddik et al., 2007; Gonzalez-Islas et al., 2016). This 
cholinergic downregulation of inhibitory release during development helps to maintain 
sufficient spontaneous network activity in the embryonic network thus contributing to 
appropriate assembly of network connectivity and synaptic fidelity (Ren and Greer, 
2003; Gonzalez-Islas et al., 2016). The actions of nAChRs on GABAergic and 
glycinergic transmission are also involved in the modulation of sympathetic 
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preganglionic neurones (Seddik et al., 2007) and lamina X INs (Bradaïa & Trouslard 
2002; Bradaïa et al. 2005) in the neonatal rat. 
The non-selective nAChR blocker, tubocurarine, has no effect on ACh-induced 
excitation of rat lumbar locomotor networks, achieved using ACh-esterase inhibitors 
(Jordan et al., 2014), suggesting that nAChRs do not have a prominent role in the 
modulation of the spinal CPG. However, nAChRs are involved in the activation of 
Renshaw cells whose activation by MNs modulates inhibitory inputs back to MNs thus 
resulting in recurrent inhibition. MNs have axon collaterals that project back into the 
spinal cord and contact Renshaw cells. At these synapses MNs release glutamate and 
ACh with blockade of nAChRs containing α4β2 and α7-subunits reducing the effect of 
MN activation on Renshaw cells (Alvarez et al., 1999; Mentis et al., 2005; Nishimaru et 
al., 2005; Lamotte d’Incamps and Ascher, 2008; O’Donovan et al., 2010). Despite the 
lack of evidence of involvement of nAChRs in the generation of locomotor activity in 
the newborn rat (Jordan et al., 2014), in early embryonic stages nAChRs seem to be 
responsible for bursts of patterned locomotor-like activity (Milner and Landmesser, 
1999; Hanson and Landmesser, 2003; Myers et al., 2005) which are important for 
appropriate assembly of spinal locomotor circuitry during development (Myers et al., 
2005).  
 
1.4.3. Muscarinic acetylcholine receptors 
There are 5 types of mAChRs (M1-M5) found in the central nervous system 
(Scarr, 2012). Within the spinal cord, only M2 and M3 muscarinic receptors appear to 
play an active role in the modulation of sensory and motor networks (Kurihara et al., 
1993; Jordan et al., 2014). M2 muscarinic receptors act via Gi proteins which decrease 
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the levels of cAMP generally leading to inhibitory effects, whereas M3 receptors are 
coupled to the Gq class of proteins which activate phospholipase C and up-regulate the 
intracellular levels of Ca2+ resulting in excitation. In addition to their canonical 
pathways, in the central nervous system mAChRs can activate multiple signalling 
cascades that depend on the type of synapse being studied making it difficult to predict 
the physiological consequences of the activation of a certain subtype of receptor (Scarr, 
2012). Therefore, throughout this work, the role of both M2 and M3 muscarinic 
receptors will be detailed and explored based on physiological evidence from previous 
works and the data obtained. 
Application of muscarine to isolated segments of the cat spinal cord provided 
early evidence of the presence of excitatory muscarinic receptors on lateral horn cells 
(Yoshimura and Nishi, 1982). In later studies, muscarine was shown to depolarize rat 
MNs (Jiang and Dun, 1986) and also brainstem astrocytes (Hösli et al., 1988). Early 
immunohistochemical and binding studies indicated the presence of mAChRs in the 
spinal cord (Oguz Kayaalp and Neff, 1980; Gillberg et al., 1988). The density of 
mAChRs is greater in the ventral horn compared to the dorsal horn (Oguz Kayaalp and 
Neff, 1980), which could suggest that these receptors have a more prominent role in the 
modulation of CPG networks involved in the generation of rhythmic motor patterns. 
The precise location of M2 and M3 muscarinic receptors in the spinal cord has not been 
completely characterized. Autoradiographic studies have indicated the presence of M2 
receptors in both ventral and dorsal horns whereas M3 receptors were mostly present in 
the dorsal horn (Höglund and Baghdoyan, 1997). In adult rats, large MNs (diameters 
greater than 35µm) displayed intense immunorreactivity across the plasma membrane 
for the M2 receptor whereas small MNs were weakly labelled (Welton et al., 1999). 
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Large MN somas are usually attributed to alpha MNs whereas small MN cell bodies are 
presumably gamma MNs, thus, M2 receptor expression might vary across different MN 
subtypes (Welton et al., 1999). In another study it was shown that clusters of the M2 
receptor on MNs were juxtaposed with large, cholinergic C-bouton terminals (Hellström 
et al., 2003) that were later revealed to derive from Pitx2+ INs (Miles et al., 2007; 
Zagoraiou et al., 2009). The distribution of M3 muscarinic receptors on MNs is less 
understood with immunohistochemical studies suggesting that these receptors are 
present in fine cytoplasmic puncta on MNs (Wilson et al., 2004).  
 
1.4.3.1. Role of mAChRs in the modulation of spinal locomotor 
networks 
The first evidence of a modulatory role for muscarinic receptors within spinal 
circuits came from studies performed in the neonatal rat in which ventral root potentials 
were recorded after electrical stimulation of the saphenous nerve in isolated spinal cord-
saphenous nerve preparations or after application of noxious skin stimuli in isolated 
spinal cord-saphenous nerve-skin preparations (Kurihara et al., 1993). This work 
demonstrated that activation of M2 muscarinic receptors decreased whereas activation 
of M3 receptors increased saphenous nerve-evoked potentials. M2 receptor activation 
also potentiated the ventral root potential evoked by capsaicin application to skin 
(Kurihara et al., 1993). This highlighted a role for muscarinic modulation of spinal 
networks involved in nociceptive transmission. Due to the presence of mAChRs in the 
dorsal horn it would be expected that these receptors would play a role in the regulation 
of sensory inputs. In addition, likely due to the prevalence of mAChRs in the ventral 
33 
 
horn, a prominent role for mAChRs in the modulation of CPG networks was also later 
described.  
To understand the modulatory role of cholinergic receptors in mammalian spinal 
locomotor circuits researchers have recorded ventral root output in isolated neonatal rat 
spinal cords while increasing the levels of ACh. Elevation of ACh levels in the spinal 
cord of the neonatal rat can be achieved by exogenous application of ACh or inhibition 
of the ACh-esterase enzyme (Cowley and Schmidt, 1994, 1997; Kiehn et al., 1996; 
Jordan et al., 2014). Although both methods have been shown to induce locomotor-like 
bursts of activity, the activity is erratic and does not exhibit appropriate alternation 
between left and right sides and antagonist muscles. Thus elevation of ACh probably 
leads to an increase in the excitability of the CPG network that does not contribute to 
adequate rhythm. The use of muscarinic antagonists revealed that these locomotor-like 
bursts are initiated by the activation of M3 muscarinic receptors that excite CPG 
neurons. On the other hand, M2 antagonism decreased the amplitude of ACh-induced 
activity, suggesting that this receptor subtype might be important in the modulation of 
the strength of the motor output. The use of nicotinic receptor blockers and other 
muscarinic receptor antagonists did not affect ACh-elicited bursts, revealing that M2 
and M3 muscarinic receptors are solely responsible for cholinergic modulation of CPG 
networks in the rat (Jordan et al., 2014). Muscarine has also been shown to evoke 
irregular bursts of activity in the neonatal mouse spinal cord (Jiang et al., 1999) with 
M2 receptor blockade decreasing burst amplitude during NMDA, DA and 5-HT-
induced locomotion (Miles et al., 2007).  
Groups of cholinergic INs in the sacral region of the spinal cord project rostrally 
to the lumbar segments and modulate the locomotor CPG through M2 muscarinic 
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receptor activation. Electrical stimulation of sacral afferents in the neonatal rat can 
evoke rhythmic bursts of activity that can be recorded through suction electrodes 
attached to lumbar ventral roots (Etlin et al., 2014; Finkel et al., 2014; Anglister et al., 
2017). Restricted application of ACh-esterase inhibitors to the sacral region of the 
spinal cord during stimulation increases burst amplitude and slows the frequency of the 
lumbar rhythm. Both of these effects are blocked by M2 muscarinic receptor 
antagonism. Anatomical studies have shown that clusters of cholinergic neurons provide 
ascending excitatory projections from the sacral segments of the spinal cord into the 
lumbar region through the ventral funiculus and the lateral white matter funiculi. These 
groups of rostral projecting cholinergic sacral neurons are thought to mediate the 
described physiological network effect of ACh (Etlin et al., 2014; Finkel et al., 2014; 
Anglister et al., 2017).  
The limited studies of the role of M2 and M3 muscarinic receptors in 
mammalian locomotor circuits suggests that these receptors differently modulate 
rhythmic output. M3 muscarinic receptors are important in the cholinergic activation of 
neurons within the locomotor network that might drive the CPG (Jordan et al., 2014) 
whereas M2 receptors seem to regulate the amplitude of the motor output (Miles et al., 
2007; Jordan et al., 2014; Anglister et al., 2017). These actions of M2 and M3 receptors 
on locomotor output might reflect the effects of ACh on the cellular properties of 
different spinal INs and MNs that comprise the mammalian locomotor circuits. 
 
1.4.3.2. Physiological effects of mAChRs on spinal INs and MNs 
The effects of muscarinic receptor activation have been studied in both dorsal 
and ventral INs as well as in MNs. These effects are likely to account for the previously 
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described actions of muscarinic receptors on sensory and motor networks. In spinal 
sensory circuits, M2 and M3 muscarinic receptors are involved in afferent fibre-evoked 
nociception in the neonatal rat spinal cord (Kurihara et al., 1993). In the dorsal horn M3 
receptors potentiate glycinergic release whereas the M2 subtype enhances the release of 
GABA and reduces the release of glutamate to INs  which are important for spinal 
nociception (Wang et al., 2006; Cai et al., 2009; Zhang et al., 2009; Jeong et al., 2013; 
Chen et al., 2014).  
A range of different effects of muscarinic receptor activation has been observed 
in ventral horn INs that are part of the mammalian CPG. In the neonatal rat spinal cord, 
application of muscarine depolarizes INs located around the central canal, increases the 
amplitude of voltage dependent burst oscillations and leads to a more unstable 
locomotor rhythm when coapplied with NMDA and 5-HT (Kiehn et al., 1996). 
Experiments using organotypic spinal cord slices from rat embryos have demonstrated 
that exogenous application of muscarine increases intrinsic spiking in the ventral horn 
area by depolarizing and triggering firing in silent spinal neurons (Czarnecki et al., 
2009). In mice expressing the enhanced green fluorescent protein (EGFP) driven by the 
c-fos promoter it is possible to visualize active INs after perfusion of locomotor drugs 
or behavioural tasks. In EGFP+ INs from these animals, ACh increased firing output, 
decreased action potential threshold, increased input resistance, decreased mAHP 
amplitude and decreased the hyperpolarization activated current (Ih) (Dai et al., 2009; 
Dai and Jordan, 2010). Given their role in whole locomotor network output (Jordan et 
al., 2014), it would be expected that these observations reflect modulation of M2 and 
M3 muscarinic receptors in INs. However, this remains to be determined because M2 
and M3 receptor antagonists were not employed in these previous studies.  
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Studies focused on the characterization of cholinergic modulation of MNs have 
revealed a variety mAChR-dependent mechanisms affecting MN excitability. In the 
salamander spinal cord, muscarine increases MN firing output, decreases the mAHP, 
decreases the hyperpolarization activated current (Ih), positively modulates IKIR but has 
no effect on spike amplitude, width or input resistance (Chevallier et al., 2006, 2008). 
Recordings from MNs from neonatal mouse spinal cord slices have also demonstrated a 
muscarine-induced increase in MN firing output that is dependent on M2 receptor 
activation and appears to result from a decrease in the mAHP amplitude which leads to 
an increase in the number of evoked spikes (Miles et al., 2007). A group of bilaterally 
projecting cholinergic INs in lamina VII close to the central canal, known as partition 
cells, (Sherriff and Henderson, 1994), and commissural cholinergic INs located in 
lamina X (Bertrand and Cazalets, 2011) are known to project to contralateral MNs. 
These cholinergic INs are thought to enhance locomotor output by causing the closure 
of the slowly activating voltage-regulated K+ current (M-current), which is dependent 
on muscarinic receptor activation (Bertrand and Cazalets, 2011). M3 muscarinic 
receptors present at the synapses between these commissural cholinergic terminals and 
MNs were suggested to be involved in this modulation which is also able to depolarize 
MNs (Bertrand and Cazalets, 2011). The synaptic drive to MNs mediated by mAChRs 
has been shown to originate from ventromedial INs near the central canal (which 
includes Pitx2+ INs), thus suggesting that muscarinic modulation of locomotor output 
might be anatomically restricted to this area in the spinal cord (Gillberg et al., 1988, 
1990; Sherriff and Henderson, 1994; Bertrand and Cazalets, 2011). 
Cholinergic-dependant changes in the output of INs involved in rhythm stability 
(Kiehn et al., 1996; Dai et al., 2009; Dai and Jordan, 2010) and MNs (Chevallier et al., 
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2006, 2008; Miles et al., 2007) indicate that ACh modulates cellular properties of 
neurons that shape both the rhythm as well and the strength of motor bursting. The 
cholinergic modulation of CPG INs and MNs will shape the network output recorded 
from ventral root bursting (Jordan et al., 2014).  
Despite the above-mentioned studies, the cellular mechanisms and the exact role 
of M2 and M3 muscarinic receptor-mediated modulation of the mammalian locomotor 
CPG remains to be fully addressed. Although studies have addressed M2 and M3 
receptor-mediated modulation of ACh-induced bursts of activity (Cowley and Schmidt, 
1994, 1997; Kiehn et al., 1996; Jordan et al., 2014), this output lacks the physiological 
pattern of locomotor-like rhythm  which is observed during NMDA, DA and 5-HT-
induced bursting (Jiang et al., 1999). The majority of the studies performed on INs and 
MNs only assessed the pharmacological effects of ACh and the non-selective 
muscarinic receptor antagonist oxotremorine (Dai et al., 2009; Dai and Jordan, 2010), 
which prevents any conclusions from being drawn regarding the receptor subtypes 
involved. The work described in this thesis attempts to provide valuable information 
regarding the physiological effects of M2 and M3 muscarinic receptors on MN function 
and understand the impact of this muscarinic modulation in appropriate alternating and 
rhythmic lumbar locomotor activity. Another impediment towards a more complete 
understanding of muscarinic actions on spinal motor circuits is the lack of well-defined 
genetic markers for cholinergic neurons in the spinal cord. Taking advantage of the Cre-
lox genome engineering technology, the work in this thesis also focused on 
understanding the role of genetically traceable cholinergic, Pitx2+ INs in the control of 
locomotor networks.  
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1.5. Pitx2+ spinal cholinergic INs 
Cholinergic, Pitx2+ INs of the spinal cord are known to form specialised 
synaptic contacts with MNs, termed C-boutons. C-boutons were first described in early 
studies characterizing the structure of different synaptic contacts on cat MNs. In these 
early studies large C-shaped presynaptic terminals that synapsed with MNs were termed 
C-boutons (Conradi, 1969; Conradi and Skoglund, 1969). C-boutons were later reported 
in different animals including humans (Pullen et al., 1992) and mice (Wilson et al., 
2004).  The cellular origin of C-bouton synapses was unknown when they were first 
described. Later work provided evidence that C-boutons expressed cholinergic markers 
(Li et al., 1995). It was eventually found that C-boutons derive from cholinergic INs 
clustered around the central canal, which are marked by expression of the transcription 
factor Pitx2 (Miles et al., 2007; Zagoraiou et al., 2009).  
Several proteins have been identified at C-bouton synapses. The M2 muscarinic 
receptor is located postsynaptically along with the voltage-gated K+ channel 2.1 
(Kv2.1), N-type Ca2+ channels and the SK channel (Wilson et al., 2004; Deardorff et 
al., 2014). Postsynaptic sigma-1 receptors have also been identified at the C-bouton 
synapse beneath the plasma membrane, on subsurface cisternae (Mavlyutov et al., 
2012). Immunolabelling studies have suggested the presence of nAChRs (Khan et al., 
2003), urotensin II receptors (Bruzzone et al., 2010) and ATP receptors (Deng and 
Fyffe, 2004) at the presynaptic site.  
Genetic tools have facilitated detailed studies of the anatomy and function of C-
boutons in spinal networks. Although cholinergic C-boutons derive from Pitx2+ INs, 
this population of INs can be subdivided into two different phenotypes: cholinergic 
Pitx2+ neurons that express choline acetyltransferase (ChAT) and vesicular 
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acetylcholine transporter (vAChT), and glutamatergic Pitx2+ neurons that express 
vesicular glutamate transporter 2 (vGlutT2). At the upper lumbar level Pitx2+ INs are 
predominantly cholinergic. The majority of Pitx2+ INs that express vGlutT2 are found 
in more caudal segments. In the lumbar cord, cholinergic Pitx2+ INs are outnumbered 
by MNs by a factor of 1:10 with each individual Pitx2+ IN forming up to 1000 synapses 
with MNs resulting in approximately 80-100 C-bouton contacts per MN. This high 
innervation rate is suggestive of a general modulatory role in MN function. The 
majority of Pitx2+ INs project ipsilaterally, while one third also branch contralaterally. 
Cholinergic Pitx2+ INs also appear to project to spinal INs around the ventromedial 
area, however the specificity of this connection is unclear (Zagoraiou et al., 2009). It 
has also been suggested that the distribution of modulatory inputs from cholinergic cells 
around the central canal (which includes Pitx2+ INs) might be more complex. Some of 
these cholinergic INs project ipsilaterally whereas others bifurcate bilaterally through 
several segments of the lumbar spinal cord (Stepien et al., 2010). Recent work has 
shown that terminals from neurons of the lateral vestibular nucleus involved in co-
activation of extensor and flexor muscles, that are important for postural control, were 
found near cholinergic Pitx2+ INs. Authors suggested that perhaps these INs might be 
part of a pathway involving MN modulation through Pitx2+ INs, resulting in muscle co-
activation (Murray et al., 2018). In fact, bilateral projecting cholinergic INs have been 
observed to project to MN pools responsible for the control of posture (Stepien et al., 
2010).  
Given the complex anatomy of Pitx2+ INs, functional readouts have provided 
much of the insights into the physiological effects of these INs on locomotor output. 
Most of the Pitx2+ INs are tonically active at rest and receive glutamatergic, 
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GABAergic and serotonergic inputs that might drive Pitx2+ INs  activity (Zagoraiou et 
al., 2009). These inputs are not derived from premotor spinal INs (Stepien et al., 2010), 
suggesting that this subpopulation receives connections from different descending 
and/or local projections that could trigger activation of Pitx2+ INs. In fact, their spiking 
increases during fictive locomotion (NMDA, DA and 5-HT-induced) with firing 
patterns that are in phase with segmentally-aligned ventral root bursts (Zagoraiou et al., 
2009). Since cholinergic Pitx2+ INs are part of the locomotor network, provide 
modulatory inputs to MNs and are active during locomotion, behaviour experiments 
were carried out to understand the role of this population in adult animals (Zagoraiou et 
al., 2009). The expression of ChAT was genetically supressed at the C-bouton synapse 
in mice, thus rendering cholinergic Pitx2+ INs modulation inefficient. Authors then 
recorded gastrocnemius activation through electromyograms during walking followed 
by swimming (Zagoraiou et al., 2009). The activation of hindlimb muscles is greater 
during swimming when compared to walking (Leon et al., 1994), and elimination of 
cholinergic modulation from C-boutons enable a understanding of the contribution of 
cholinergic Pitx2+ INs in different degrees of muscle activation. Analysis during 
swimming tests revealed that these animals exhibited decreased hindlimb muscle 
activity when compared to control mice. This suggested that cholinergic Pitx2+ INs 
might exhibit a task-dependent modulation by enhancing MN firing when higher muscle 
activation is required (Zagoraiou et al., 2009). 
The exact mechanism through which Pitx2+ INs modulate MN function is still 
not fully defined. Indirect evidence suggests that activation of Pitx2+ INs and therefore 
C-boutons regulates motor output through M2 muscarinic receptors to match muscle 
activation with behavioural demands (Miles et al., 2007; Zagoraiou et al., 2009). This 
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could be achieved through M2 receptor-mediated inhibition of SK channels which 
would reduce the mAHP thus allowing for increased MN firing rate (Miles et al., 2007). 
However, other channels which are present in MNs soma juxtaposed to C-boutons, such 
as Kv2.1 and N-type Ca2+ channels, could also be involved in M2 receptor-mediated 
regulation of MN output (Witts et al., 2014). 
This subpopulation of INs also seems to play a role in dysfunction and disease. 
Cholinergic inputs to motoneurons are markedly reduced after spinal cord injury 
(Kapitza et al., 2012; Skup et al., 2012) and sprouting of cholinergic fibres at the injury 
site is known to be important for recovery of hindlimb stepping (Jakeman et al., 1998). 
This decreased cholinergic innervation after spinal cord injury has functional 
implications for locomotor behaviour. Reduced numbers of these C-boutons onto MNs 
in spinal cord injury have been implicated in the rapid exhaustion of neuronal activity 
underlying locomotor output (Kapitza et al., 2012) and previous experiments in 
spinalized cats have shown a parallel between the increase in the number and size of 
these C-boutons and recovery of locomotor function (Pullen and Sears, 1983). Changes 
in cholinergic connectivity in the spinal cord is also accompanied by a hyper-
cholinergic state involving spinal muscarinic receptor function (Jordan et al., 2014). In 
neurodegenerative diseases, such as Amyotrophic Lateral Sclerosis (ALS) abundance 
and enlargement of C-boutons relates to disease pathophysiology (Herron and Miles, 
2012; Milan et al., 2015). When studying the development of Pitx2+ IN contacts with 
MNs in mice, authors found that in healthy animals there is a maturation process 
involving an increase in the area of the C-bouton synapse and increased expression and 
clustering of postsynaptic M2 muscarinic receptors. In the SOD1(G93A) mouse model 
of ALS C-boutons are smaller at birth and their density increases throughout early post-
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natal development with a decline around symptomatic stages that is followed by 
decreased M2 muscarinic receptor expression in the spinal cord (Milan et al., 2015). 
This will ultimately lead to reduced MN modulation by cholinergic Pitx2+ INs in ALS 
and therefore decreased muscle activation. Recent evidence suggests that Pitx2+ INs 
express the α3-subunit of the Na+/ K+ ATPase, which is thought to be responsible for an 
ultra-slow AHP that is important for activity-dependent changes in motor function. 
Mutations in the α3-subunit are related with diseases impairing the control of movement 
such as alternating hemiplegia of childhood and rapid-onset dystonia Parkinsonism and 
CAPOS syndrome (Picton et al., 2017).  
Given the range of pathological conditions that may involve Pitx2+ INs and C-
boutons, a greater understanding of the mechanisms by which Pitx2+ INs modulate 
motor output will not only provide valuable information about the physiology of spinal 
circuits involved in the control of movement, but also important knowledge which may 
help to develop therapeutic approaches to treat spinal injury and disease.    
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2.  RESEARCH FRAMEWORK 
The knowledge of the circuits and signalling pathways responsible for the 
generation of rhythmic motor patterns in the mammalian nervous system is incomplete. 
Despite the identification of several populations of spinal INs that express specific 
transcription factors allowing concise anatomical and behavioural studies, there is still 
knowledge lacking regarding the modulation of the mammalian CPG (Goulding, 2009; 
Miles and Sillar, 2011; Arber, 2012).  
ACh is an important intrinsic neuromodulator arising from different INs from 
within the spinal cord, that is able to adjust the rhythmicity of the CPG and fine-tune the 
strength of motor output. Muscarinic receptors are thought to be accountable for the 
cholinergic actions on spinal networks responsible for the generation of movement with 
M2 and M3 muscarinic receptors being the subtypes involved (Miles et al., 2007; 
Bertrand and Cazalets, 2011; Jordan et al., 2014; Anglister et al., 2017). However, 
previous studies have only partially addressed the roles and mechanisms of these 
receptors on CPG networks. The first part of this thesis therefore aimed to (1) describe 
the physiological relevance of these receptors for spinal motor circuits controlling 
locomotion and (2) explore and define the cellular mechanisms underlying M2 and M3 
muscarinic receptor modulation of MN function. 
After characterizing the role of M2 and M3 receptors in the modulation of 
locomotor network output and MN function, the next aim of this thesis was to 
understand which particular subset of cholinergic INs underlies some of the muscarinic 
modulation of spinal locomotor control networks. Pitx2+ INs are the only subpopulation 
of cholinergic INs that can be genetically identified and are thought to modulate motor 
output through M2 muscarinic receptors (Zagoraiou et al., 2009; Witts et al., 2014). 
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Prior to the current study, no research had addressed the direct effect of Pitx2+ IN 
activation on motor output. Cre-lox recombination provides a resourceful instrument to 
study the role of these neurons by allowing the selective expression of proteins in Pitx2+ 
INs such as fluorescent tags or Designer Receptor Exclusively Activated by Designer 
Drugs (DREADDs). DREADD technology allows the expression of excitatory 
(CHRM3) or inhibitory (CHRM4) engineered receptors in neurons that can only be 
activated with a designer drug (Roth, 2016; Zhu et al., 2017). Expression of DREADDs 
in Pitx2+ INs combined with the use of muscarinic receptor antagonists was used to: (1) 
excite Pitx2+ INs and investigate the fundamental mechanism underlying changes in 
MN excitability and (2) inhibit Pitx2+ INs during fictive locomotion and study their role 
in the modulation of rhythmic bursts of locomotor-related activity.  
Genetic deletion of neuronal populations has been successfully utilised to 
determine the role of different subtypes of INs within spinal circuits (Goulding, 2009; 
Arber, 2012). Therefore, after detailing the mechanisms of Pitx2+ INs-mediated 
modulation of motor output, cre-lox recombination was finally used to genetically 
ablate Pitx2+ cells to determine the effects on rhythmic locomotor network output. 
Using muscarinic receptor pharmacology in these animals during fictive locomotion, the 
physiological roles of the Pitx2+ IN system were further revealed.     
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3. METHODS 
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3.1. Animal ethics and husbandry 
All the procedures described in this work were conducted in accordance with the 
UK Animals (Scientific Procedures) Act 1986 under Home Office project licences (PPL 
6004369 and P6F7B721E) held by Dr Gareth B. Miles and personal licence 
(I27F5EFDC) held by Filipe Nascimento. Adult mice were crossed in pairs or trios (2 
females and 1 male) for no longer than 6 litters in double or 12 litters in triple housed 
cages. Animals younger than 12 months were used for breeding.  
 
3.2. Genotyping 
For genetically modified mice (GM mice) a polymerase chain reaction (PCR) 
was conducted using DNA isolated from neonatal tail or adult ear samples. A tissue 
dissociation kit (Sigma Aldrich®) was used to obtain genomic DNA that was then 
added to the REDExtract-N-Amp PCR Reaction Mix (Sigma Aldrich®) along with 
required primers for DNA amplification using a standard PCR reaction (with 35-50 
cycles). The amplified DNA was then directly loaded to an agarose gel (1.5%) and a gel 
electrophoresis was used to separate the fragments based on their molecular weight. 
DNA bands were visualized under ultraviolet light. 
 
3.3. Animal lines 
C57/BL6 neonates from postnatal day 1-12 were used for standard experiments. 
These animals do not carry any mutation that affects motor phenotype and thus are 
considered as wild type (WT). To visualize Pitx2+ INs cre-lox recombination was used 
by crossing Pitx2::Cre (W. Liu et al., 2003) with homozygous ROSA-loxP-STOP-loxP-
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tdTomato fluorescent reporter animals (Madisen et al., 2010). The Pitx2::Cre:ROSA-
loxP-STOP-loxP-tdTomato mouse (Pitx2-Cre;TdTomato) exhibits fluorescence 
allowing Pitx2+ INs to be targeted for single cell electrophysiology (Zagoraiou et al., 
2009). Pitx2::Cre and Pitx2::Cre:ROSA-loxP-STOP-loxP-tdTomato mice were crossed 
with B6N;129-Gt(ROSA)26Sortm2(CAG-CHRM3*,-mCitrine)Ute/J animals in order to 
generate Pitx2-Cre;CHRM3 and Pitx2-Cre;TdTomato;CHRM3 offspring which express 
the hM3Dq DREADD receptor in Pitx2+ INs. Pitx2+ mice were also crossed with 
B6N.129-Gt(ROSA)26Sortm1(CAG-CHRM4*,-mCitrine)Ute/J to obtain Pitx2-
Cre;CHRM4 and Pitx2-Cre;TdTomato;CHRM4 animals that express the hM4Di 
DREADD receptor in Pitx2+ INs. The chemical activation of these engineered 
signalling proteins can be triggered by CNO which will increase or induce Pitx2+ IN 
firing (hM3Dq through Gq pathway) or reduce their activity (hM4Di through Gi 
signalling) (Zhu et al., 2017). Crossing Pitx2::Cre with loxP-STOP-loxP-DTA (made by 
L. Zagoraiou, Academy of Athens) animals (producing Pitx2-Cre;DTA offspring) 
allowed the expression of diphtheria toxin A in cholinergic Pitx2+ INs thus selectively 
ablating this particular subset of cells. 
 
3.4. In vitro spinal cord preparation isolation 
Spinal cords from neonatal mice were obtained as previously described (Jiang et 
al., 1999). Neonatal mice (postnatal day 0-12) were euthanized using cervical 
dislocation (schedule 1 killing procedure), decapitated and eviscerated. The animal was 
pinned into a chamber containing “dissecting” artificial cerebrospinal fluid (aCSF) 
continuously gassed with 95% O2 and 5% CO2 at a temperature of ~4°C. Spinal 
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vertebrae were cut and whole spinal cord was isolated from cervical to upper sacral 
segments.  
For spinal cord slice preparation, both the ventral and dorsal roots were trimmed 
and the cord was glued to a 3% agar support. This was placed in a vibrating microtome 
apparatus (Leica VT1200) to obtain 300µm transverse slices from the lumbar segments. 
Slices were then transferred to a “recovery” aCSF solution continuously gassed with 
95% O2 and 5% CO2 and at ~34ºC for 45-60min, before being transferred to a beaker 
with “recording” aCSF gassed with 95% O2 and 5% CO2 at room temperature (figure 
3.4a). For ventral root recordings, dorsal roots were trimmed and ventral roots from L1-
L5 were kept intact. For patch clamp recordings in intact, whole spinal cords, small 
vertical cuts were performed in the ventral meninges on the surface of the preparation 
next to the ventral root projection, allowing access to MN pools (figure 3.4b). 
 
3.4.1. Whole-cell patch-clamp recordings from spinal neurons 
 Whole-cell patch-clamp recordings were made from spinal MNs, which were 
identified based on their size and location. INs are distributed throughout the ventral 
horn, while the larger MNs are organized in discrete pools in the ventromedial and 
ventrolateral spinal cord. Once recordings were established, MN identity was further 
verified based upon their larger whole-cell capacitance (Cm), lower input resistance, and 
greater synaptic drive compared to spinal INs (Carlin et al., 2000; Witts et al., 2015; 
Picton et al., 2017). Identification and recordings of Pitx2+ INs, which reside close to 
the central canal, were aided by their expression of fluorescent proteins (Zagoraiou et 
al., 2009). 
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 Whole spinal cord preparations or spinal cord slices were immersed in a 
recording chamber with recording aCSF continuously re-perfused (50mL) at a constant 
rate (approximately 1 mL per second). Borosilicated glass microelectrodes with 
resistance between 2.5-6MΩ were pulled and filled with an intracellular solution and 
attached to an Ag-AgCl recording electrode. The reference electrode was an Ag-AgCl 
pellet immersed in the bath. Signals were amplified and filtered (4-kHz low-pass Bessel 
filter) with a MultiClamp 700B amplifier (Molecular Devices, Sunnyvale, CA, USA) 
and acquired at ≥10 kHz using a Digidata 1440A A/D board and pClamp software 
(version 10.6, Molecular Devices, Sunnyvale, CA, USA). A gigaohm seal (≥2GΩ) was 
obtained using negative pressure in the patch pipette, prior to the establishment of 
whole-cell mode in which the neuron was typically held at -60mV when in voltage-
clamp mode. Acquisition of spontaneous postsynaptic currents (PSCs), miniature 
postsynaptic currents (mPSCs), drug-induced currents and measurements of input 
resistance (by applying voltage steps; 2.5mV steps from -75 to -52.5mV) were 
performed in voltage-clamp mode (Vhold at -60mV) (figure 3.4c). Neurons with an 
holding current between 100 and -100pA for control were selected for experiments and 
outwards currents were considered as increases in positive current whereas inward 
currents were defined as an increase in negative current. Firing output was measured in 
current-clamp mode either using ‘gap-free’ acquisition for spontaneous firing, by 
applying 10ms supramaximal pulses to evoke single action potentials, by injecting 1s 
square current pulses (starting at 10pA with 50pA increases), or through a single 
supramaximal ramp pulse (1s long). For adequate comparisons, a bias current was 
applied in all current-clamp protocols to keep neurons at the same resting potential 
50 
 
(figure 3.4d). There was no correction for the liquid junction potential, which was 
calculated as 14.2mV for the solutions used (Clampex JPCalcW). 
 
3.4.2. Ventral root recordings 
 Whole spinal cords were pinned or glued ventral-side up in a recording chamber 
continuously perfused with recording aCSF and glass suction electrodes were attached 
to lumbar ventral roots (L1-L5). Locomotor-related activity (fictive locomotion) was 
triggered by bath perfusion of NMDA (5µM), 5-HT (10µM) and DA (50µM). Using 
high concentrations of these drugs contributes to the chemical excitation of CPG 
neurons in the spinal cord that will result in well-defined bursts of activity from the 
ventral roots that resemble the pattern of walking. Locomotor-related output is 
characterized by rhythmic bursts of activity which alternate between the right and left 
sides of the spinal cord and between ipsilateral extensor (L5) and flexor (L2) ventral 
roots (Jiang et al., 1999). Rhythmic bursting was considered suitable for experiments 
when the frequency, duration and amplitude was stable for at least 15-20min. Signals 
were filtered and amplified (band-pass filter 30–3000 Hz, Qjin Design) and then 
acquired at a frequency of 6kHz with a Digidata 1440A A/D board and pClamp 
software.  Custom built amplifiers (Qjin design) allowed acquisition of raw signals with 
simultaneous online rectification and integration (50-ms time constant). 
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Figure 3.4 – Representation of a spinal cord slice and whole cord preparation with the 
different patch-clamp protocols used. (a) schematic illustrating the position of MNs and 
INs throughout the surface of a spinal cord slice; (b) lumbar segments of the whole 
spinal cord with suction electrode attached to the L2 lumbar root and an example of 
recorded locomotor-related output (raw trace on top and integrated/rectified on bottom). 
Inset shows MNs  in a motor pool from the same segment with representation of patch 
electrode recording; (c) voltage-clamp protocols: PSCs recorded from a MN in gap-free 
mode (left), examples of an inward (middle, top) and outward (middle, bottom) currents 
elicited in a MN via drug application and voltage steps applied to a MN to evaluate 
changes in input resistance (right); (d) current clamp protocols: 10ms-duration current 
pulse injected to evoke a single action potential (left), example of 1s-duration current 
pulse used to elicit repetitive firing (middle) and a MN response to a 1s-duration current 
RAMP (right).   
52 
 
3.5. Drugs 
The dissecting aCSF contained (in mM): 25 NaCl, 188 sucrose, 1.9 KCl, 1.2 
NaH2PO4, 10 MgSO4, 1 CaCl2, 26 NaHCO3, 25 glucose and 1.5 kynurenic acid. The 
recovery solution contained (in mM): 119 NaCl, 1.9 KCl, 1.2 NaH2PO4, 10 MgSO4, 1 
CaCl2, 26 NaHCO3, 20 glucose and 1.5 kynurenic acid. The recording aCSF contained 
(in mM): 127 NaCl, 3 KCl, 1.25 NaH2PO4, 1 MgCl2, 2 CaCl2, 26 NaHCO3, 10 glucose. 
The intracellular solution for patch-clamp recordings was made of (in mM): 14 
KMeSO4, 10 NaCl, 1 CaCl2, 10 HEPES, 1 EGTA, 3 Mg-ATP and 0.4 GTP-Na2 (pH 
7.2–7.3, adjusted with KOH). Muscarine, 4-DAMP, methoctramine, NMDA, DA and 5-
HT were supplied by Sigma-Aldrich®; tetrodotoxin (TTX) by Bio-Techne®; CNO by 
Tocris® and Hello-Bio®; and guangxitoxin-1E by Alomone Labs®. All drugs were 
dissolved in H2O except for 4-DAMP which was dissolved in DMSO to a concentration 
that did not exceed 0.1% (vol/vol) in working solutions. Drug application was 
performed for 20-30 minutes except for CNO in which perfusion lasted 15 minutes to 
avoid desensitization and subsequent DREADD receptor downregulation (Roth, 2016). 
 
3.6. Data analysis 
 Whole-cell patch-clamp data were analysed with Clampfit (Molecular Devices, 
Sunnyvale, CA, USA) and, for PSCs and mPSCs, Mini-Analysis software (Synaptosoft 
Inc, Decatur, GA). For quantification of synaptic inputs, the last 1-2 minutes or at least 
80-100 events from control, drug and washout were used for statistical analysis. 
Changes in holding current were calculated as the difference between the current value 
immediately before drug perfusion and the maximum change in current induced by the 
drug. Majority of the neurons had an initial holding current close to 0pA (voltage hold 
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of -60mV), however due to the perfusion of some drugs which could induce changes in 
holding current for control period, only experiments in cells with a holding between 100 
and -100pA were considered for analysis of changes in holding current. Outward 
currents that were defined as increases in positive holding current and inward currents 
that were considered as increases in negative holding current, were use throughout this 
thesis to report shifts in holding current. Current-voltage relationships were constructed 
for drug-induced currents by subtracting the voltage step values from control from those 
obtained after drug perfusion. Linear regression of these values was used to calculate 
the reversal potential of drug-induced currents (X-intercept when Y=0.0). Voltage-
current relationships were used to calculate input resistance before and after drug 
perfusion which was considered as the slope of the linear regression trendline equation 
for these values. For maximum firing output, the current steps eliciting the highest firing 
frequency during control and drug conditions were compared. Single action potential 
mAHP amplitude was considered as the difference between the resting voltage before 
injecting the 10ms-long depolarizing current and the peak value of the mAHP (averaged 
across 15 traces).  For the analysis of action potential half-width and rise-time, traces 
were not averaged to avoid errors due to action potentials being slightly out of phase 
when peak time was compared. Instead, 3 or more individual spikes were used for 
analysis. For each spike a differential function (dV/dt) was calculated and the point 
where dV/dt reached 10 mV/ms was used for the estimation of half-width and rise time. 
The obtained values from the 3 or more action potentials were then averaged and used 
for statistical comparisons. The half-width and rise time values from the different spikes 
within the same protocol file did not differ more than 1.5%. The voltage threshold for 
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action potentials was calculated from the first action potential elicited by current 
RAMPs using the differential method described above. 
 Drug washouts could not be performed in all the experiments in some sections 
and therefore were not used for statistical analysis. In single cell experiments from 
intact spinal cords this was due to the technical difficulty of recording from MNs during 
long periods of time. In recordings from spinal cord slices, washouts were not 
considered for statistical analysis of mAHP, firing output and action potential half-
width due to the duration of some of the experiments (≥50 min) interfering with the 
quality of the data obtained for these parameters.  
 Data from ventral root bursting was analysed offline using DataView software 
(courtesy of Dr W. J. Heitler, University of St Andrews). Bursts were identified from 
the integrated/rectified trace from which frequency and duration were measured 
whereas amplitude was calculated from the respective segment of raw trace. Burst 
regularity was analysed as burst frequency variance. Data were averaged in 0.5-min 
time bins and normalized to a 10min pre-control period to construct time course plots.  
Statistical comparisons were made on raw data averaged over 5-min periods in each 
condition.  
Data are presented as mean±standard error. In patch-clamp experiments each “n” 
corresponds to one cell whereas in ventral root recordings it corresponds to one whole 
spinal cord preparation. Kolmogorov-Smirnov Goodness of Fit Test was used to test for 
normality. Repeated measures ANOVA followed by Tukey’s post-hoc tests were used 
to test for statistically significant differences (p<0.05) when comparing more than 2 
conditions for normally distributed populations. Friedman test followed by Dunn’s post-
test was used when comparisons were made between non-normally distributed 
55 
 
populations to test for statistical significance (p<0.05). Paired t-tests (parametric) or 
Wilcoxon matched pairs tests (non-parametric) were used for comparing differences in 
means between 2 conditions; drug and control (p<0.05). 
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4. RESULTS 
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4.1. Muscarinic modulation of locomotor network output and 
MN function 
One of the main focuses of this thesis was to understand the role of muscarinic 
receptor activation on locomotor output. Rhythmic behaviours, such as those involved 
in locomotion, are dependent upon CPG circuits that are comprised of many different 
IN subtypes. INs of the mammalian locomotor CPG are predominantly located in the 
ventral horn of the spinal cord, where they can generate patterns of activity required for 
adequate locomotor behaviours. The strength, or intensity, of the locomotor output is 
largely defined by MN firing, which in turn translates into the ventral root output signal 
that reaches the NMJs and leads to muscle contraction. Recordings of locomotor bursts 
from ventral nerve roots during fictive locomotion provide a valuable readout of the 
functional properties of CPG INs and MNs during rhythmic patterns of motor activity. 
In order to understand how M2 and M3 muscarinic receptors affect locomotor network 
output, muscarinic receptor antagonists were applied to whole spinal cord preparations 
while drug-induced locomotor activity was recorded from ventral roots and single-cell 
activity was recorded from MNs (sections 4.1.1-4.1.2). 
After accessing the network effects of M2 and M3 receptor activation during 
fictive locomotion, the range of potential modulatory actions of muscarinic receptor 
activation was next studied at a single cell level. Given the lack of a clear marker for 
essential rhythmogenetic INs of the locomotor CPG and the impractical nature of 
systematic analysis of all genetically-defined ventral horn INs, the current study did not 
directly address the range of potential modulatory actions of muscarinic receptor 
activation on ventral horn INs. Instead, the cellular mechanisms of muscarinic receptor 
activation on MN function, and thus the intensity of locomotor output, were explored by 
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performing whole-cell patch-clamp recordings from MNs in isolated neonatal mouse 
spinal cord slices (sections 4.1.3-4.1.5). 
The effects of muscarinic receptor activation were investigated by performing 
ventral root and single-cell recordings from MNs. Since ACh is released during 
locomotion (Dai et al., 2009; Jordan et al., 2014), muscarinic receptor antagonists were 
perfused during fictive locomotion to investigate their endogenous roles in the control 
of spinal motor networks. In spinal cord slices the general muscarinic receptor agonist, 
muscarine (10µM), was bath applied to activate muscarinic receptors to investigate their 
cellular mechanisms of action. Given that both the M2 and M3 receptors have been 
implicated in muscarinic-related actions on mammalian locomotor networks (Jordan et 
al., 2014) the effects of muscarinic receptor activation on the properties of spinal 
neurons were then tested in the presence of either the M2 antagonist, methoctramine 
(10µM), or the M3 receptor blocker, 4-DAMP (2µM). In spinal cord slices, muscarine 
was also bath applied in the presece of both 4-DAMP and methoctramine to reveal the 
possibility of any non-M2/M3 receptor-mediated effects on MN function.  
Single cell analysis of the effects of muscarinic receptor activation included 
investigation of subthreshold currents, neuronal output and synaptic transmission. 
Assessment of the effect of muscarinic receptor activation on the subthreshold 
properties of MNs was conducted by evaluating changes in holding current and by using 
current-voltage steps to infer any changes in input resistance. The effects of muscarinic 
receptor activation on neuronal output were studied by investigating repetitive firing 
parameters, particularly maximum firing elicited in control and in the presence of the 
muscarinic drugs. Changes in the mAHP amplitude were also analysed. For synaptic 
analysis, a mixture of PSCs was recorded. To understand if muscarine-mediated 
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changes in synaptic activity most likely involve changes in the excitability and firing 
activity of premotor networks or a direct modulation of last-order synaptic connections, 
muscarinic receptor drugs were perfused in the presence of TTX and mPSCs were 
recorded.  
In summary, the work in this section of the thesis focused on determining the 
role of M2 and M3 muscarinic receptors in controlling the output of spinal motor 
circuitry during fictive locomotion and on the characterization of the cellular 
mechanisms underlying their modulation of MN function.   
 
4.1.1. M2 muscarinic receptor blockade effects the regularity and 
reduces the amplitude of drug-induced locomotor output  
Fictive locomotion was induced via the application of NMDA (5µM), 5-HT 
(10µM) and DA (50µM) and locomotor output was recorded through suction electrodes 
attached to the ventral roots. To address the role of M2 muscarinic receptors during 
locomotor-like bursting the selective antagonist methoctramine (10μM) was perfused. 
As illustrated in figure 4.1, blockade of M2 receptors with methoctramine significantly 
reduced burst frequency variance (control: 7.528×10-3±2.280×10-3Hz2; methoctramine: 
2.224×10-3±4.831×10-4Hz2; washout: 9.381E-3±2.228×10-3Hz2; n=24; p<0.05 
Friedman’s test with Dunn’s post-hoc), reduced burst amplitude (control: 1.180±0.225; 
methoctramine:0.967±0.158; washout: 0.963±0.186; n=24; p<0.05 Friedman’s test with 
Dunn’s post-hoc), increased burst duration (control: 1454±137ms; 
methoctramine:1660±129ms; washout: 1259±134ms; n=24; p<0.05 Friedman’s test 
with Dunn’s post-hoc) and had no statistically significant effect on burst frequency 
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(control: 0.258±0.019Hz; methoctramine: 0.227±0.001Hz; washout: 0.283±0.023Hz; 
n=24).  
The finding that blockade of M2 muscarinic receptors decreased burst frequency 
variance suggests that these receptors might have a role in destabilizing the regularity of 
the rhythmic bursts. Along with the reported increase in burst duration by 
methoctramine, which could involve modulation of CPG INs (Gosgnach et al., 2006),  
these results highlight M2 receptor-mediated actions that are likely to occur at the level 
of INs that shape rhythmic output. The decrease in burst amplitude during fictive 
locomotion suggests that M2 receptors might directly modulate MN output. In 
summary, the data from this section shows that M2 muscarinic receptors modulate the 
rhythm generating component as well as the strength of motor output.   
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Figure 4.1 – M2 receptors modulate burst amplitude, duration and frequency variance 
during drug-induced locomotion. (a) raw (top) and integrated/rectified (bottom) traces 
with (b) averaged time course plots (left) and histograms of pooled data (right) 
illustrating the effects of methoctramine (10µM) on drug-induced locomotor output 
(n=24); #p<0.05 repeated measures ANOVA with Tukey’s post-test; §p<0.05 
Friedman’s test with Dunn’s post-hoc 
 
 
To study if methoctramine-induced changes in rhythmic activity reflected a 
modulation of MN output, whole-cell patch clamp recordings were performed from 
lumbar MNs during locomotor output. The amplitude of locomotor-related bursts 
recorded from ventral roots reflects the overall output generated by MNs whose axons 
project through the roots. Therefore, the decrease in ventral root burst amplitude 
observed in the presence of methoctramine would be expected to reflect a reduction in 
MN firing frequency during bursting. As illustrated in figure 4.2, during recordings 
from bursting MNs in intact spinal cord preparations, blockade of M2 receptors 
significantly decreased MN firing frequency (control: 14.05±2.05Hz; methoctramine: 
9.83±1.74Hz; n=17; p<0.05 paired t-test). These results confirm that M2 receptor 
blockade causes a reduction in the firing activity of rhythmically active MNs, which 
would account for the decrease in ventral root amplitude upon M2 muscarinic receptor 
blockade. 
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4.2 – M2 muscarinic receptor decreases burst amplitude by reducing MN firing during 
fictive locomotion. whole-cell patch-clamp recording from a bursting MN (top), raw 
(middle) and integrated/rectified (bottom) traces with firing frequencies plotted for all 
MNs tested showing the effects of methoctramine (10µM, n=17); *p<0.05 paired t-test 
 
 
4.1.2. M3 muscarinic receptor blockade disrupts drug-induced 
locomotor output 
 To characterize the role of M3 receptors in the locomotor network, the M3-
receptor antagonist 4-DAMP (2μM) was perfused while recording drug-induced bursts 
of rhythmic activity from lumbar ventral roots. Blockade of M3 receptors within spinal 
cord preparations (figure 4.3) had no significant effects on burst frequency (control: 
0.230±0.020Hz; 4-DAMP: 0.246±0.022Hz; washout: 0.228±0.018Hz; n=22) or burst 
amplitude (control: 1.116±0.224; 4-DAMP: 1.110±0.197; washout: 1.068±0.190; n=22). 
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However, M3 receptor blockade increased burst frequency variance (control: 2.765×10-
3±5.541×10-4Hz2; 4-DAMP: 6.756×10-3±1.727×10-3Hz2; washout: 5.760×10-
3±1.493×10-3Hz2; n=22; p<0.05 Friedman’s test with Dunn’s post-hoc) and decreased 
burst duration (control: 1502±115ms; 4-DAMP: 1257±93ms; washout: 1765±153; 
n=22; p<0.05 Friedman’s test with Dunn’s post-hoc).  
 The finding that blockade of M3 receptors during fictive locomotion 
destabilized the locomotor rhythm by increasing the burst frequency variance and 
decreasing burst duration, indicate that M3 muscarinic receptors exclusively modulate 
rhythm generating neurons since there was no significant change on burst amplitude. 
These findings with 4-DAMP contrast the results obtained in the presence of 
methoctramine, highlighting that these receptors seem to have opposite actions on the 
modulation of spinal CPG circuits during locomotion. 
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Figure 4.3 – M3 receptors modulate locomotor rhythm stability. (a) raw (top) and 
integrated/rectified (bottom) traces with (b) averaged time course plots (left) and 
histograms of pooled data (right) showing the effects of 4-DAMP (2µM) on drug-
induced locomotor output (n=22); #p<0.05 repeated measures ANOVA with Tukey’s 
post-test; §p<0.05 Friedman’s test with Dunn’s post-hoc 
 
To explore if blockade of M3 muscarinic receptors would impact on the 
excitability of MNs during episodes of drug-induced locomotion, single cell activity 
was recorded during bursts of activity. As seen in figure 4.4, 4-DAMP had no 
significant effect on the firing frequency of MNs within intact spinal cord preparations 
(control: 7.07±1.61Hz; 4-DAMP: 7.16±2.16Hz; n=7). The apparent mismatch between 
MN activity and ventral root bursting in figure 4.4 in the presence of 4-DAMP is a clear 
example of the disruptive nature of M3 receptor blockade during fictive locomotion.  
 This demonstrates that M3 muscarinic receptor-mediated modulation during 
fictive locomotion is predominantly focused on the regulation of INs that comprise the 
CPG network. Activation of these receptors in CPG neurons might be important to 
stabilize the rhythm by conferring appropriate regularity to set adequate patterns of 
activity.  
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4.4 – Blockade of M3 muscarinic receptors during drug-induced locomotion does not 
affect MN firing. whole-cell patch-clamp recording from a bursting MN (top), raw 
(middle) and integrated/rectified (bottom) traces with firing frequencies plotted for all 
MNs tested illustrating the effects of M3 receptors blockade with 4-DAMP (2µM, n=7); 
p>0.05 Wilcoxon matched pairs test 
 
4.1.3. Muscarine reveals both M2 receptor-mediated outward currents 
and M3 receptor-dependent inwards currents that vary 
dependent on MN size 
To explore changes in neuronal excitability mediated by muscarinic receptors, 
subthreshold properties of MNs were first studied by evaluating changes in holding 
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current and input resistance upon muscarine application during voltage-clamp 
recordings.  
Two different responses to muscarine were observed (figure 4.5a). In one subset 
of MNs, muscarine induced an inward current (-50.96±8.13pA n=20), which was 
associated with an increase in input resistance (control: 92.83±24.75MΩ, muscarine: 
118.54±29.29MΩ, reversal -78.43mV, n=9). While in other MNs, muscarine elicited an 
outward current (43.32±15.57pA; n=10), which was associated with a decrease in input 
resistance (control: 134.38±20.14MΩ, muscarine: 105.96±19.71 MΩ, reversal -
92.61mV, n=6). Interestingly, MNs in which an inward current was observed were 
larger, as indicated by whole-cell capacitance values (Cm=146±6pF, n=20), than those 
in which an outward current was induced (Cm=97±7pF, n=10).  
To reveal if these muscarine-induced currents were due to direct activation of 
postsynaptic muscarinic receptors on MNs, muscarine was next perfused in the presence 
of TTX (figure 4.5b). Under these conditions, muscarine again induced an outward 
current in small MNs (35.80±7.67pA; Cm=91±6pF; n=11), which was associated with a 
decrease in input resistance (TTX: 51.70±10.31MΩ, TTX and muscarine: 
57.68±10.98MΩ, reversal -90.18mV, n=6), while in larger MNs it caused an inward 
current (-42.86±13.57pA; Cm= 146±12pF; n=8) that was accompanied by an increase in 
input resistance (TTX: 64.14±8.87MΩ, TTX and muscarine: 53.17± 6.10 MΩ, reversal 
-76.08mV, n=6). 
Changes in current in the presence of muscarine indicate that activation of 
muscarinic receptors preferentially depolarizes large and hyperpolarizes small MNs. 
These differences seem to involve modulation of muscarinic receptors that are 
expressed on MNs. 
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Figure 4.5 – Muscarine induces an inward current in large MNs and outward current in 
small MNs thought a mechanism involving last-order synapse muscarinic receptor 
modulation. (a) voltage clamp transient (left) with respective I-V plots (middle) and 
MN capacitance (right), illustrating inward (top, n=20) and outward (bottom, n=10) 
holding currents elicited by muscarine (10µM) that were accompanied by an increase 
(n=9) and decreased (n=6) in input resistance, respectively; (b) changes in holding 
current in the presence of TTX (0.5µM, left) with input resistance (middle) and MN size 
statistical comparison (right) illustrating the inward current (n=8)  and increase in input 
resistance (n=6) in large MNs and a outward current (n=11) in smaller MNs that 
decreased cell resistance (n=6). *p<0.05**p<0.01***p<0.001 unpaired t-test 
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To understand which receptor subtypes are responsible for the muscarine-
induced changes in holding current, the non-selective agonist muscarine was next 
perfused in the presence of the M2 receptor antagonist methoctramine or the M3 
receptor antagonist 4-DAMP.  
In the presence of methoctramine, muscarine elicited an inward current (-
53.52±6.64pA, n=17) and increased input resistance (methoctramine: 90.90±3.78MΩ, 
methoctramine and muscarine: 104.68±3.52MΩ, reversal -116.10mV, n=8) (figure 
4.6a). To check if these currents involved activation of postsynaptic muscarine receptors 
on MNs, experiments were performed when evoked transmission was blocked by TTX. 
As seen in figure 4.6b, activation of muscarinic receptors with methoctramine and TTX 
present still induced an inward current (-35.24±7.62pA, n=17) and also increased input 
resistance (TTX and methoctramine: 54.08±5.65MΩ, TTX, methoctramine and 
muscarine: 64.69±6.61MΩ, reversal -76.40mV, n=8).  
Activation of muscarinic receptors with muscarine in the presence of 
methoctramine, revealed an inward current in all MNs tested. Since there was no 
evidence of an outward current when M2 receptors were blocked, these results indicate 
that M2 receptors are responsible for the hyperpolarizing currents previously 
demonstrated in MNs in response to muscarine application.  
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Figure 4.6 – Muscarine in the presence of M2 receptor antagonism induces an inward 
current on MNs. Voltage clamp representative traces (left) and I-V plots (right) 
illustrating that (a) muscarine (10µM) co-applied with the M2 selective antagonist 
(10µM) induced an inward current (n=17) leading to an increase in membrane 
resistance (n=8) even in (b) the presence of TTX (0.5µM, n=17 for left figure and n=8 
for right figure). 
 
To investigate whether M3 receptors might be responsible for the inward current 
induced by muscarine when M2 receptors were blocked, muscarine was next perfused 
with the M3 blocker 4-DAMP. Co-application of 4-DAMP and muscarine elicited an 
outward current (88.22±13.69pA, n=14). In a group of MNs this was associated with a 
decrease in input resistance (4-DAMP: 117.15±22.94MΩ, 4-DAMP and muscarine: 
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85.70±19.85MΩ, reversal -106.70mV, n=6) while in another subset of MNs input 
resistance was increased (4-DAMP: 66.68±5.18MΩ, 4-DAMP and muscarine: 
81.21±6.9MΩ, reversal -71.86mV, n=9) (figure 4.1.7a). There was no significant 
difference in capacitance between both groups of MNs (MNs with increased input 
resistance:  141±10pF, n=9; MNs with decreased input resistance: 132.12±16pF, n=6). 
When TTX was bath applied, muscarine in the presence of 4-DAMP still induced an 
outward current (47.62±16.94pA, n=15) and increased input resistance in a subset of 
MNs (TTX and 4-DAMP: 82.40±11.13MΩ, TTX, 4-DAMP and muscarine: 
72.37±10.53MΩ, reversal -79.85mV, n=6) while in another subgroup of MNs it 
decreased input resistance (TTX and 4-DAMP: 69.94±9.54MΩ, TTX, 4-DAMP and 
muscarine: 75.87±10.77MΩ, reversal -94.56mV, n=6) (4.1.7b). There was again no 
significant difference in capacitance between the MNs with increased (133.63±6.86pF, 
n=6) and decreased input resistance (107.99±12.23pF, n=6). 
Since no inward currents were induced by muscarine in the presence of 4-
DAMP, these results suggest that M3 receptors are responsible for the muscarine-
induced inward currents revealed earlier in MNs. The increase and decrease observed in 
input resistance when muscarine was co-perfused with 4-DAMP suggests that activation 
of M2 receptors results in different changes in input resistance. These data indicate that 
M2 receptor activation might have variable effects on ion channels in different MNs. 
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Figure 4.7 – Muscarine in the presence of 4-DAMP induces a outward current on MNs. 
Voltage clamp representative traces (left) and I-V plots (right) illustrating that (a) 
muscarine (10µM) in the presence of 4-DAMP (2µM) elicited an outward current 
(n=14) and in a group of MNs decreased (n=6) while in other MNs it increased input 
resistance (n=9) and (b) when TTX (0.5µM) was applied, muscarine with 4-DAMP also 
elicited an outward current on MNs (n=15) and decreased (n=6) or increased (n=6) 
input resistance in different MNs. 
 
Next, to address the potential role of endogenous ACh in the induction of 
currents in MNs, the effects of each of the muscarinic receptor subtype antagonists on 
holding current were explored. Application of methoctramine induced an inward current 
in MNs (-38.57±6.21pA, n=18) and increased input resistance (control: 70.67±7.92MΩ, 
methoctramine: 82.50±7.07MΩ, reversal -79.54mV, n=8) (figure 4.8a). 4-DAMP 
induced an outward current (51.95±15.00pA, n=17) and a decrease in input resistance in 
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MNs (control: 89.50±7.60MΩ, 4-DAMP: 72.75±7.22MΩ, reversal -82.68mV, n=7) 
(figures 4.8b). 
These data show that blockade of M2 receptors removes a tonic outward current 
while antagonism of M3 receptors removes a tonic inward current. The results further 
indicate that M2 receptors might modulate a change in current, which would result in 
MN hyperpolarization, whereas M3 receptors modulate an inward current that would 
depolarize MNs. M2 and M3 muscarinic receptors have opposite actions on the 
modulation of subthreshold properties pointing out the possibility of a reciprocal 
interaction on the regulation of MN function. 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.8 – Methoctramine induces an inward and 4-DAMP elicits an outward current 
on MNs. Voltage clamp representative traces (left) and I-V plots (right) illustrating that 
(a) 4-DAMP (2µM) induced an outward current (n=18) and increased input resistance 
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(n=7) and (b) methoctramine (10µM) caused an inward current on MNs (n=17) and 
increase input resistance (n=8). 
 
To determine whether if any non-M2/M3 receptors were involved in the 
previously described muscarinic receptor actions, the non-selective agonist muscarine 
was perfused in the presence of both methoctramine and 4-DAMP while recording from 
MNs. As seen in figure 4.9, in the presence of methoctramine and 4-DAMP, muscarine 
had no effects on holding current (-1.0±8±6.17pA, n=10) or input resistance (4-DAMP 
and methoctramine: 97.13±14.21MΩ, 4-DAMP, methoctramine and muscarine: 
95.31±17.81MΩ, n=7).  
 Since muscarine did not have any significant effects on MNs in the presence of 
methoctramine and 4-DAMP, these results suggest that M2 and M3 receptors in spinal 
cord slices are solely responsible for the muscarinic modulation of spinal motor 
function which is in agreement with previous evidence from the rat spinal cord (Jordan 
et al., 2014).  
 
 
 
 
 
 
 
Figure 4.9 – Muscarine affects MN excitability exclusively through M2 and M3 
receptors activation. Voltage-clamp transient showing no current change by muscarine 
in the presence of 4-DAMP (2µM) and methoctramine (10µM, left, n=10) and 
respective input resistance relationship (right, n=7). 
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4.1.4. Muscarine increases MN maximum firing output via activation 
of both M2 and M3 muscarinic receptors 
To investigate the modulatory effects of muscarinic receptor activation on MN 
firing output, muscarine was perfused while action potentials (repetitive or single 
spikes) were elicited in MNs via current injection in current-clamp mode.  
First, the effects of muscarinic receptor activation on repetitive MN firing were 
assessed. Repetitive firing was induced using a series of current steps of increasing 
magnitude. Comparisons of repetitive firing elicited in control conditions and in the 
presence of muscarine revealed that muscarine receptor activation increased MN 
maximum firing (control: 32.24±2.69Hz; muscarine: 35.01±2.80Hz; n=14; p<0.01 
paired t-test; figure 4.10a).  
Given previous reports that muscarine receptor activation affects MN firing by 
modulating mAHPs (Miles et al., 2007), muscarine was next applied during short 
current steps which elicited only single action potentials followed by a clear mAHP. 
These single action potential protocols showed that muscarine significantly decreased 
mAHP amplitude (control: -4.93±1.08mV; muscarine: -2.96±0.82mV; p<0.05 
Wilcoxon matched pairs test) (figure 4.10b). 
These data confirm that muscarinic receptor activation increases MN output and 
decreases mAHP amplitude, as previously described (Miles et al., 2007). The activation 
of muscarinic receptors resulted in an overall increase in MN spiking output. The 
reduction in mAHP amplitude could contribute to augmented firing which was a feature 
associated with M2 receptor activation (Miles et al., 2007). Experiments utilising 
muscarinic receptor antagonists were next performed to investigate the contribution of 
M2 and M3 muscarinic receptors to the muscarinic modulation of MN firing.  
77 
 
100ms
1mV
Control
Muscarine
10mV
500ms
MuscarineControl
0 500 1000 1500 2000 2500
0
10
20
30
40
50
Control
Muscarine
Current (pA)
F
re
q
u
e
n
c
y
 (
H
z
)
C
on
tr
ol
M
us
ca
ri
ne
-8
-6
-4
-2
0
¤¤
m
A
H
P
 a
m
p
li
tu
d
e
 (
m
V
)
C
on
tr
ol
M
us
ca
ri
ne
0
10
20
30
40 **
M
a
x
im
u
m
 f
ir
in
g
 (
H
z
)
a
b
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.10 – Muscarine increases MN maximum firing output and decreases mAHP 
amplitude; (a) representation of increased MN maximum firing in response to 
increments of current injection in the presence of muscarine (10µM, left) with 
respective f-I plot (middle) and averaged maximum firing (right, n=14); (b) truncated 
single actions potentials showing the effects of muscarine on mAHP amplitude (n=17). 
**p<0.01 paired t-test. ¤ ¤p<0.01 Wilcoxon matched pairs test 
  
 
To address the role of M2 receptors in modulating MN firing properties, MN 
output was studied during perfusion of muscarine in the presence of the M2 receptor 
antagonist methoctramine. As illustrated in figure 4.11a, muscarine did not change MN 
maximum firing in the presence of methoctramine (methoctramine: 28.76±1.58Hz; 
methoctramine and muscarine: 29.69±2.00Hz; n=11). The M2 antagonist also 
effectively blocked the muscarine-dependent reduction in mAHP amplitude 
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(methoctramine: -4.65±1.16mV; methoctramine and muscarine: -3.58±0.77mV; n=11) 
(figure 4.11b). 
The absence of muscarine-induced changes in maximum firing and mAHP 
amplitude with methoctramine indicate that M2 muscarinic receptors are important 
mediators of cholinergic modulation of MN output, as previously suggested (Miles et 
al., 2007). In addition, these results indicate that the activation of M3 receptors, in the 
presence of M2 receptor blockade, is insufficient to increase MN output.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.11 - M2 receptor blockade removes the effect of muscarine on MN maximum 
firing. (a,c) step of current (left) with respective f-I plot (middle) and averaged 
maximum firing (right) and (b,d) truncated single actions potentials (left) with mean 
mAHP amplitude plots (right) illustrating the recorded effects of the presence of 
muscarine (10µM) co-perfused with methoctramine (10µM) on firing output (n=11) and 
mAHP (n=11). p>0.05 paired t-test and p>0.05 Wilcoxon matched pairs test. 
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To reveal the potential impact of M3 receptors on MN firing, muscarine was 
next perfused with 4-DAMP and changes in maximum firing rates and the mAHP were 
studied. Blockade of M3 receptors prevented the muscarine-induced increase in 
maximum firing (4-DAMP: 29.32±1.40Hz; 4-DAMP and muscarine: 27.92±1.73Hz; 
n=15) but not the muscarine-induced decrease in mAHP amplitude (4-DAMP: -
5.54±0.55mV; 4-DAMP and muscarine: -3.17±0.67mV; n=10; p<0.05 paired t-test) 
(figure 4.12).  
Blocking M3 receptors removed the increase in maximum firing but did not 
affect the decrease in mAHP amplitude induced by muscarine, suggesting that these 
receptors may play a role in modulating MN excitability via a mechanism that does not 
target the mAHP. Surprisingly, both M2 and M3 receptor antagonists effectively 
prevented the muscarine-mediated increase in maximum firing. This perhaps indicates 
that a balance between M2 and M3 receptor activation is required for the reported 
cholinergic increase in output. These data show that both M2 and M3 muscarinic 
receptors are important in cholinergic modulation of MN firing.  
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Figure 4.12 - M3 muscarinic receptors are involved in muscarine-induced increase in 
MN output. (a,c) injected step of current (left) with respective current-frequency plot 
(middle) and averaged maximum firing (right) and (b,d) truncated single actions 
potentials with mean mAHP amplitude plots (left) exemplifying the recorded effects in 
the presence of 4-DAMP (2µM) co-perfused with muscarine (10µM) on firing output 
(n=15) and mAHP (n=10); **p<0.01 paired t-test.  
 
 
To reveal the presence of any endogenous activation of M2 and M3 muscarinic 
receptors that could underlie tonic cholinergic modulation of MN firing properties, 
selective antagonists were perfused and MN output was studied. Methoctramine 
application did not affect MN maximum firing (control: 29.80±1.80Hz; methoctramine: 
28.59±1.70Hz; n=14) nor mAHP amplitude (control: -4.74±0.47mV; methoctramine: -
4.63±0.57mV; n=17) (figures 4.13a-b). Similarly, 4-DAMP had no significant effects 
on MN maximum firing (control: 30.04±2.11Hz; 4-DAMP: 27.89±2.43Hz; n=11) nor 
mAHP amplitude (control: -5.92±0.66mV; 4-DAMP: -5.81±065mV; n=12) (figures 
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4.13c-d). There could be changes in overall cell resistance noticeable during the current 
step (see figures 4.13a and 4.13c) which could affect neuronal excitability, however no 
significant change in averaged maximum firing output were observed. 
 These results indicate that blockade of M2 or M3 muscarinic receptors does not 
affect MN output indicating that activation at rest of these receptors does not 
significantly modulate MN firing in spinal cord slice preparations.   
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Figure 4.13 - M2 and M3 muscarinic receptor blockade does not affect MN output (a,c) 
step of current (left) with respective f-I plot (middle) and averaged maximum firing 
(right) and (b,d) truncated single actions potentials (left) with mean mAHP amplitude 
plots (right) illustrating the recorded effects of the presence of methoctramine (10µM) 
on firing (n=14) and mAHP (17) and exemplifying the recorded effects in the presence 
of 4-DAMP (2µM) on MN maximum output (n=11) and mAHP (12). 
 
 
4.1.5. M2 and M3 muscarinic receptors modulate synaptic inputs to 
MNs 
The effects of M2 and M3 muscarinic receptor activation could also affect MN 
function by modulating synaptic inputs from spinal INs. To address this, mixed PSCs 
were recorded from MNs while muscarinic receptors were either activated or inhibited. 
Muscarine was first bath applied to spinal cord slices while whole-cell patch-
clamp recordings were performed from MNs to explore whether muscarinic receptor 
activation effected synaptic drive to MNs.  As seen in figure 4.14a, muscarine had an 
initial excitatory (less than 10 minutes of perfusion) followed by a delayed inhibitory 
effect on the frequency of synaptic events. This was revealed by an initial decrease, 
followed by a later increase in inter-event interval (control: 559.08±84.54ms; muscarine 
before 10min: 290.68±63.53ms; muscarine 15-30min: 896.36±156.44ms; washout: 
629.357±107.29ms; n=12; p<0.05 repeated measures ANOVA with Tukey’s post-test). 
Muscarine also caused a transient increase in the amplitude of PSCs recorded from MNs 
(control: 26.93±2.01pA; muscarine before 10min: 32.10±2.77pA; muscarine 15-30min: 
25.35±2.31pA; washout: 26.10±2.41pA; n=12; p<0.05 repeated measures ANOVA with 
Tukey’s post-test).  
Muscarinic changes in synaptic activity could reflect decreased output from 
presynaptic neurons or direct modulation of synaptic transmission via pre- and/or 
84 
 
postsynaptic mechanisms. To address this, evoked activity was blocked with TTX and 
mPSCs were recorded in the presence of muscarine. Muscarine increased the inter-event 
interval (TTX: 551.04±93.13ms; TTX and muscarine: 751.37±122.76ms; washout 
(TTX): 720.36±89.67ms; n=15; p<0.05 Friedman’s test with Dunn’s post-hoc) and 
decreased the amplitude (TTX: 15.85±0.77pA; TTX and muscarine: 13.90±0.82pA; 
washout TTX: 13.04±0.66pA; n=15; p<0.05 repeated measures ANOVA with Tukey’s 
post-test) of recorded mPSCs (figure 4.14b).  
These results indicate that muscarine can have 2 distinct, time-dependent actions 
on synaptic inputs to MNs: an initial increase followed by a subsequent decrease in 
synaptic drive. The changes in both the amplitude and inter-event interval of mPSCs 
indicate that muscarinic modulation of synaptic transmission might involve activation 
of both pre- and postsynaptic receptors. 
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Figure 4.14 - Muscarine has a biphasic action on synaptic drive to MNs. (a) 
representative traces of recorded PSCs (left) with respective inter-event interval and 
amplitude histogram (right) illustrating the effects of muscarine (10µM) on PSCs 
(n=12); (b) example of acquired mPSCs (left) with inter-event interval and amplitude 
histogram (middle) and inter-event and amplitude cumulative fraction plots (right) of 
the effects of muscarine on spontaneous activity (n=15); all recordings were performed 
at a holding potential of -60mV. #p<0.05 repeated measures ANOVA with Tukey’s 
post-test; §p<0.05 Friedman’s test with Dunn’s post-hoc 
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Having addressed the role of the general agonist, muscarine, on synaptic drive to 
MNs, the next step was to understand which receptor subtype, M2 or M3, was 
responsible for the actions of muscarine.  
The potential role of M3 receptors in the time-dependent effects of exogenous 
activation of muscarinic receptors on synaptic inputs to MNs (see figure 4.14) was first 
assessed. The effects of muscarine, applied in the presence of the M2 antagonist to 
isolate actions mediated by M3 receptors, were assessed at multiple time points after 
drug application. When co-perfused with methoctramine, muscarine decreased PSCs 
inter-event interval (methoctramine: 436.18±99.64ms; methoctramine and muscarine 
before 10min: 212.09±48.18ms; methoctramine and muscarine 15-30min: 
208.33±53.94ms; washout methoctramine: 522.33±95.66ms; n=12; Friedman’s test with 
Dunn’s post-hoc) but had no effect on PSC amplitude (methoctramine: 22.25±2.87pA; 
methoctramine and muscarine before 10min: 22.20±3.23pA; methoctramine and 
muscarine 15-30min: 22.67±3.09pA; washout methoctramine: 20.95±2.68pA; n=12) 
(figure 4.15a).  
As discussed earlier, muscarinic receptor activation might involve both pre- and 
postsynaptic transduction mechanisms. This was again addressed for M3 receptor-
dependent effects by investigating mPSCs in the presence of TTX. Muscarine co-
applied with methoctramine in the presence of TTX (figure 4.15b) significantly 
increased mPSC inter-event interval (TTX and methoctramine: 611.00±73.03ms; TTX, 
methoctramine and muscarine: 947.45±156.59ms; washout TTX and methoctramine: 
783.79±130.01ms; n=16; p<0.05 Friedman’s test with Dunn’s post-hoc) but did not 
affect mPSC amplitude (TTX and methoctramine: 14.98±1.09pA; TTX, methoctramine 
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and muscarine: 14.30±0.61pA; washout TTX and methoctramine: 13.38±0.82pA; 
n=16). 
Activation of muscarinic receptors in the presence of methoctramine had an 
excitatory effect on the frequency of mPSCs, indicating that M3 receptors are involved 
in presynaptic modulation of last-order synapses on MNs. In addition, M2 muscarinic 
receptor blockade removed the delayed muscarine-induced decrease in synaptic inputs 
to MNs, suggesting that activation of M2 receptors decreases the neuronal drive to 
MNs.    
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Figure 4.15 – Muscarine in the presence of M2 receptor blockade increases synaptic 
inputs to MNs; (a) PSCs recorded from a MN illustrating the effect on synaptic drive by 
muscarine (10µM) in the presence of methoctramine (10µM, n=12); (b) recorded 
mPSCs in the presence of methoctramine and muscarine (left) with respective inter-
event interval and amplitude histogram (middle) and cumulative inter-event interval and 
amplitude fraction plots (right) (n=16); all recordings were performed at a holding 
voltage of -60mV; §p<0.05 Friedman’s test with Dunn’s post-hoc 
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To further study the role of M2 muscarinic receptor activation in the time-
dependant muscarinic modulation of synaptic inputs to MNs, the non-selective agonist 
muscarine was perfused in the presence of the M3 receptor blocker 4-DAMP. 
Muscarine in the presence of 4-DAMP increased PSC inter-event interval (4-DAMP: 
348.90±59.23ms; 4-DAMP and muscarine before 10min: 504.44±78.86ms; DAMP and 
muscarine 15-30min: 573.38±95.98ms; washout 4-DAMP: 468.10±77.45ms; n=10; 
p<0.05 repeated measures ANOVA with Tukey’s post-test) and decreased PSC 
amplitude (4-DAMP: 17.08±1.42pA; 4-DAMP and muscarine before 10min: 
15.65±1.28pA; 4-DAMP and muscarine 15-30min: 14.93±1.21pA; washout 4-DAMP: 
14.52±1.42pA; n=10; p<0.05 repeated measures ANOVA with Tukey’s post-test) 
(figure 4.16a).  
Since activation of muscarinic receptors involves last-order synapse modulation, 
mPSCs were again also studied. The muscarine-induced decrease in mPSC amplitude 
remained in the presence of 4-DAMP (TTX and 4-DAMP: 13.94±1.04pA; TTX, 4-
DAMP and muscarine: 12.79±0.7pA; Washout TTX and 4-DAMP: 11.92±0.76pA; 
n=16; p<0.05 repeated measures ANOVA with Tukey’s post-test). However, muscarine 
had no effect on mPSC inter-event interval in the presence of 4-DAMP (TTX and 4-
DAMP: 424.43±59.10ms; TTX, 4-DAMP and muscarine: 503.09±76.73ms; Washout 
TTX and 4-DAMP: 581.49±109.19ms; n=16) (figure 4.16b). 
During M3 receptor blockade muscarine reduced synaptic drive to MNs 
indicating that M2 receptor activation decreases synaptic drive. Interestingly, M2 and 
M3 receptor activation have opposing effects on the synaptic drive to MNs. M3 
receptors increase synaptic inputs whereas M2 receptors decrease the frequency of 
inputs to MNs. Analysis of mPSCs indicates that both M2 and M3 receptors directly 
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modulate synaptic connections with MNs, with M3 receptors likely located on 
presynaptic terminals and M2 receptors positioned postsynaptically.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.16 – Muscarine in the presence of 4-DAMP decreases synaptic inputs to MNs. 
(a) example of acquired PSCs (left) with inter-event interval and amplitude histogram 
graph (right) in the presence of 4-DAMP (2µM) co-perfused with muscarine (10µM, 
n=10); (b) representative traces of mPSCs (with 0.5µM TTX) recorded in the presence 
of 4-DAMP and muscarine (left) with average inter-event interval and amplitude plots 
(middle) and cumulative inter-event interval and amplitude fractions (right) (n=16). All 
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recordings were performed at a holding voltage of -60mV; #p<0.05 repeated measures 
ANOVA with Tukey's post-test 
 
Results from previous sections indicated the presence of endogenous M2 and 
M3 receptor-dependent actions on MNs, even in spinal cord slice preparations (see 
figure 4.8). To address if endogenous release of ACh also modulates synaptic inputs to 
MNs via activation of muscarinic receptors, M2 and M3 receptor antagonists were 
perfused and PSCs were recorded from MNs. Perfusion of methoctramine in spinal cord 
slices (figure 4.17a) decreased PSC inter-event interval (control: 519.99±113.58ms; 
methoctramine: 375.10±96.49ms; washout: 578.15±114.24ms; n=8; repeated measures 
ANOVA with Tukey’s post-test) but had no effect on PSC amplitude (control: 
19.31±3.06pA; methoctramine: 17.93±2.91pA; washout: 15.82±1.44pA; n=8). 
Application of the M3 receptor antagonist 4-DAMP (figure 4.17b) increased PSC inter-
event interval (control: 400.08±82.19ms; 4-DAMP: 630.86±106.93ms; washout: 
735.02±133.45ms; n=6; p<0.05 repeated measures ANOVA with Tukey’s post-test) but 
had no effect on PSC amplitude (control: 19.87±2.30pA; 4-DAMP: 18.13±2.24pA; 
washout: 16.72±2.02pA; n=6). 
These data demonstrate that endogenous activation of M2 and M3 receptors in 
spinal cord slice preparations modulates synaptic drive to MNs: M2 receptors decrease 
synaptic drive whereas M3 receptors increase synaptic inputs to MNs. 
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Figure 4.17 – M2 receptor antagonism increases and M3 receptor blockade decreases 
synaptic inputs to MNs. (a) recorded PSCs (left) with inter-event interval and amplitude 
histogram (right) in the presence of methoctramine (10µM, n=8); (b) example of 
acquired PSCs (left) with inter-event interval and amplitude histogram graph (right) in 
the presence of 4-DAMP (2µM, n=6); All recordings were performed at a holding 
voltage of -60mV; #p<0.05 repeated measures ANOVA with Tukey's post-test 
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4.2. Chemogenetic interrogation of Pitx2+ IN-derived 
cholinergic modulation of MNs and locomotor output 
Having characterized muscarinic modulation of MN function and lumbar spinal 
locomotor circuitry, this work next focused on understanding which subpopulations of 
cholinergic INs are responsible for some of the endogenous, muscarinic receptor-
mediated effects that were revealed via pharmacological experiments. Pitx2+ INs are the 
only group of cholinergic spinal INs that have been genetically identified (Zagoraiou et 
al., 2009). These INs form large C-bouton synapses on MNs with indirect evidence 
suggesting that Pitx2+ cells modulate MN output through postsynaptic M2 receptors 
(Miles et al., 2007; Zagoraiou et al., 2009; Witts et al., 2014). Given the previously 
indirect methods used to investigate the likely roles of Pitx2+ INs and C-boutons in 
controlling MN output, the present study sort to provide more direct evidence of the 
effect of Pitx2+ cell activation on MN properties.  
DREADD technology allows the expression of excitatory (Gq) or inhibitory (Gi) 
metabotropic receptors that can only be activated with a designer drug (CNO) thus 
allowing chemogenetic activation or inhibition of neuronal activity (Zhu et al., 2017). 
Meanwhile, the cre-lox recombination system enables the selective expression of genes 
in specific neuronal subtypes. DREADD technology and cre-lox recombination were 
therefore used to enable the selective manipulation of Pitx2+ INs in order to help 
understand the cholinergic mechanisms by which this particular subset of INs modulates 
motor output.  
DREADD mice were used to test the role of the activation (Pitx2-Cre;CHRM3) 
and inhibition (Pitx2-Cre;CHRM4) of Pitx2+ INs on MN function and locomotor 
network output. Considering that the majority of Pitx2+ INs are spontaneously active at 
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low firing rates (Zagoraiou et al., 2009), it was first assessed whether DREADD-
engineered proteins could increase or decrease tonic Pitx2+ IN activity in spinal cord 
slices from Pitx2-Cre;TdTom;CHRM3/CHRM4 mice (sections 4.2.1 and 4.2.4). After 
verifying the ability of DREADDs to manipulate Pitx2+ IN activity, experiments 
investigated whether MN output was altered in response to activation of Pitx2+ INs with 
CNO in intact spinal cords from Pitx2-Cre;CHRM3 mice. Considering the indirect 
evidence suggesting that M2 receptors are responsible for Pitx2+ IN-mediated 
modulation of MN output (Miles et al., 2007; Witts et al., 2014) and that Kv2.1 
channels are clustered postsynaptically at C-bouton synapses (Wilson et al., 2004; 
Deardorff et al., 2014), it was explored if these proteins were part of the mechanism 
underlying Pitx2+ IN-mediated modulation of MN function (sections 4.2.1-4.2.3). After 
investigating the mechanism through which this subset of cholinergic INs affects MN 
output, the next step was to investigate the role of Pitx2+ IN-derived cholinergic 
modulation in rhythmically active locomotor networks. Since Pitx2+ INs are active 
during fictive locomotion, with their activity typically in phase with the ventral root 
output of the lumbar segment in which they reside (Zagoraiou et al., 2009), inhibition of 
Pitx2+ IN activity in Pitx2-Cre;CHRM4 mice was utilised to investigate their 
contribution to drug-induced locomotor-related output. This was assessed via recordings 
from single MNs or ventral roots of isolated spinal cord preparations (section 4.2.1-
4.2.7). 
The effects of the designer drug CNO and its metabolites have not been 
completely characterized however the majority of the authors suggest that it is 
pharmacologically inert at lower doses and concentrations (Roth, 2016). To insure that 
the effects of CNO application in tissue in which DREADDS were selectively 
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expressed by Pitx2+ INs was due to their chemogenetic activation and inactivation, 
CNO was perfused in spinal cords from animals that had the LoxP-STOP-LoxP cassette 
for DREADDs but did not express Cre-recombinase rendering the engineered receptor 
expression null (sections 4.2.1, 4.2.2 and 4.2.6). 
 
4.2.1. Pitx2+ INs can be excited using DREADD technology  
 It was first tested whether Pitx2+ INs could be activated using excitatory 
(hM3Dq receptor) DREADD expression. This was assessed using whole-cell patch-
clamp recordings of Pitx2+ INs in spinal cord slices obtained from Pitx2-
Cre;TdTomato;CHRM3 mice. In these mice Pitx2+ cells express both the hM3Dq 
receptor and the TdTomato red fluorescent reporter, which allowed them to be 
identified for single-cell electrophysiology. As reported previously (Zagoraiou et al., 
2009), Pitx2+ INs were found to be tonically active at rest (figure 4.18a). Application of 
CNO (1µM) was found to increase the tonic firing rate of Pitx2+ INs in slices from 
Pitx2-Cre;TdTomato;CHRM3 mice  (control: 1.82±0.48Hz; CNO: 2.98±0.84Hz; n=8; 
p<0.05 paired t-test). 
The exact mechanism of action of CNO on DREADD receptors has often been a 
theme of controversy with recent work suggesting that the by-product of CNO – 
clozapine – is the compound responsible for activation of the engineered receptors 
(Gomez et al., 2017). Authors have pointed out that there might be nonspecific actions 
of CNO and clozapine both in vivo and in vitro (MacLaren et al., 2016; Roth, 2016) 
implying the need for rigorous control experiments. To address this, CNO was perfused 
in spinal cord slices from Pitx2-Cre;TdTomato neonates that express the red fluorescent 
reporter in Pitx2+ INs, but not the DREADD receptor. Changes in spontaneous firing 
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activity were recorded to check if CNO would significantly affect the output of these 
INs. In spinal cord slices from Pitx2-Cre;TdTomato mice application of CNO did not 
change spontaneous firing (control: 0.921±0.094Hz; CNO: 0.851±0.103Hz; n=5 (figure 
4.18b).  
Taken together, these data confirm that Cre recombinase-based selective 
expression of the hM3Dq receptor, can be used to selectively activate Pitx2+ INs. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.18 – Pitx2+ INs can be activated using DREADD technology. (a) firing of a 
Pitx2+ IN from a Pitx2-Cre;TdTom;CHRM3 mouse in the presence of CNO (1µM, left) 
with mean spontaneous firing plot (right, n=8); (b) Spontaneous firing of a Pitx2+ IN 
from Pitx2-Cre;TdTom mice before and in the presence of CNO (left) and respective 
firing plot (right, n=5); *p<0.05 paired t-test 
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4.2.2. Chemogenetic activation of Pitx2+ INs induces an inward current 
in MNs  
Knowing that Pitx2+ INs could be activated by CNO in Pitx2;CHRM3 mice, the 
effects of Pitx2+ INs and their C-bouton contacts with MNs were next assessed by 
performing whole-cell patch-clamp recordings of MNs in whole spinal cord 
preparations. It was first investigated whether Pitx2+ IN activation induced any 
subthreshold currents in MNs.  
In spinal cords from Pitx2;CHRM3 mice, activation of Pitx2+ INs with CNO 
elicited an inward current in MNs (-37.49±5.88pA, n=14) that was associated with an 
increase in input resistance (control: 76.82±8.68MΩ, CNO: 89.69±11.46MΩ, reversal -
78.57mV, n=11; figure 4.19a). Given that M2 receptors are clustered postsynaptically at 
C-bouton synapses formed by Pitx2+ INs on MNs, it was then tested whether this 
inward current was blocked by methoctramine. In the presence of methoctramine, the 
application of CNO no longer induced an inward current in MNs (-2.16±4.07pA, n=9; 
figure 4.19b). It was next assessed whether the blockade of Kv2.1 channels, which are 
also clustered postsynaptically at C-bouton synapses, might underlie this change in 
holding current and associated increase in input resistance in MNs upon Pitx2+ IN 
activation.  However, when CNO was applied in the presence of the Kv2.1 blocker 
guangxitoxin-1E (50nM), inwards currents (-29.50±6.51pA, n=10) and an increase in 
input resistance (guangxitoxin-1E: 50.09±3.77MΩ, guangxitoxin-1E and CNO: 
56.74±3.62MΩ, reversal -77.49mV, n=8) were still recorded in MNs (figures 4.19c). 
In CHRM3 mice the absence of Cre-recombinase means the CHRM3 gene is not 
expressed. In these animals CNO was perfused and electrophysiological properties were 
recorded from MNs from intact spinal cords to check for any nonspecific effects on 
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MNs when hM3Dq was not expressed in Pitx2+ INs. As seen in figures 4.19d, in 
CHRM3 mice, CNO did not induce change in holding current in MNs (n=14).  
These data demonstrate that activation of Pitx2+ INs leads to a depolarizing 
current and increase in input resistance in MNs which involves activation of M2 
muscarinic receptors but does not involve Kv2.1 channels located at the C-bouton 
synapse.  
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Figure 4.19 – Pitx2+ INs activation induces an inward current in MNs through the 
activation of M2 muscarinic receptors. voltage clamp currents (left) and current-voltage 
relation (right) from MNs in intact spinal cord preparations from Pitx2-Cre;CHRM3 
mice in the presence of (a) CNO (1µM, n=14 and n=11) and (b) CNO co-applied with 
methoctramine (10µM, n=9 and n=8) or (c) guangxitoxin-1E (50nM, n=10 and n=8). 
(d) example of changes in voltage-clamp current from a MN from CHRM3 mice 
(n=14). 
 
4.2.3. Chemogenetic activation of Pitx2+ INs increases MN firing via 
activation of M2 receptors and regulation of Kv2.1 channels 
Following the demonstration that Pitx2+ INs could be activated with CNO in 
Pitx2;CHRM3 mice and that this resulted in modulation of the holding current and input 
resistance of MNs, it was next assessed whether activation of Pitx2+ INs modulated the 
firing output of MNs.  
MN input-output relationships were investigated using a series of depolarising 
current steps (50pA increments; 1s duration) applied in current-clamp mode during 
whole-cell patch-clamp recordings of MNs in isolated spinal cord preparations.  As seen 
in figure 4.20a, when Pitx2+ INs were activated using CNO, the maximum firing 
frequency of MNs increased (control: 26.08±2.05Hz; CNO: 30.20±2.00Hz; n=25; 
p<0.001 paired t-test).  
Next, the postsynaptic receptors and channels involved in this Pitx2+ IN-
mediated modulation in MN output were assessed. Activation of Pitx2+ INs in the 
presence of the M2 receptor antagonist methoctramine had no effect on MN firing 
(methoctramine: 32.00±2.72Hz; methoctramine and CNO: 30.50±2.33Hz; n=12). 
Similarly, blockade of Kv2.1 channels with guangxitoxin-1E (50nM) prevented changes 
in MN firing upon Pitx2+ IN activation (guangxitoxin-1E: 28.80±1.90Hz; guangxitoxin-
1E and CNO: 28.67±1.66Hz; n=15) (figures 4.20b-c).  
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In CHRM3 only animals lacking DREADD expression, CNO did not affect 
maximum firing (control: 25.92±2.00Hz; CNO: 26.33±1.68Hz; n=17; figure 4.20d). 
These results again demonstrate that CNO alone does not affect MN function in mice.   
These results indicate that activation of Pitx2+ INs through the hM3Dq receptor 
signalling pathway resulted in activation of M2 muscarinic receptors juxtaposed to C-
boutons, which led to an increase in the maximum firing capability of MNs. In addition, 
data support that Kv2.1 channels are required for this increase in MN output. 
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Figure 4.20 – Pitx2+ INs increase MN maximum firing through the activation of M2 
muscarinic receptors and subsequent modulation of Kv2.1. Representative firing step 
(left) with respective current-frequency plot (middle) and histogram of MN maximum 
firing averages (right) from Pitx2-Cre;CHRM3 mice showing that (a) activation of 
Pitx2+ INs (CNO 1µM) increased the maximum firing rate observed in MNs (n=25), 
which was (b) blocked by methoctramine (10µM, n=12) and (c) guangxitoxin-1E 
(50nM, n=15); (d) example of firing step (left) with respective frequency-current plot 
(middle) and averaged maximum firing (n=17, right) from CHRM3 mice MNs in 
presence of CNO.*p<0.001 paired t-test 
 
4.2.4. Pitx2+ INs increase MN firing via M2 receptor/Kv2.1 channel-
dependent shortening of action potential half-width 
The mechanisms by which activation of Pitx2+ INs and their C-bouton contact 
with MNs modulates MN output was next investigated. Previous, indirect evidence 
suggested that activation of M2 receptors at C-boutons is likely to increase MN output 
through a reduction in the amplitude of the mAHP (Miles et al., 2007). It was therefore 
first assessed whether chemogenetic activation of Pitx2+ INs reduced the action 
potential AHP of MNs within isolated spinal cord preparations from Pitx2-Cre;CHRM3 
mice. Single action potentials were evoked in current-clamp mode using brief (10ms) 
depolarising current steps and mAHPs were measured. Surprisingly, DREADD-
mediated activation of Pitx2+ INs increased the mAHP amplitude in MNs (control: -
2.00±0.35mV; CNO: -3.07±0.50mV; n=22; p<0.01 Wilcoxon matched pairs test). This 
effect was dependent on M2 receptor activation, as revealed by its block by 
methoctramine (methoctramine: -3.00±0.70mV; methoctramine and CNO: -
2.55±0.45mV; n=7), but did not involve Kv2.1 channels, as indicated by a lack of 
blockade by guangxitoxin-1E (guangxitoxin-1E: -1.46±0.22mV; guangxitoxin-1E and 
CNO: -2.17±0.32mV; n=11; p<0.05 paired t-test) (figure 4.21a).  
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The increase in MN mAHP observed after activation of Pitx2+ INs indicates that 
mAHP modulation does not underlie increases in MN firing, therefore other protocols 
were used to further explore potential mechanisms by which Pitx2+ INs increase MN 
output. A depolarising current ramp (1s long) was used to check for changes in MN 
action potential threshold. As illustrated in figure 4.21b, Pitx2+ INs activation decreased 
action potential threshold (control: -39.20±3.20mV; CNO: -41.85±3.03mV; n=12; 
p<0.05 Wilcoxon matched pairs test), even in the presence of the Kv2.1 blocker 
(guangxitoxin-1E: -33.17±3.20mV; guangxitoxin-1E and CNO: -35.12±3.40mV; n=5; 
p<0.05 paired t-test), but not with prior M2 receptor blockade (methoctramine: -
37.70±1.65mV; methoctramine and CNO: -35.70±1.04mV; n=5). Thus, although a 
Pitx2+ IN-dependent decrease in firing threshold may contribute to increased MN 
excitability, given that guangxitoxin-1E did not block the change in firing threshold, 
this is unlikely to underlie increases in the maximum rate of MN firing which were 
blocked by the Kv2.1 channel antagonist (see figure 4.20).        
Modulation of voltage-gated K+ channels, such as Kv2.1 channels, can increase 
neuronal firing by decreasing the action potential half-width (Bean, 2007; Fletcher et 
al., 2017). To address if the activation of Pitx2+ INs affected action potential kinetics, 
the half-width of single action potentials recorded from MNs of Pitx2-Cre;CHRM3 
mice was next investigated (figure 4.21c). Following activation of Pitx2+ INs with 
CNO, the half-width of MN action potentials was found to decrease (control: 
1.50±0.07ms; CNO: 1.37±0.07ms; n=20; p<0.001 Wilcoxon matched pairs test). This 
effect was blocked by both methoctramine (methoctramine: 1.44±0.13ms; 
methoctramine and CNO: 1.52±0.14ms; n=11) and guangxitoxin-1E (guangxitoxin-1E: 
1.19±0.07ms; guangxitoxin-1E and CNO: 1.21±0.05ms; n=13), demonstrating a 
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dependence upon M2 receptors and Kv2.1 channels respectively. The kinetics of 
voltage-gated Na+ channels can affect the action potential rise time but also the half-
width of action potentials (Bean, 2007). The potential influence of modulation of Na+ 
channels in Pitx2+ IN-dependent reduction in MN action potential half-width was 
therefore also assessed by measuring action potential rise-time. However, no significant 
change in the rise time of MN action potentials was observed after activation of Pitx2+ 
INs by CNO (control: 0.89±0.07ms; CNO: 0.85±0.05ms; n=20).  
These results indicate that chemogenetic activation of Pitx2+ INs results in an 
increase in MN output through a mechanism involving activation of M2 muscarinic 
receptors and a Kv2.1 channel-dependent shortening of MN spike half-width. The 
activation of Pitx2+ INs also decreased voltage threshold and increased mAHP 
amplitude in MNs which was dependent on M2 receptors but not Kv2.1. This suggests 
that Pitx2+ INs modulate MN output through multiple pathways that are dependent on 
M2 receptor signalling cascades at the C-bouton synapse, not all of which involve 
actions on Kv2.1 channels. Overall, these experiments provide novel evidence of direct 
modulation of MN output by Pitx2+ INs and their C bouton synapses.  
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Figure 4.21 - Activation of Pitx2+ INs increases MN output through a reduction of the 
spike half-width and involves M2 receptors and Kv2.1 channels. (a) truncated single 
action potentials illustrating changes in the amplitude of the mAHP after DREADD-
based activation of Pitx2+ INs (CNO 1µM, n=22), in the presence of the M2 antagonist 
(10µM, n=7) and guangxitoxin-1E (50nM, n=11) with respective average plots; (b) 
example of MN response to a depolarizing current ramp (1s duration) illustrating action 
potential threshold upon perfusion of CNO (n=12), methoctramine with CNO (n=5) and 
guangxitoxin-1E with CNO (n=5); (c) superimposed action potentials recorded from a 
MN before and after CNO illustrating action potential half-width following activation of 
Pitx2+ INs (n=20), with methoctramine (n=11) and the Kv2.1 blocker (n=13); *p<0.05 
paired t-test; ¤¤p<0.01 ¤¤¤p<0.001 Wilcoxon matched pairs test 
 
 
4.2.5. Pitx2+ INs can be inhibited using DREADD technology  
Having characterized mechanisms of Pitx2+ IN-mediated modulation of MN 
firing, the next experiments aimed to understand the role these neurons play in 
controlling behaviourally-relevant MN output, such as that produced to control 
locomotion. Pitx2+ INs are known to be active during fictive locomotion (Zagoraiou et 
al., 2009). Therefore, increasing their activity further with excitatory DREADDs may 
not clearly reveal their roles and could paradoxically reduce their activity due to a 
‘depolarising block’ involving inactivation of Na+ channels. A strategy utilising 
inhibitory DREADDs (hM4Di inhibitory receptor) was therefore chosen to help 
interrogate the role of Pitx2+ INs in controlling locomotor-related MN output.  
It was first assessed whether the hM4Di inhibitory receptor (encoded by the 
CHRM4 gene) could be used to selectively inhibit Pitx2+ INs. Whole-cell patch-clamp 
recordings were performed from Pitx2+ INs in slices prepared from Pitx2-
Cre;TdTomato;CHRM4 mice, which selectively express both the fluorescent TdTomato 
protein and the inhibitory DREADD receptor in Pitx2+ INs.  As seen in figure 4.22 
perfusion of CNO significantly decreased the spontaneous firing of Pitx2+ INs (control: 
1.64±0.43Hz; CNO: 1.17±0.39Hz; n=10; p<0.05 paired t-test). Thus, Pitx2+ INs can be 
inhibited with DREADDs.  
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Figure 4.22 – Pitx2+ INs activity can be decreased using DREADDs. Spontaneous 
firing of a Pitx2+ IN from Pitx2-Cre;TdTom;CHRM4 mice before and in the presence of 
CNO (1µM) with mean spiking plot (n=10); *p<0.05 paired t-test  
 
4.2.6. Chemogenetic inhibition of Pitx2+ INs reveals tonic currents in 
MNs 
Having established that DREADD technology can be used to inhibit Pitx2+ IN 
activity, the effects of this inhibition on MN function were next investigated. Whole-
cell patch-clamp recordings were performed from MNs within intact spinal cord 
preparations from Pitx2-Cre;CHRM4 mice. Given that the goal was to assess the effects 
of reducing Pitx2+ IN activity, MN recordings were performed in the presence of drugs 
used to induce locomotor-related activity (NMDA, DA and 5-HT) because Pitx2+ INs 
are known to be particularly active during fictive locomotion. It was first accessed 
whether inhibition of Pitx2+ INs blocked tonic inwards currents expected to be induced 
by Pitx2+ IN activity (see figure 4.19a).   Inhibition of Pitx2+ INs with CNO elicited a 
outward current (102.04±13.92pA, n=11) that was associated with a decrease in input 
resistance (NMDA, DA and 5-HT: 91.92±10.33MΩ, NMDA, DA, 5-HT and CNO: 
65.57±5.17MΩ, reversal -114.60mV, n=6). This effect of CNO was blocked by 
methoctramine (n=3) (figure 4.23).  
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These results demonstrate that, in the presence of locomotor drugs, inhibition of 
Pitx2+ INs hyperpolarizes MNs and decreases their input resistance via an M2-
dependent pathway. These effects are opposite to those observed using DREADD-based 
activation of Pitx2+ INs (Pitx2-Cre;CHRM3 mice; section 4.2.1). This indicates that 
inhibition of Pitx2+ INs blocks a resting depolarizing current that is present due to tonic 
activity of Pitx2+ INs. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.23 –Inhibition of active Pitx2+ INs elicits an outward during fictive 
locomotion. (a) MN recording in voltage clamp mode from intact spinal cord 
preparations illustrating changes in current (left, n=11) and respective current-voltage 
relation (right, n=6) after Pitx2+ IN activation (CNO 1µM) and (b) change in holding 
current in the presence of methoctramine (10µM, n=3) in Pitx2-Cre;CHRM4 mice. 
 
  
4.2.7. Chemogenetic inhibition of Pitx2+ INs reduces MN firing 
To address if DREADD-based inhibition of Pitx2+ INs would impact MN 
output, single-cell recordings were performed from MNs during drug-induced 
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locomotion. Passive, gap-free recordings were used to assess the firing rates of MNs 
that demonstrated locomotor-related bursting activity, while current steps were applied 
to MNs that were not active or exhibited very few action potentials during the 
pharmacologically-induced locomotor-related activity. Figures 4.24 shows that the rate 
of MN firing per burst during locomotor-related bursting was reduced when Pitx2+ INs 
were chemogenetically inhibited (control: 12.20±1.99Hz; CNO: 4.31±1.05Hz; n=4; 
p<0.05 paired t-test). Analysis of the firing rates of MNs in which current steps could be 
applied revealed a reduction in maximum firing rate when Pitx2+ INs were inhibited 
with CNO (control: 24.57±3.20Hz; CNO: 12.43±2.30Hz; n=7; p<0.05 paired t-test). 
Together these results demonstrate that inhibition of Pitx2+ INs in Pitx2-
Cre;CHRM4 mice reduces MN firing. These results support that Pitx2+ INs are 
important for the increase in firing output of MNs during episodes of fictive 
locomotion. 
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Figure 4.24 – DREADD-mediated inhibition of Pitx2+ INs decreased MN firing during 
episodes of fictive locomotion. (a) spontaneous firing from a MN during fictive 
locomotion (left) with average firing frequency per burst plots (right, n=4) and (b) 
representation of MN maximum output in response to increments of current injection 
after Pitx2+ INs inhibition (CNO 1µM, left) with respective current-frequency plot 
(middle) and firing averages histogram (right, n=7); *p<0.05 paired t-test. 
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4.2.8. Chemogenetic inhibition of Pitx2+ INs during fictive locomotion 
decreases ventral root burst amplitude 
Next, the effects of DREADD-based inhibition of Pitx2+ INs on population level 
MN output were assessed. This was achieved by performing ventral root recordings 
from spinal cords isolated from Pitx2-Cre;CHRM4 mice during pharmacologically-
induced (NMDA, DA and 5-HT) locomotor activity. Pitx2+ INs were inhibited via 
perfusion of CNO. As seen in figure 4.25, inhibition of Pitx2+ INs during fictive 
locomotion decreased ventral root burst amplitude (control: 0.803±0.105; CNO: 
0.715±0.096; washout: 0.779±0.115; n=14; p<0.05 one-way ANOVA with Tukey’s 
post-test). However, inhibition of Pitx2+ INs had no significant effects on burst duration 
(control: 2252±618ms; CNO: 1893±557ms; washout: 1829±504ms; n=14), burst 
frequency (control: 0.229±0.033Hz; CNO: 0.229±0.034Hz; washout: 0.251±0.038Hz; 
n=14) or burst frequency variance (control: 5.560×10-3±2.283×10-3Hz2; CNO: 
7.547×10-3±1.984×10-3 Hz2; washout: 8.744×10-3±3.812×10-3Hz2; n=14).  
In CHRM4 only animals, which lack DREAD expression, CNO had no 
significant effects on locomotor-related ventral root burst frequency (control: 
0.227±0.038Hz; CNO: 0.240±0.041Hz; washout: 0.297±0.056Hz; n=8), frequency 
variance (control: 7.320±2.390×10-3Hz2; CNO: 6.816×10-3±2.012×10-3Hz2; washout: 
7.637×10-3±1.963×10-3Hz2; n=8), duration (control: 2074±555ms; CNO: 1639±366ms; 
washout: 1604±349ms; n=8) or amplitude (control: 0.630±0.118; CNO: 0.626±0.103; 
washout: 0.553±0.110; n=8) (figure 4.26). This confirms that CNO has no non-specific 
actions on spinal neurons and spinal locomotor network output.   
These data demonstrate that Pitx2+ INs are active during locomotion and that 
their activity contributes to an intensification of the strength of locomotor-related motor 
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output. Meanwhile, Pitx2+ INs appear to have little influence on rhythm or pattern 
generating elements of spinal motor circuits.  
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Figure 4.25 – Inhibition of Pitx2+ INs during fictive locomotion decreases burst 
amplitude (a) raw (top) and integrated/rectified (bottom) traces and (b) averaged time 
course plots (left) and histograms of pooled data (right) showing the effects of inhibition 
of Pitx2+ INs (CNO 1µM) on ventral root output (n= 14); #p<0.05 repeated measures 
ANOVA with Tukey’s post-test 
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Figure 4.26 – CNO has no unspecific effects on ventral root output in control mice. (a) 
raw (top) and integrated/rectified (bottom) traces with (b) averaged time course plots 
(left) and mean pooled data (right) showing no effect of CNO (1µM) in CHRM4 mice 
drug-induced locomotor output (n=8). p>0.05 repeated measures ANOVA 
 
 
4.2.9. The regulation of locomotor-related MN output by Pitx2+ INs 
involves M2 muscarinic receptors 
The role of M2 muscarinic receptors, found at C-bouton synapses, in the Pitx2+ 
IN-mediated modulation of locomotor output was next investigated. CNO was applied 
in the presence of the M2 receptor antagonist methoctramine, to isolated spinal cord 
preparations from Pitx2Cre;CHRM4 mice during pharmacologically-induced, fictive 
locomotion. DREADD-mediated inhibition of Pitx2+ INs in the presence of 
methoctramine (figure 4.27) had no significant effects on burst frequency 
(methoctramine: 0.281±0.057Hz; methoctramine and CNO: 0.242±0.053Hz; washout 
(methoctramine): 0.255±0.050Hz; n=8), frequency variance (methoctramine: 4.504×10-
3±2.383×10-3Hz2; methoctramine and CNO: 7.653×10-3±3.666×10-3Hz2; washout 
(methoctramine): 4.873×10-3±1.117×10-3Hz2; n=8), burst duration (methoctramine: 
2644±1023ms; methoctramine and CNO: 2880±1213ms; washout (methoctramine): 
2682±1094ms; n=8) or burst amplitude (methoctramine: 0.935±0.134; methoctramine 
and CNO: 0.912±0.137; washout (methoctramine): 0.900±0.128; n=8).  
The above results further confirm that M2 muscarinic receptors at the C-bouton 
synapse are involved in the modulation of MN function. Blockade of M2 receptors 
removed the Pitx2+ IN-mediated modulation of MN output and as a result CNO-induced 
inhibition of Pitx2+ INs no longer decreased ventral root burst amplitude. This is in line 
with the results with methoctramine from previous experiments in Pitx2-Cre;CHRM3 
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mice (section 4.2.2) highlighting the involvement of M2 muscarinic receptors as the key 
target underlying cholinergic modulation from this subset of spinal INs.  
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Figure 4.27 - DREADD-mediated inhibition of Pitx2+ INs during fictive locomotion is 
dependent on M2 receptors. (a) raw (top) and integrated/rectified (bottom) traces with 
(b) averaged time course plots (left) and mean pooled data (right) showing the effect of 
prior blockade of M2 receptors with methoctramine (10µM) on the inhibitory actions of 
CNO (1µM) in Pitx2-Cre::CHRM4 mice drug-induced locomotor output (n=8). p>0.05 
repeated measures ANOVA 
 
 
 
 
4.3. Genetic ablation of Pitx2+ INs and C-boutons reveals M2 
muscarinic receptor-mediated modulation of the intensity 
of locomotor-related output 
Results from the previous sections indicate that Pitx2+ INs modulate MN output 
via M2 receptors found at C-bouton synapses, with activity of Pitx2+ INs causing an 
increase in MN output. Genetic ablation of interneuronal populations in the spinal cord 
has proven useful to fully understand the role of specific types of INs in locomotor 
circuitry (Goulding, 2009; Arber, 2012). The effects of ablating cholinergic Pitx2+ INs 
on locomotor network output was therefore next assessed.  
Pitx2::Cre mice were crossed with novel VAChT-loxP-STOP-loxP-DTA animals 
in order to achieve conditional ablation of cholinergic Pitx2+ INs via diphtheria toxin A, 
whose Cre-inducible expression has been widely used for in vivo genetic deletion of 
spinal INs (Crone et al., 2008). As illustrated in figure 4.28, 25 day old Pitx2-
Cre;TdTomato;DTA mice exhibit a clear reduction of C-boutons to MNs. This was 
calculated as a 92.3% loss of cholinergic Pitx2+ INs, indicating a high degree of 
efficiency in the conditional ablation of these INs (figure and quantification courtesy of 
Maria Mina and Laskaro Zagoraiou, Academy of Athens).  
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Figure 4.28 – Genetic ablation of cholinergic Pitx2+ INs eliminates C-boutons around 
MN soma. Spinal cord from a 25 days old Pitx2-CreTdTomato;DTA (bottom) and age-
matched control Pitx2-Cre;TdTomato mice (top), depicting the lack of cholinergic C-
boutons to MNs. Tmt – TdTomato fluorescent reported; ChAT – choline 
acetyltransferase; VAChT – vesicular acetylcholine transporter; C-boutons are 
highlighted in white boxes (top). Figure is a courtesy of Maria Mina and Laskaro 
Zagoraiou, Academy of Athens. 
 
The effects of the genetic ablation of cholinergic Pitx2+ INs, and their C-
boutons, was assessed during pharmacologically-induced locomotion in spinal cord 
preparations from Pitx2-Cre;DTA mice. The M2 antagonist methoctramine was 
perfused to investigate if the previously described decrease in burst amplitude (section 
4.1.1) was removed when Pitx2+ INs and their C boutons were absent. As illustrated in 
figure 4.29, bath application of methoctramine in Pitx2-Cre;DTA mice significantly 
decreased burst frequency variance (control: 1.572×10-3±7.370×10-4Hz2; 
methoctramine: 9.403×10-4±5.946×10-4Hz2; washout: 9.762×10-4±4.990×10-4Hz2; n=4; 
p<0.05 repeated measures ANOVA with Tukey’s post-test) and increased burst duration 
(control: 1757±332ms; methoctramine: 3696±850ms; washout: 2274±924ms; n=4; 
p<0.05 Friedman’s test with Dunn’s post-test). However, the M2 receptor antagonist 
had no significant effect on burst frequency (control: 0.252±0.097Hz; methoctramine: 
0.201±0.083Hz; washout: 0.206±0.079Hz; n=4) or burst amplitude (control: 
1.128±0.115; methoctramine: 1.132±0.102; washout: 1.182±0.152; n=4).  
The data from these experiments suggest that Pitx2+ INs and their C-bouton 
contacts with MNs are solely responsible for the M2 muscarinic receptor-mediated 
modulation of the intensity of locomotor-related output. In addition, these data suggest 
that the additional effects of M2 receptor activation on locomotor network function do 
not involve Pitx2+ INs or C-bouton synapses.  
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Figure 4.29 – Genetic ablation of Pitx2+ INs in Pitx2-Cre;DTA mice removes 
inhibitory effect on burst amplitude elicited by methoctramine. (a) raw (top) and 
integrated/rectified (bottom) traces with (b) averaged time course plots (left) and mean 
pooled data (right) illustrating the effects of methoctramine (10µM) on Pitx2-Cre;DTA 
ventral root output (n=4); p<0.05 repeated measures ANOVA with Tukey’s post-test. § 
p<0.05 Friedman’s test with Dunn’s post-test 
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5. DISCUSSION 
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5.1. Muscarinic modulation of spinal locomotor networks 
and MN function in the neonatal mouse spinal cord 
ACh is released during locomotion (Huang et al., 2000; Dai et al., 2009; Dai and 
Jordan, 2010) acting as a neuromodulator of CPG networks in mammals (Cowley and 
Schmidt, 1994; Miles et al., 2007; Jordan et al., 2014). High concentrations of ACh or 
muscarine in the neonatal rat spinal cord can increase network excitability which can 
result in the generation of bursts of motor activity, however these can be erratic with no 
stable right-left alternation or extensor-flexor phase relationship for long-lasting periods 
of time (Cowley and Schmidt, 1994; Kiehn et al., 1996; Jordan et al., 2014). In the 
mouse spinal cord exogenous application of muscarine evokes irregular ventral root 
discharges with no locomotor-like pattern of activity (Jiang et al., 1999). The increase 
in the levels of ACh in the mammalian spinal cord during locomotion does not appear to 
be involved in the initiation and establishment of appropriate rhythmic CPG activity but 
instead in the fine-tuning of spinal locomotor networks through the activation of 
mAChRs (Cowley and Schmidt, 1994; Miles et al., 2007; Dai et al., 2009; Dai and 
Jordan, 2010; Jordan et al., 2014). This characteristic confers ACh a powerful 
modulatory role in spinal locomotor circuitry that required further understanding.  
In order to study the effects of muscarinic receptors on locomotor network 
output, experiments were performed in neonatal mouse spinal cords in the presence of 
NMDA, 5-HT and DA that induced locomotor-related bursts of rhythmic activity stable 
for long periods of time and that exhibit adequate right-left and extensor-flexor 
alternation (Jiang et al., 1999). Considering that M2 and M3 muscarinic receptors are 
widely expressed in the spinal cord (Oguz Kayaalp and Neff, 1980; Welton et al., 1999; 
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Wilson et al., 2004) and appear to be solely responsible for cholinergic modulation of 
locomotor output in isolated rat spinal cord preparations in which ACh levels were 
enhanced by blocking ACh esterase activity (Jordan et al., 2014), selective antagonists 
of these two muscarinic receptors were perfused to study the role of each receptor 
subtype in the modulation of rhythmically active CPG networks and MN output in 
mice. This is the first study that used both muscarinic receptor antagonists in drug-
induced neonatal mouse spinal cord preparations to study endogenous cholinergic 
modulation. In these preparations the levels of ACh were not manipulated nor was 
endogenous ACh used to elicit rhythmic bursts, thus providing a more physiological 
readout and allowing to isolate the effects of each antagonist on the CPG network and 
MN output during in vitro locomotor patterns that resemble walking (Jiang et al., 1999). 
M2 muscarinic receptor antagonism decreased the variability of the locomotor bursts 
while also reducing the amplitude of the ventral root signal. This indicates that 
activation of M2 receptors is responsible for modulation of CPG INs involved in the 
generation of the locomotor rhythm as well as modulation of properties of MNs that 
define the strength of the motor output (section 5.1.1). Pharmacological blockade of M3 
muscarinic receptors destabilized the drug-evoked bursting without a significant effect 
on burst amplitude, indicating that these receptors are important for adequate rhythm 
assembly during fictive locomotion without significantly affecting MN output (section 
5.1.2).  
To explore changes in cellular properties following muscarinic receptor 
activation, single cell recordings were performed from MNs within spinal cord slices. 
MNs are the last target in the locomotor network before initiation of muscle contraction 
and therefore insights regarding the impact of muscarinic receptor activation on these 
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cells will provide valuable information about cholinergic modulation of motor output. 
Exogenous application of muscarine was found to effect subthreshold properties, firing 
output of MNs and synaptic drive to MNs. These effects were found to exclusively 
dependent on M2 and M3 muscarinic receptors. M2 receptor activation elicited an 
outward current, decreased the mAHP amplitude possibly contributing to increased MN 
output and decreased the frequency of synaptic inputs to MNs (section 5.1.3). M3 
receptor activation caused an inward current, influenced MN maximum firing output 
and increased synaptic inputs to MNs (section 5.1.4). Interestingly, M2 and M3 
muscarinic receptors seem to have opposite roles on the modulation of CPG networks 
and MN function in the mouse lumbar spinal cord, indicating that a balance between 
M2 and M3 receptor actions is present (section 5.1.5). 
The interpretation of the results obtained was based on the pharmacological 
effectiveness of the general agonist, muscarine, and the selective M2 and M3 
antagonists, methoctramine and 4-DAMP, respectively. The development of selective 
agonists for muscarinic receptors has been slowed down by the highly conserved 
orthosteric binding site (i.e. active binding site) among the different subtypes of 
receptors due to the shared homology in the transmembrane domains with some of the 
antagonists also displaying concentration-dependent lack of specificity in allosteric 
regulation. This makes the use of muscarinic receptor agonists limited to non-selective 
agonists, with selective antagonists being used to discriminate receptor specificity 
(Korczynska et al., 2018). Methoctramine has high affinity for the M2-receptor with 
approximately 16 times less binding affinity to the M3 receptor (Korczynska et al., 
2018). Some studies have suggested that methoctramine might also have high affinity 
for the M4 muscarinic receptor subtype (M. Waelbroeck et al., 1990), with radioligand 
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binding experiments pointing to the presence of this receptor in the dorsal horn of the 
spinal cord (Höglund and Baghdoyan, 1997). Neurochemistry and electrophysiological 
experiments in double M2/M4-knockout studies performed in the mouse spinal cord 
have implicated the M4 receptor subtype in nociception but not in the control of 
locomotor networks (H. M. Zhang, Zhou, et al., 2007; Zhang et al., 2009; Chen et al., 
2014). However due to the poor selective affinity of M4 receptor ligands, the exact role 
of this receptor in spinal nociception is still unclear. Hence, the actions of 
methoctramine in this work will be discussed as a pharmacological block of only M2 
muscarinic receptors. 4-DAMP has a preference for the M3 muscarinic receptor subtype 
but can also exhibit some affinity for the M1 receptor subtype (Eglen et al., 1994; 
Ehlert, 1996). The M1 subtype does not seem to be present in the spinal cord (Höglund 
and Baghdoyan, 1997) thus the interpretation of the results with 4-DAMP will be 
focused exclusively on the M3 muscarinic receptor.  
 
5.1.1. Modulation of spinal locomotor output by M2 muscarinic 
receptors  
The M2 muscarinic receptor antagonist, methoctramine, decreased the variance 
of burst frequency and increased burst duration indicating that these receptors are 
involved in setting up the regularity of the drug-induced locomotor rhythm. 
Experiments with M2 blockers in ACh-induced bursts of activity in rat spinal cord 
preparations showed that methoctramine increased the frequency of locomotor events 
(Jordan et al., 2014). Also in the neonatal rat spinal cord, experiments stimulating sacral 
dorsal roots while simultaneously increasing the levels of ACh in the sacral region with 
ACh-esterase inhibitors, decreased the frequency of bursts of activity recorded from 
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lumbar ventral roots, an effect that was blocked by methoctramine (Anglister et al., 
2017). The current observations from ventral root recordings in the presence of NMDA, 
DA and 5-HT with methoctramine in mice do not show a statistically significant 
difference in burst frequency between control and drug but report an increase in burst 
duration by methoctramine which could be indicative of a slowing of the rhythm. The 
differences between these results and the observations from other authors (Jordan et al., 
2014; Anglister et al., 2017) could indicate that (1) there are functional differences on 
M2 muscarinic receptor modulation of the frequency of spinal motor output between 
mouse and rat or (2) these modulations are different between NMDA, DA and 5-HT 
induced rhythmogenesis and locomotor activity generated in the presence of ACh-
esterase inhibitors, which will greatly increase the levels of ACh present. As mentioned 
before, there are indeed differences regarding cholinergic-induced locomotion between 
mouse and rat, with perfusion of muscarine eliciting regular bursts of activity in the rat 
spinal cord but not in mice (Kiehn et al., 1996; Jiang et al., 1999). Another important 
factor is that in the present work rhythmic bursting evoked with the locomotor cocktail 
is more regular and exhibits phase alternation between right-left and extensor-flexor 
output, contrary to the experiments performed in the rat spinal cord (Jordan et al., 
2014). In addition, the concentration of released ACh during alternating fictive 
locomotion might be more physiological than when in the presence of high 
concentrations of ACh elicited by ACh-esterase inhibitors or general cholinergic 
agonists, as illustrated by experiments in the mudpuppy spinal cord in which carbacol 
(ACh analog) and physostigmine disrupted the fictive walking rhythm induced by 
NMDA (Fok and Stein, 2002). These differences could underlie changes in M2 receptor 
activation and/or network excitability that might explain the variations in the results on 
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burst frequency with methoctramine when comparing the current results with previous 
work (Jordan et al., 2014; Anglister et al., 2017). Despite these incongruities in the 
experimental setup, recordings performed in the rat lumbar spinal cord also indicated 
that M2 receptor antagonism reduced burst amplitude (Jordan et al., 2014; Anglister et 
al., 2017) which mirrors the decrease in ventral root amplitude elicited by 
methoctramine that is reported in this work. This suggests that there is a level of 
conservation regarding M2 muscarinic receptor effects on motor output amplitude in 
mouse and rat, even with the different approaches used, indicating that activation of 
these receptors increases the strength of locomotor output. 
Groups of cholinergic INs in the spinal cord could be responsible for the 
reported muscarinic effects on the locomotor network. However, apart from Pitx2+ INs, 
there remain a lack of genetic markers for subtypes of spinal cholinergic INs. 
Researchers proposed that cholinergic neurons from sacral segments that project to the 
lumbar region could directly modulate CPG networks and MN output (Etlin et al., 2014; 
Finkel et al., 2014; Anglister et al., 2017). These sacral projecting cholinergic neurons 
could include a variety of different populations of premotor ACh-releasing INs that are 
known to project intersegmentally (Stepien et al., 2010). Most of the cholinergic INs 
that could be involved in modulation of CPG-mediated rhythmogenesis are located in 
the ventromedial area of the spinal cord and they comprise Pitx2+ INs, partition cells 
and contralaterally projecting INs that form synapses with MNs and other spinal INs 
(Sherriff and Henderson, 1994; Huang et al., 2000; Zagoraiou et al., 2009; Bertrand and 
Cazalets, 2011). Pitx2+ INs are suggested to directly modulate MN output through M2 
muscarinic receptors (Miles et al., 2007; Zagoraiou et al., 2009) thus, they are likely to 
be responsible for the decrease in burst amplitude and MN firing caused by 
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methoctramine. The potential roles of these INs in drug-induced locomotion will be 
addressed in later sections discussing the results from DREADD experiments in which 
Pitx2+ INs were selectively activated and inhibited (section 5.2).  
Phase alternation between antagonistic muscles and right-left sides is crucial for 
adequate spinal locomotor activity (Brown, 1911). This can be replicated during in vitro 
drug-induced locomotor-bursts of activity in the neonatal mouse spinal cord allowing to 
study effects of modulators that may affect these phase relationships (Jiang et al., 1999). 
This study did not systematically measure any eventual variations in extensor-flexor or 
right-left alternation, however a clear breakdown of these relationships upon blockade 
of muscarinic receptors was not observed. The data obtained during fictive locomotion 
reports changes in ventral root burst duration, frequency and variance in the presence of 
the antagonists used, which could reflect a modulation of different types of CPG INs in 
the mouse spinal cord. In V1 knockout mice, the duration of the bursts during stepping 
behaviour was decreased (Gosgnach et al., 2006). V1 INs do not express cholinergic 
markers however they receive some cholinergic innervation from primary afferents 
(Alvarez et al., 2005), which could suggest that M2 muscarinic receptors that are 
expressed in dorsal INs and control presynaptic release from these afferents (Stewart 
and Maxwell, 2003; Wang et al., 2006; H. M. Zhang, Chen, et al., 2007; H. M. Zhang, 
Zhou, et al., 2007; H. Zhang et al., 2007) could be acting directly or having an indirect 
network effect on this population of CPG INs that could be responsible for observed 
increases in burst duration. V2a INs that control right-left alternation in mice (Crone et 
al., 2008) have sparse cholinergic innervation (Zagoraiou et al., 2009). Furthermore, 
V2a genetic ablation did not change cycle period, amplitude or duration of bursts 
(Crone et al., 2008). Thus, it is unlikely that cholinergic modulation of the locomotor 
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CPG involves this IN subpopulation. The dI6 INs are located around the ventromedial 
area of the spinal cord, are active during locomotion and seem to be important for the 
formation of rhythmic patterns (Lanuza et al., 2004; Dyck et al., 2012). The clustering 
of cholinergic INs in ventromedial regions (Bertrand and Cazalets, 2011) might 
facilitate local cholinergic modulation of INs near laminas X and VII involved in 
stabilizing the locomotor rhythm, which could include populations such as dI6 INs. Due 
to their sparse distribution in the spinal cord (Wilson et al., 2004), it is plausible that the 
effects of M2 muscarinic receptors on the drug-induced rhythm are a reflection of a 
modulation on several types of INs that form the locomotor CPG rather than an action 
on one particular type of IN. 
 
5.1.2. Modulation of spinal locomotor output by M3 muscarinic 
receptors 
There has been less previous work defining the role of M3 muscarinic receptors 
in spinal CPG circuits. In the present study blockade of M3 receptors disrupted the 
drug-induced locomotor rhythm as evidenced by an increase in the variance of burst 
frequency and a decrease in burst duration. There were no significant changes in the 
amplitude of locomotor-related bursts nor MN firing suggesting that M3 muscarinic 
receptors do not have a role in the modulation of MN output during fictive locomotion. 
During ACh-induced bursts of activity in the neonatal rat spinal cord, application of the 
M3 receptor antagonist 4-DAMP decreased burst frequency and could stop ventral root 
activity at concentrations in the nanomolar range. Based on this, the authors suggested 
that M3 muscarinic receptors were responsible for the endogenous action of ACh in the 
generation of motor bursting (Jordan et al., 2014). There is some evidence that these 
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receptors are expressed in laminas VII, VII and X (Wilson et al., 2004) suggesting that 
M3 muscarinic receptors could influence CPG neurons in the ventral horn. Activation of 
this receptor subtype could therefore affect firing properties of CPG INs involved in 
stabilization of the rhythm such as dI6 (Lanuza et al., 2004; Dyck et al., 2012) and V1 
INs (Alvarez et al., 2005; Gosgnach et al., 2006), as previously discussed for the M2 
muscarinic receptor. With very limited studies focused on M3 muscarinic receptors in 
the spinal cord, this is the first time a functional description for this receptor subtype has 
been highlighted during in vitro alternating hindlimb locomotion. The few studies on 
M3 receptor distribution in the spinal cord (Wilson et al., 2004) and mechanism of 
action (Bertrand and Cazalets, 2011; Jordan et al., 2014) limit interpretation of the 
findings of the current work. M3 muscarinic receptors can inhibit the M-current which 
results in increased neuronal excitability (Brown and Passmore, 2009; Bertrand and 
Cazalets, 2011), however no study has addressed the role of this current in spinal 
locomotion. Blocking M3 muscarinic receptors with 4-DAMP could have removed the 
cholinergic downregulation of the M-current which would decrease the activity of some 
CPG INs that are key in maintaining burst regularity. A recent study has shown that in 
the rat parafacial respiratory group, which is an important expiratory oscillator, 
activation of M3 muscarinic receptors increased the excitation of rhythmic neurons 
which in turn recruited adequate expiratory activity (Boutin et al., 2017). Previous work 
done in the neonatal rat suggested that in a medullary region of the brainstem that 
contains neurons responsible for the generation of the respiratory rhythm - the 
preBötzinger complex - M3 muscarinic receptors are helpful to ensure adequate 
frequency of respiratory patterns by modulating the activity of neurons important in 
rhythm generation (Shao and Feldman, 2000, 2005). Considering that M3 muscarinic 
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receptors seem to be important in modulating rhythmicity in the respiratory system 
(Shao and Feldman, 2000, 2005; Boutin et al., 2017) and the phylogenetical and 
functional similarities between brainstem and spinal CPGs (Smith et al., 2013; Berg, 
2017) it may follow that M3 receptor modulation in the locomotor circuitry at the 
lumbar region is also important for ensuring adequate rhythmic patterns of activity. 
Results from this thesis indicate that M3 muscarinic receptors are important in 
maintaining rhythm stability during fictive locomotion. 
  
5.1.3. Modulation of MN function by M2 muscarinic receptors 
 To explore changes in the cellular properties of MNs induced by muscarinic 
receptor activation, whole-cell patch clamp recordings were performed and MN 
function was studied. When investigating whether muscarinic receptor activation had 
any subthreshold effects on MNs that might modulate their resting membrane potential, 
two different types of changes in current were observed upon application of muscarine, 
either an inward or an outward current. Activation of M2 muscarinic receptors was 
responsible for the outward current in MNs. Similar results have been reported in 
sympathetic preganglionic spinal INs in which authors observed that M2 receptor 
activation decreased input resistance and elicited a hyperpolarization whose magnitude 
was reduced by lowering the extracellular levels of K+ (Gibson and Logan, 1995). 
Interestingly all MNs tested seemed to have a M2 muscarinic receptor-dependent 
outward current in the presence of the M3 receptor antagonist, however when the 
general agonist was perfused alone this feature was only detected in a subset of smaller 
MNs. This could reflect diverse expression of M2 receptors in different MNs or a 
balance between M2 and M3 receptors (see section 5.1.5). Immunolabelling studies 
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have suggested a preferential expression of M2 muscarinic receptors by large MNs with 
some smaller MNs displaying weak labelling (Welton et al., 1999), therefore 
differential expression of M2 receptors on MN soma is unlikely to explain the 
predominance of M2 receptor-mediated responses in smaller MNs. M2 muscarinic 
receptors are also expressed by cholinergic INs scattered around the dorsal and 
ventromedial areas of the spinal cord (Stewart and Maxwell, 2003; Wilson et al., 2004) 
which raises the possibility of a network effect being responsible for the M2 muscarinic 
receptor-mediated changes in current. However, given that M2 receptor-mediated 
outward currents were present when evoked activity was blocked with TTX, just like in 
preganglionic INs (Gibson and Logan, 1995), it seems that these currents reflect 
activation of M2 receptors on MNs. The reversal potential for K+ in the solutions used is 
-98mV whereas the reversal for Cl- is -62mV. The current-voltage relationship of the 
outward current measured in MNs in response to muscarine alone or muscarine co-
applied with the M3 receptor antagonist in the presence or absence of TTX showed a 
reversal potential between -90 and -100mV, near to the reversal for K+ in the solutions 
used. Thus, M2 receptor activation appears to induce a hyperpolarizing, possibly 
outward current in MNs by opening leak K+ channels due to the linearity of the I-V 
trace. These channels help to regulate resting membrane potential by maintaining the 
voltage below the threshold for action potential initiation and their modulation can 
induce dynamic changes in cell excitability (Bockenhauer et al., 2001). Leak K+ 
channels have been shown to be regulated by a range of intrinsic modulators of spinal 
neurons, for example, adenosine-induced hyperpolarization in ventral horn INs occurs 
through A1 adenosine receptor activation that leads to the opening of leak K+ channels 
(Witts et al., 2015). In electrophysiological recordings from the salamander spinal cord, 
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muscarine hyperpolarized MNs and decreased input resistance with a slope that had a 
reversal value close to the equilibrium potential for K+ (Chevallier et al., 2006). This 
hyperpolarization was show to be mediated by IKIR (Chevallier et al., 2006) which could 
suggest that perhaps the presently described M2 muscarinic receptor effects on the 
holding current from mouse MNs could also result from a modulation of IKIR. Future 
experiments with Ba2+ (IKIR blocker) in the presence of 4-DAMP and muscarine would 
help to clarify this hypothesis.  
Surprisingly, some MNs in which outward currents were observed when 
muscarine was perfused with 4-DAMP (in the presence or absence of TTX) had an 
increase in input resistance. The capacitance of these neurons was not statistically 
different than the MNs that displayed a decrease in input resistance. Despite overall M2 
muscarinic receptor activation inducing an outward current, the opposing changes in 
input resistance in these 2 groups of MNs could underlie particular M2 receptor 
modulations that could arise from distinctive cholinergic inputs (see section 5.2.1) or 
coupling to different pathways and downstream channels in different MNs that might 
not directly interfere with M2 receptor-dependent changes in transient current. 
 In recordings from neonatal mouse MNs, muscarine increased MN output and 
decreased mAHP amplitude with both being blocked by methoctramine. These data  are 
in line with results from previous work (Miles et al., 2007). This particular modulation 
was presumed to be mediated by Pitx2+ INs that form large C-boutons on MNs and 
activate postsynaptic M2 muscarinic receptors (Miles et al., 2007; Zagoraiou et al., 
2009; Witts et al., 2014). Immunolabelling studies indicated the presence of M2 
receptors around the cell soma (Welton et al., 1999) of MNs with intense postsynaptic 
clustering at C-bouton synapses (Wilson et al., 2004). At the postsynaptic site in these 
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synapses there is evidence of other proteins that could be a target for M2 muscarinic 
receptor regulation such as small conductance Ca2+-activated K+ channel (SK) and 
Kv2.1 channels (Witts et al., 2014). Modulation of SK channels by muscarine has been 
shown to account for decreased mAHP in spinal MNs in the salamander (Chevallier et 
al., 2006) which could be part of the cholinergic mechanism involved in the increase of 
MN output in mice (Miles et al., 2007). The particular mechanisms of MN modulation 
by M2 receptors and other proteins that are present at C-bouton synapses will be 
discussed in more detail in a later section which addresses the experiments performed 
using DREADD-mediated activation and inactivation of Pitx2+ INs in mice (section 
5.2.1). Since M2 receptors are also present on areas of the MN soma that are not 
juxtaposed of C-boutons (Welton et al., 1999; Wilson et al., 2004), other signalling 
pathways that do not comprise Pitx2+ INs might be involved in the presently described 
cholinergic modulation of MN function. In the salamander spinal cord, authors found 
that although muscarine increased MN output, it also decreased the Ih current which 
usually leads to a decrease in spiking probability (Chevallier et al., 2006). Blockade of 
Ih can induce a small hyperpolarization (Chevallier et al., 2006, 2008) which is known 
to affect MN resting membrane potential (Kjaerulff and Kiehn, 2001). Activation of the 
M2 muscarinic receptor subtype is involved in the inhibition of Ih in cholinergic 
striatum neurons (Zhao et al., 2016). Whether the M2 muscarinic receptor subtype also 
regulates Ih in mammalian MNs, thus affecting muscarine-induced increases in 
maximum firing and contributing to a hyperpolarization, could be investigated under the 
presence of low concentrations of Cs+ that are known to block the Ih current (Chevallier 
et al., 2006).  
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 The increase in synaptic inputs, that is attributed to M3 receptor activation, was 
observed in the first minutes of perfusion and it was followed by a M2 receptor-
mediated decrease in PSCs. Experiments performed by Bertrand & Cazalets (2011) 
have shown that electrical stimulation of the ventral commissure in spinal cord slices 
triggers the activation of neurons around the central canal area, where the majority of 
cholinergic INs seem to be located, which elicits synaptic potentials that can be 
recorded from MNs. In the presence of another M2 muscarinic receptor antagonist - AF-
DX116 – the authors found a decrease in the amplitude and duration of these 
postsynaptic potentials, suggesting that M2 receptor activation increases network 
excitation of MNs. In the work from this thesis, recordings from MNs from isolated 
spinal cord slices showed that M2 muscarinic receptor activation decreased neuronal 
drive to MNs. Although the data clearly shows a modulation of synaptic activity, the 
PSCs could include excitatory and/or inhibitory inputs since the reversal for Cl- in our 
solutions (-62mV) is close to the holding potential during voltage clamp recordings (-
60mV). In the mid-lumbar spinal cord of rats around 37-45% of dorsal and lamina X 
cholinergic INs were found to express the M2 muscarinic receptor with the majority of 
these INs also expressing GABAergic and glycinergic markers (Stewart and Maxwell, 
2003). In recordings from dorsal horn INs, activation of presynaptic M2 muscarinic 
receptors was suggested to increased GABA release through a phosphoinositide 3-
kinase mediated pathway (Wang et al., 2006; Zhang et al., 2009) and inhibit glycine 
release to other spinal INs (H. M. Zhang, Zhou, et al., 2007). Most of the studies on M2 
receptor modulation of GABA and glycine release are related with the role of these 
receptors in nociception (Kurihara et al., 1993; Gibson and Logan, 1995; Stewart and 
Maxwell, 2003; Wang et al., 2006; H. M. Zhang, Zhou, et al., 2007; Cai et al., 2009; 
140 
 
Zhang et al., 2009; Jeong et al., 2013) and no direct relation was established with MN 
function. However, considering that M2 muscarinic receptors are involved in the 
inhibition of the monosynaptic reflex activated by nociceptive stimuli (Kurihara et al., 
1993) which might affect lumbar locomotor CPGs (Mandadia et al., 2009) an eventual 
M2 receptor-mediated modulation of inhibitory inputs from dorsal INs to MNs cannot 
be discounted. This subtype of muscarinic receptor has also been shown to decrease 
glutamatergic transmission from primary sensory afferents to lamina II INs (H. M. 
Zhang, Chen, et al., 2007; Jeong et al., 2013) and muscarinic receptor activation 
decreased evoked AMPA-mediated synaptic currents recorded from mouse MNs after 
stimulation of the spinal cord dorsolateral funiculus (Mejia-Gervacio, 2012), suggesting 
that perhaps the observed decrease in synaptic drive could also reflect M2 muscarinic 
receptor actions on glutamatergic synapses. To fully address if activation of the M2 
receptor exclusively affects excitatory and/or inhibitory PSCs, voltage-clamp 
experiments should be repeated with muscarine co-perfused with 4-DAMP (to activate 
exclusively M2 receptors) in the presence of strychnine and picrotoxin allowing the 
acquisition of excitatory PSCs. Conversely, clamping MNs at a holding potential of -
40mV would enable isolation and investigation of inhibitory PSCs. Nevertheless, the 
results obtained indicate that M2 receptor activation decreased the overall synaptic drive 
to MNs. 
 
5.1.4. Modulation of MN function by M3 muscarinic receptors  
 The M3 muscarinic receptor antagonist 4-DAMP has previously been shown to 
block ACh-mediated depolarizations in mouse MNs (Bertrand and Cazalets, 2011). In 
the present work activation of M3 muscarinic receptors elicited an inward current in 
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MNs from spinal cord slices which was accompanied by an increase in input resistance 
that had a reversal potential close to -80/-90mV. The M3 receptor antagonist itself 
decreased input resistance with the current-voltage linear regression showing a reversal 
around -83mV. All these values are relatively close to the reversal potential for K+ in 
the solutions used (-98mV) suggesting that these receptors could modulate leak K+ 
channels in MNs, as has been shown in corticocallosal neurons (Jones and Baughman, 
1992) and sacral relay neurons (Zhu and Uhlrich, 1998). This would result in an 
increase in excitability by bringing the MN resting potential closer to the firing 
threshold. The M3 receptor-dependent inward current and increase in input resistance 
could also result from a modulation of other mechanisms, such as M-currents. In spinal 
MNs the M-current can be inactivated by M3 receptors (Bertrand and Cazalets, 2011) 
thus modulating the voltage threshold and up-regulating MN basal excitability 
(Lombardo and Harrington, 2016). Pharmacological activation of the channels 
responsible for the M-current can cause a hyperpolarization and decrease in input 
resistance whereas blockade can increase membrane resistance and depolarize MNs 
(Lombardo and Harrington, 2016). This could suggest that the observed inward current 
and increased input resistance as a result of M3 receptor modulation could reflect a 
negative regulation of the M-current in MNs. The use of XE991 to selectively block this 
particular current followed by M3 receptor activation could help to resolve whether 
some of the M3 muscarinic receptor effects on input resistance and holding current are 
partially a result of the modulation of the M-current.  
 Regarding MN output, activation of M3 muscarinic receptors in the presence of 
M2 antagonists had no significant effect on MN maximum output or mAHP amplitude. 
However, blockade of these receptors with 4-DAMP removed the muscarine-induced 
142 
 
increase in maximum firing suggesting that activation of M3 receptors is involved in 
cholinergic modulation of MN output. Very few studies have addressed the role of M3 
muscarinic receptors in the modulation of MN output with the majority of observations 
within motor systems coming from studies performed in brainstem INs. In recordings 
from INs of the preBötzinger Complex involved in the generation of respiratory-related 
rhythmicity, 4-DAMP removed an increase in tonic firing elicited by raising the levels 
of ACh with ACh-esterase inhibitors (Shao and Feldman, 2000, 2005). This activation 
of muscarinic receptors in the preBötzinger Complex induced a current that was 
associated with an increase in input resistance and a reversal potential of -11.4mV. The 
authors suggested this reflected the opening of a non-selective channel permeable to 
both Na+ and K+ that is not Ca2+ activated (Shao and Feldman, 2000). This assumption 
contrasts with the I-V relationship results for the experiments performed in mouse MNs 
(reversal at -80/-90mV) indicating that M3 muscarinic receptor-modulation might be 
different amongst different subtypes of spinal and brainstem neurons.  
One of the subsequent targets of M3 receptor modulation in neurons are M-
channels which are K+ channels exclusively modulated by ACh that generate a delayed 
rectifier current (M-current) which can limit action potential threshold and firing output 
(Brown and Passmore, 2009). In the central nervous system the M-current is exclusively 
modulated by M1 and M3 receptors (Brown and Passmore, 2009) and its modulation 
may affect MN function (Bertrand and Cazalets, 2011). In hippocampal pyramidal 
neurons this current supresses the duration and frequency of trains of spikes and 
blockade or genetic suppression of M-currents increases maximum firing and spike 
adaptation (Brown and Passmore, 2009). Considering that the M-current might be 
tonically active in lumbar MNs and can be downregulated by M3 muscarinic receptor 
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activation (Bertrand and Cazalets, 2011) it can be hypothesized that M3 receptors might 
be partially necessary for the increase in MN output elicited by muscarine. Perhaps 
activation of M3 receptors is followed by a subsequent downregulation of M-channels 
which will allow MNs to fire at higher frequencies in the presence of an excitatory 
stimuli, as has been reported for hippocampal synapses (Brown and Passmore, 2009). 
As discussed before, the Ih current can also be modulated by ACh in MNs (Chevallier et 
al., 2006, 2008). In relay cells in the rat lateral geniculate nucleus, M3 muscarinic 
receptor activation increases Ih and decreases leak K
+ conductance resulting in increased 
neuronal excitability (Zhu and Uhlrich, 1998). Considering that M2 receptors 
downregulate Ih (Chevallier et al., 2006; Zhao et al., 2016), perhaps a balance between 
both M2 and M3 receptor activation is necessary for muscarine to increase MN output 
(section 5.1.5). Nonetheless, the results from this thesis show that M3 muscarinic 
receptors are involved in the muscarine-induced increase in MN excitability. Whether 
the M-current or other channels represent the target for M3 receptor regulation of MN 
output remains to be explored.  
In experiments using electrical stimulation of the ventral commissure in spinal 
cord slices, high concentrations of 4-DAMP increased the amplitude and duration of 
postsynaptic potentials recorded from MNs indicating that M3 receptor activation 
decreases network excitation to MNs (Bertrand and Cazalets, 2011). In the current 
reported experiments, M3 receptor activation increased synaptic drive to MNs. As 
previously discussed, the acquired PSCs might comprise both excitatory and inhibitory 
currents. Somatodendritic M3 muscarinic receptors potentiate glycine release from 
lamina II INs (Wang et al., 2006) and do not seem to modulate GABAergic release 
from the dorsal horn (Zhang et al., 2009). In M3 knockout mice, oxotremorine (non-
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selective mAChR antagonist) decreased the frequency of inhibitory inputs from lamina 
II spinal neurons (H. M. Zhang, Zhou, et al., 2007) suggesting that M3 receptors 
modulate inhibitory synaptic drive in dorsal INs. Revealing of inhibitory PSCs at a 
holding voltage of -40mV would help to clarify an eventual involvement of GABA 
and/or glycine release in M3 muscarinic receptor-mediated modulation of synaptic 
inputs to MNs. Since M3 activation can increase excitation of motor networks which 
contribute to the generation of bursts of ventral root activity in the rat (Jordan et al., 
2014), it could be possible that the M3 subtype is responsible for an increase in 
excitatory input to MNs. Experiments with blockers of inhibitory transmission in the 
presence of methoctramine and muscarine to record excitatory PSCs would help to 
clarify the role of M3 receptors. Nevertheless, the data shows that M3 receptor 
activation increased overall network input to MNs.  
 
5.1.5.  M2 and M3 muscarinic receptors differently modulate spinal 
locomotor circuits 
Voltage-clamp recordings performed in MNs from the neonatal mouse spinal cord 
have demonstrated opposing effects associated with the activation of M2 and M3 
muscarinic receptors. Regarding synaptic inputs, M2 receptor activation decreased PSC 
frequency, whereas M3 receptor activation caused an increase in synaptic drive to MNs. 
M2 muscarinic receptors were responsible for a outward current and a decrease in input 
resistance while M3 receptors depolarized MNs and increased input resistance. 
Differences in the functional roles of M2 and M3 muscarinic receptors in spinal 
physiology have been highlighted previously. Stimulation of the saphenous nerve can 
evoke lumbar ventral root potentials that are potentiated by methoctramine and 
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supressed by 4-DAMP (Kurihara et al., 1993). In the dorsal horn, M3 receptors are 
present at glycinergic INs and potentiate glycine release, while M2 receptors counteract 
the effects on synaptic glycine release to dorsal INs (Wang et al., 2006). In M3 receptor 
knockout mice, oxotremorine decreased the frequency of inhibitory PSCs whereas in 
M2 receptor knockout animals it increased the frequency of these inhibitory inputs to 
lamina II INs (H. M. Zhang, Zhou, et al., 2007). The opposing effects of M2 and M3 
muscarine receptors have not only been reported in the spinal cord but also in other 
central synapses. In the cerebellum-projecting medial vestibular nucleus M2 muscarinic 
receptors inhibit glutamate release from vestibular afferents whereas M3 muscarinic 
receptors increase excitability of neurons projecting from this nucleus to the cerebellum 
(Zhu et al., 2016). M2 muscarinic receptors were responsible for an inhibitory response 
of ACh in parafascicular neurons whereas an excitatory component was mediated by 
M3 receptors (Ye et al., 2009). Formation of heterodimers has often been implicated in 
functional interactions between G-protein coupled receptors (Maggio et al., 1999). For 
example, D2 dopamine receptors and A2A adenosine receptors can form heterodimers 
that are involved in neuroplasticity in the basal ganglia and in neurogenerative diseases 
such as Parkinson’s disease (K. Fuxe et al., 2003; Kjell Fuxe et al., 2005). The A1 
(inhibitory) and A2A (excitatory) adenosine receptors can also form dimeric structures 
that may be responsible for functional crosstalk at several synapses prompting a balance 
between an adenosinergic status of excitation and inhibition (Sheth et al., 2014), which 
can be dysfunctional in diseases involving spinal MNs such as ALS (Nascimento et al., 
2014, 2015). M2 and M3 muscarinic receptors can also cross-interact with each other 
and form heterodimeric receptors (Maggio et al., 1999; Novi et al., 2005; Goin and 
Nathanson, 2006; Clovis et al., 2016). However, immunoreactivity for M3 and M2 
146 
 
muscarinic receptors in the spinal cord suggests that there might not be an overlap that 
could be indicative of heterodimerization, at least on the soma of MNs. M2 muscarinic 
receptors are preferentially clustered at the C-bouton synapse whereas the M3 receptor 
subtype was not present at this synapse but in fine cytoplasmic puncta in MNs (Wilson 
et al., 2004). Some INs in laminas X, VII and VIII exhibited M3 receptor 
immunoreactivity (Wilson et al., 2004) whereas M2 muscarinic receptors were mostly 
found in laminas II-III, IV-VI and lamina X (Stewart and Maxwell, 2003). This 
suggests that there is a likelihood of both receptors being expressed in synapses around 
the ventromedial area of the spinal cord where some CPG INs responsible for the 
generation of locomotor patterns are located. Whether M2/M3 heterodimers or 
functional crosstalk is involved in the modulation of spinal neurons, remains a 
possibility that could be addressed in the future. The possibility of protein-protein 
interactions between M2 and M3 receptors in the spinal cord could be explored using 
bioluminescence resonance energy transfer to study the molecular details and functional 
role of such possible oligomeric assembly (Pfleger et al., 2006). 
An interesting feature from the results obtained is the loss of muscarine-induced 
increase in MN maximum firing in the presence of 4-DAMP or methoctramine. Several 
studies suggested that some muscarinic receptor-dependent actions result from 
synergistic or a balanced activation of different receptors (Novi et al., 2005; González et 
al., 2011; Matsuyama et al., 2013). For example, in recordings from lamina II INs, both 
M2 and M3 muscarinic receptors were shown to regulate glutamate release with M2 
receptor modulating release from primary afferents while the M3 subtype regulated 
transmission in a group of glutamatergic INs in the spinal cord (H. Zhang et al., 2007). 
In a different study, intrathecal administration of methoctramine or 4-DAMP in the rat 
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spinal cord decreased the animal’s sexual behaviour, suggesting that blockade of any of 
the two receptors disrupts muscarinic receptor actions (Gómez-Martínez and Cueva-
Rolón, 2009). Considering the contrasting role of M2 and M3 muscarinic receptors in 
the regulation of currents such as Ih (Chevallier et al., 2006; Zhao et al., 2016; Zhu et 
al., 2016) and leak K+ channels (Jones and Baughman, 1992; Zhu and Uhlrich, 1998; 
Chevallier et al., 2006) and their different distribution on the surface of MNs but also on 
diverse spinal INs (Hellström et al., 2003; Stewart and Maxwell, 2003; Wilson et al., 
2004), it could be assumed that the muscarine-induced increase in MN output is not a 
direct outcome of the activation of one type of muscarinic receptor but instead a result 
of a balance between M2 and M3 receptor actions.  
Blocking M2 muscarinic receptors during NMDA, DA and 5-HT-induced 
locomotion decreased the variance of burst frequency and increased the duration of 
locomotor-related bursts. In contrast, M3 receptor antagonists disrupted the rhythmicity 
of the evoked bursts while also decreasing burst duration. These results indicate that M2 
and M3 muscarinic receptors have contrasting effects on the CPG network and therefore 
suggest that ACh, which is released during locomotion, facilitates a balance between 
M2/M3 actions to ensure effectiveness of locomotor-related network output. M3 
muscarinic receptors seem to be important in setting up adequate inter-burst intervals 
and thus avoiding formation of clusters of erratic bursts. The change between 
disorganized patterns of activity (e.g. multirhythm, diverse pattern) and continuously 
rhythmic activity relies on appropriate network excitability. Neuromodulators such as 
dopamine or 5-HT can shift disorganized bursts that were elicited at low doses into 
regular bursting when perfused at high concentrations (Sharples and Whelan, 2017). 
Regarding dopamine modulation, concentration-dependent sequential activation of 
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different receptor subtypes seemed to be responsible for this transition (Sharples et al., 
2015). Neuromodulation is largely influenced by network state, which could indicate 
that perhaps M3 muscarinic receptors are important in stabilizing the drug-induced 
rhythm by raising network excitability possibly through inactivation of the M-current in 
different CPG INs. On the other hand, M2 muscarinic receptors seem to be important in 
maintaining some degree of irregularity in the locomotor rhythm. By allowing burst 
events to be shorter (decreased duration) it could grant some degree of flexibility to the 
spinal network by allowing a modulator or a supraspinal stimulus to elicit a faster 
locomotor pace. Differences in M2 and M3 muscarinic receptor modulation of rhythmic 
outputs have not only been evidenced in the rat spinal cord (Jordan et al., 2014) but also 
in peripheral synapses where M2 and M3 receptors differentially regulate the intestinal 
motor activity with the M2 subtype being responsible for the generation of rhythmic 
motor activity while M3 receptors control periodicity of the rhythm (Tanahashi et al., 
2013). In addition, synergistic responses to activation of both receptors is involved in 
the cholinergic excitation of intestinal motor activity (Matsuyama et al., 2013). Based 
on the above discussion one can assume that a balanced M2/M3 muscarinic receptor 
activation adequately regulates episodic bursting during generated by spinal locomotor 
networks. 
 
5.2. Manipulation of Pitx2+ INs activity with DREADDs and impact on 
MN output and spinal locomotor networks 
 No work has been published yet on the expression of either excitatory or 
inhibitory DEADD receptors in genetically defined subsets of spinal INs that are part of 
the mammalian locomotor CPG. Considering this, the efficiency of DREADD 
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expression and impact on neuronal physiology will first be discussed and compared 
with reports using DREADD manipulation in other central systems. In CA1 pyramidal 
neurons expressing viral-injected hM3Dq, CNO increased firing frequency and 
recurrent bursting (Alexander et al., 2009). Similarly, in agouti-related protein neurons 
from the hypothalamus, Cre-dependent expression of this receptor elicited rapid 
depolarization of the membrane potential and increased firing rates (Krashes et al., 
2011). In hippocampal neurons activation of the genetically inserted inhibitory hM4Di 
receptor decreased firing output (Zhu et al., 2014) and was able to silence the 
occurrence of spontaneous action potentials (Armbruster et al., 2007). In the present 
study, activation and inhibition of Pitx2+ INs was achieved in Pitx2-
Cre;TdTom;CHRM3 and  Pitx2-Cre;TdTom;CHRM4 animals since spontaneous firing 
from these cells increased or decreased in the presence of CNO, respectively. Some 
constitutive actions of DREADD receptors have been reported recently (Armbruster et 
al., 2007; Sheikhbahaei et al., 2018), which could influence their use for the 
activation/inhibition of Pitx2+ INs. Pitx2+ INs are tonically active at rest at a frequency 
of approximately 3Hz (Zagoraiou et al., 2009). In the current work it is reported that 
Pitx2+ INs exhibited spontaneous activity at approximately 1.8Hz and 1.6 Hz in Pitx2-
Cre;TdTom;CHRM3 and Pitx2-Cre;TdTom;CHRM4  mice, respectively, while in 
controls it as close to 1Hz. The reported values for Pitx2+ INs spontaneous firing are 
lower when compared to the means (3Hz) previously reported (Zagoraiou et al., 2009) 
probably because these recordings were performed in spinal cord hemisections where 
synaptic drive and neuronal arborization is more preserved than in the circuitry from 
spinal cord slices used in this work. Despite the spontaneous firing frequency being 
slightly higher in Pitx2+ INs from DREADD than control animals, these average values 
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are not statistically different from each other which suggests the absence of a 
constitutive action of DREADDs on Pitx2+ INs. In addition, if a constitutive action from 
DREADDs was to be noticed, changes in MN maximum firing would be present, since 
Pitx2+ IN activation or inhibition significantly modulated MN output. When comparing 
MN maximum firing before CNO perfusion, both excitatory and inhibitory DREADD 
and control mice exhibit similar maximum spike frequency (approximately 25/26Hz). 
Due to the small evidence of constitutive DREADD activity in the vast repertoire of 
Cre-lox DREADD recombinations used (Roth, 2016; Zhu et al., 2017) and the 
similarity in firing properties of Pitx2+ INs and MNs in DREADD and control mice 
before perfusion of CNO, a constitutive action of DREADDs on Pitx2+ INs was deemed 
improbable in the currently reported data.  
The expression of DREADD receptors in the animals used in this work should be 
consistent with the pattern of expression of the Cre driver (Zhu et al., 2017). Cre-
dependent expression of fluorescent reporters in Pitx2+ INs was observed in more than 
90% of cholinergic Pitx2+ INs and more than half of the glutamatergic Pitx2+ INs 
(Zagoraiou et al., 2009). Immunohistochemical studies to address the percentage of 
Pitx2+ INs that express hM3Dq or hM4Di were not performed, however is it likely that 
the expression of DREADD receptors was similar to the high expression observed for 
fluorescent reporters using the same Pitx2-Cre driver line (Zagoraiou et al., 2009; Zhu 
et al., 2017).  
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5.2.1. Activation of Pitx2+ INs increases MN output via M2 muscarinic 
receptor-dependent modulation of Kv2.1 channels 
The activation of Pitx2+ INs in Pitx2-Cre;CHRM3 mice induced a small, 
methoctramine-sensitive, inward current in MNs that was accompanied by an increase 
in input resistance and had a reversal potential of approximately -80mV. An increase in 
input resistance with a similar value for reversal was also observed in a group of MNs 
from WT mice after M2 muscarinic receptor activation. However, in these WT animals, 
activation of M2 muscarinic receptors induced an outward current as opposite of the 
Pitx2+ IN-mediated inward current, indicating that overall M2 receptor modulation in 
WT mice involves contribution from other sources of cholinergic inputs that are not 
Pitx2+. It is known that the expression of M2 muscarinic receptors is more prominent on 
large compared to small MNs, with particular clustering on MN areas juxtaposed to C-
boutons (Welton et al., 1999; Wilson et al., 2004). The abundance of C-boutons does 
seem to vary between different MN pools.  For example, MNs innervating groups of 
fast-twitch fibres within the medial gastrocnemius muscle have more C-boutons than 
those innervating the slow-twitch soleus muscle (Hellström et al., 2003). Since fast-
twitch fibres are innervated by large alpha MNs whereas slow-twitch muscle fibres 
receive projections from smaller alpha MNs, Pitx2+ INs could have an important role in 
the size principle of motor unit recruitment (Henneman et al., 1965; Llewellyn et al., 
2010). Due to the heterogenous anatomical distribution of C-boutons to different MN 
pools (Welton et al., 1999; Hellström et al., 2003; Wilson et al., 2004) perhaps the 
increase in input resistance in MNs from WT mice after M2 receptor activation could be 
a reflection of a modulation involving Pitx2+ INs. Perhaps these MNs have more C-
boutons than other groups of MNs in which a decrease in input resistance was observed 
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when M2 receptors were activated. This could be clarified in the future with 
experiments addressing modulation of MN function by: (1) studying changes in input 
resistance after activating M2 receptors but in spinal cord slices of Pitx2-Cre;DTA mice 
in which C-boutons are ablated or (2) retrogradely label fast (gastrocnemius) or slow 
twitch (soleus) muscles that are differently innervated by Pitx2-INs (Hellström et al., 
2003) and record M2 receptor responses from the labelled MNs. When comparing 
results regarding M2 receptor-mediated modulation of subthreshold properties from WT 
and excitatory DREADD mice, it appears that the effects of Pitx2+ INs and C-bouton 
synapses may only account for a small portion of the overall M2 muscarinic receptor-
mediated modulation of input resistance and current observed in WT mice. Experiments 
from Pitx2-Cre;CHRM3 mice indicate that activation of Pitx2+ INs increases cell 
excitability by depolarizing MNs and increasing input resistance through a M2 receptor-
dependent mechanism that does not involve Kv2.1 channels, but perhaps includes other 
proteins that are expressed at the postsynaptic terminal opposite C-boutons and that 
might ultimately influence MN output (Witts et al., 2014).  
In Pitx2-Cre;CHRM3 mice activation of the hM3Dq receptor, and hence 
activation of Pitx2+ INs, with CNO increased MN firing. This effect was eliminated by 
a M2 muscarinic receptor antagonist or with prior blockade of Kv2.1 channels. M2 
muscarinic receptors are clustered on MN soma juxtaposed to C-boutons and have 
previously been implicated in modulation of motor output by Pitx2+ INs (Hellström et 
al., 2003; Wilson et al., 2004; Miles et al., 2007; Zagoraiou et al., 2009; Witts et al., 
2014). By stimulating Pitx2+ INs while recording MN output, the current study provides 
the first direct evidence that M2 receptors contribute to muscarinic modulation of spinal 
locomotor output. Several proteins, which are clustered near M2 muscarinic receptors at 
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the C-bouton synapse such as SK channels, Kv2.1 channels and N-type Ca2+ channels, 
could be downstream targets of M2 receptors for subsequent regulation (Witts et al., 
2014). Previous experiments hypothesised that SK channels are subject to M2 
muscarinic receptor-mediated modulation at C-boutons leading to a decrease in mAHP 
amplitude which could translate into increased MN excitability (Miles et al., 2007). 
However, in the current study, DREADD-mediated activation of Pitx2+ INs resulted in 
an increase in the mAHP in MNs which does not match previous suggestions (Miles et 
al., 2007). Experiments performed in WT mice revealed that a muscarine-induced 
decrease in mAHP was dependent on M2 receptor activation. Perhaps M2 muscarinic 
receptors that are also known to be present outside the C-bouton synapse (Wilson et al., 
2004) could be responsible for the decrease in mAHP amplitude in WT mice. N-type 
Ca2+ channels can also modulate mAHP kinetics and affect SK-mediated 
hyperpolarizations. Ca2+ entry through N-type Ca2+ channels after an action potential 
can activate SK channels leading to an increase in the mAHP (Hallworth et al., 2003; 
Kasten et al., 2007; Vrindab et al., 2016). SK-mediated currents have been shown to be 
activated by N-type Ca2+ channels in rat MNs (Li and Bennett, 2007). Perhaps 
activation of Pitx2+ INs could increase mAHP amplitude by indirect regulation of an 
SK-dependent AHP through modulation of N-type Ca2+ channels that are known to be 
positioned on MN somata and terminals at C-bouton synapses and might increase Ca2+ 
influx to activate SK channels. In dorsal root ganglia neurons, blockade of Kv2.1 
channels decreases mAHP amplitude (Tsantoulas et al., 2014), suggesting that a 
functional up-regulation of Kv2.1 channels could be responsible for changes in the MN 
mAHP. However, a role for Kv2.1 channels in the regulation of the mAHP in MNs is 
very unlikely since mAHP amplitude was still increased following activation of Pitx2+ 
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INs in the presence of the Kv2.1 channel blocker guangxitoxin-1E. Therefore, the 
increase in mAHP amplitude involves M2 muscarinic receptor-mediated modulation 
that does not target Kv2.1 channels. The channels involved and the molecular pathways 
underlying changes in the amplitude of the mAHP in MNs as a result of activation of 
Pitx2+ INs in Pitx2-Cre;CHRM3 mice remain to be fully determined.  
The current study revealed a decrease in the voltage threshold for action potential 
generation after activation of Pitx2+ INs in Pitx2-Cre;CHRM3 mice. The decrease in 
threshold was associated with M2 muscarinic receptors but not of Kv2.1 channels, 
suggesting that other proteins present at the C-bouton synapse, such as SK and N-type 
Ca2+ channels, could be responsible for the reported change in action potential 
threshold. In subthalamic nucleus neurons inhibition of N-type Ca2+ channels in the 
absence of SK channel activity resulted in an increase in action potential threshold 
(Hallworth et al., 2003), while SK channel blockade depolarized the action potential 
threshold in midbrain dopamine neurons (Iyer et al., 2017). Whether M2 muscarinic 
receptors regulate the action potential threshold of MNs via actions on  SK or N-type 
Ca2+ channels at the C-bouton synapse could be addressed in future work. By 
decreasing the voltage threshold for action potentials, Pitx2+ INs decrease the current 
necessary from an incoming stimulus to trigger MN firing which in turn translates into 
amplified motor unit excitability.  
Increased MN spiking after the activation of Pitx2+ INs was dependent on Kv2.1 
channels, and their regulation of the half-width of evoked action potentials. Kv2.1 
channels are not only expressed at the C-bouton synapse but also at other synaptic sites 
on MNs associated with contacts from presumptive excitatory INs (Muennich and 
Fyffe, 2004; Fletcher et al., 2017). Kv2.1 currents enable repetitive firing in a wide 
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range of neuronal types (Malin and Nerbonne, 2002; Guan et al., 2013; Liu and Bean, 
2014), playing an important role in the repolarization phase of action potentials in MNs 
(Gao and Ziskind-Conhaim, 1998). The reduction in MN spike frequency observed in a 
mouse model of Spinal Muscular Atrophy has recently been attributed to a reduction in 
Kv2.1 currents, which lead to an increase in the half-with of MN action potentials thus 
limiting firing output (Fletcher et al., 2017). By increasing K+ conductance through 
modulation of Kv2.1 channels, M2 muscarinic receptors at the C-bouton synapse allow 
for shorter duration action potentials, which translates into increased repetitive firing.  
This feature seems to be exclusively mediated by Kv2.1 channels and probably 
independent from other proteins at the C-bouton synapse. Modulation of SK channels 
has been shown to affect mAHP and not action potential duration (Gao and Ziskind-
Conhaim, 1998) while N-type channel blockers did not change the half-width of action 
potentials in hippocampal pyramidal neurons (Shah and Haylett, 2000).  
Kv2.1 channels can be subjected to different modulatory influences including 
phosphorylation (Mohapatra, 2006). In hippocampal neurons muscarinic stimulation via 
M1 or M3 receptors increased calcineurin-meditated dephosphorylation of Kv2.1 
channels, which reduced their activity (Mohapatra et al., 2007). Authors also found that 
the C-terminus of Kv2.1 channels can act as a transferable “muscarinic response 
element” conferring muscarinic modulation of function and location (Mohapatra et al., 
2007). M2 muscarinic receptor activation can lead to subsequent activation of several 
phosphorylation pathways (Shapiro et al., 1999), which could ultimately regulate Kv2.1 
channel phosphorylation at C-bouton synapses thus increasing MN firing (Muennich 
and Fyffe, 2004).  
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The results reported here provide direct evidence that Pitx2+ INs modulate MN 
output in the neonatal mouse spinal cord. The lack of evidence of anything else than a 
cholinergic modulation from Pitx2+ INs in DREADD mice supports a role for C-
boutons in the modulation of MN output. However, since some Pitx2+ INs are 
glutamatergic and their contribution to MN function perhaps through polysynaptic 
pathways that might affect dorsal cholinergic INs that might modulate MN output 
remains a possibility open to discussion. In sum, the data show that Pitx2+ INs modulate 
MN function through the activation of M2 muscarinic receptors at the C-bouton 
synapse, which increase firing output by reducing action potential duration through 
regulation of Kv2.1 currents.  
 
5.2.2. Pitx2+ INs influence the strength of motor output during 
locomotion 
 As discussed previously, a constitutive action of hM4Di on Pitx2-Cre;CHRM4 
mice was excluded, therefore the results indicate that activation of the DREADD 
receptor with CNO was able to effectively inhibit Pitx2+ INs. This cholinergic subset of 
INs is active during fictive locomotion exhibiting bursts of spikes that are in phase with 
segmentally aligned ventral root output (Zagoraiou et al., 2009). CNO-induced 
inhibition of Pitx2+ INs elicited a M2 receptor-dependent outward current in MNs that 
was associated with a decrease in input resistance and had a reversal potential close to 
the equilibrium potential for K+ in the solutions used (-98mV). This could indicate that 
removing the input from Pitx2+ INs to MNs during drug-induced locomotion 
contributed to a reduction in MN excitability due to MNs becoming more 
hyperpolarized following the opening of leak K+ channels. The effects of reducing MN 
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excitability in Pitx2-Cre;CHRM4 would lead to a decrease in MN spiking in the 
presence of locomotor drugs. This indicates that activation of Pitx2+ INs during 
locomotion might change the intrinsic properties of MNs rendering them capable of 
firing at higher frequencies during NMDA, 5-HT and DA-induced locomotion.  
The decrease in MN output observed in Pitx2-Cre;CHRM4 mice resulted in an 
reduction in ventral root burst amplitude suggesting that the prominent role of this 
subpopulation of INs during fictive bursting is the fine-tuning of the strength of motor 
output. Despite there being some evidence of connectivity between Pitx2+ INs and other 
spinal INs, with glutamatergic Pitx2+ INs projecting to dorsal INs and a low density of 
Pitx2+ cholinergic boutons observed in the intermediate zone of the spinal cord 
(Zagoraiou et al., 2009), neither ventral root burst frequency or duration changed with 
CNO application in Pitx2-Cre;CHRM4 mice. Since the effects of inhibition of Pitx2+ 
INs were dependent on M2 muscarinic receptor activation and no changes in the 
frequency or duration of locomotor-related bursts were observed, data from experiments 
involving DREADD-mediated inhibition of Pitx2+ INs strongly support a primary role 
for Pitx2+ INs and C-boutons in the control of MN output with little or no impact on 
CPG INs.   
 Pitx2+ INs are active enhancers of MN output during drug-induced locomotion. 
Silencing these INs reduced MN excitability resulting in decreased ventral root motor 
output. The fact that methoctramine blocked the effects of DREADD-mediated 
inhibition of Pitx2+ INs indicates that modulation by M2 muscarinic receptors at the C-
bouton synapse is involved, as seen in experiments utilising Pitx2-Cre;CHRM3 animals 
for DREADD-mediated excitation of Pitx2+ INs. The possibility of other modulatory 
effects on motor control being attributable to this particular subset of cholinergic INs 
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could be explored in different experimental settings. For example, future experiments 
could utilise DREADDs to manipulate Pitx2+ IN activity during sensory-evoked motor 
activity in isolated spinal cords, brainstem stimulation in intact animals, or during 
behavioural tests in adult animals, such as reaching tasks and rota-rod tests. Such 
experiments would help determine if the modulatory roles of Pitx2+ INs extend beyond 
control of MN output during locomotion.  
 
5.3.  Genetic ablation of cholinergic Pitx2+ INs removes M2 
receptor-dependent modulation of the amplitude of motor 
output during locomotion 
Cre-dependent expression of diphtheria toxin A has been widely used to 
genetically ablate specific populations in the spinal cord to study locomotor networks 
involved in the control of hindlimb movement (Gosgnach et al., 2006; Crone et al., 
2008). Pitx2-Cre;DTA mice exhibit 90% less C-boutons than control mice, thus 
illustrating the high degree of efficiency in the genetic removal of cholinergic Pitx2+ 
INs in this animal model. Results from WT mice indicated that blocking M2 muscarinic 
receptors with methoctramine reduced burst amplitude, while experiments utilising 
DREADDs to activate Pitx2+ INs showed that M2 receptors are responsible for the 
regulation of MN output at the C-bouton synapse. Removal of cholinergic Pitx2+ INs 
allowed for further investigation of the physiological relevance of these neurons in 
spinal circuits. Previous work showed that elimination of cholinergic Dbx-1 expressing 
INs, which includes ACh-expressing Pitx2+ INs, did not affect the viability of mice nor 
general locomotor pattern (Zagoraiou et al., 2009). Therefore we would expect that 
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ablation of cholinergic Pitx2+ neurons in Pitx2-Cre;DTA mice would not produce overt 
phenotypes in mice. The Pitx2 transcription factor is expressed in the dorsal and ventral 
midbrain and may be important in the differentiation of restricted GABAergic and 
glutamatergic populations of neurons (Waite et al., 2011). However, it is not known if 
cholinergic Pitx2+ INs are present in the brain and if they impact motor function. 
Although, no specific tests were performed to ascertain if Pitx2-Cre;DTA mice 
exhibited changes in development, growth or general locomotion, no overt motor 
phenotypes were observed in these mice. It is possible that compensatory mechanisms 
might operate to reduce the effect of the loss of cholinergic Pitx2+ INs. Such 
compensation has been reported during embryonic spinal cord development in mice 
lacking ChAT enzyme, although these mice did exhibit a partial lack of locomotor 
fidelity (Myers et al., 2005). Experiments in the current study demonstrated that isolated 
neonatal spinal cords obtained from Pitx2-Cre;DTA mice were viable and exhibited 
regular bursts of locomotor activity. Since methoctramine did not affect the amplitude 
of ventral root bursting in Pitx2-Cre;DTA spinal cords, results further highlighted the 
role of M2 muscarinic receptors at C-bouton synapses in the modulation of the strength 
of motor output.  
Adjusting the amplitude of motor output during locomotion will help to match 
the strength of muscle contraction to behavioural demands. Pitx2+ INs appear to be part 
of an intrinsic spinal cholinergic modulatory system that regulates the strength of the 
motor output during coordinated locomotion. Previous work suggested that recruitment 
of this modulation occurs in a task-dependent fashion (Zagoraiou et al., 2009) and 
therefore descending or sensory inputs that could relate to motor commands such as 
posture control (Stepien et al., 2010; Murray et al., 2018) could trigger activation of 
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Pitx2+ INs which would in turn release ACh at the C-bouton synapses thus increasing 
MN firing through M2 receptor-dependant mechanisms (Miles et al., 2007; Zagoraiou 
et al., 2009; Witts et al., 2014). Beyond this clear role for the Pitx2+ IN system in the 
regulation of the intensity of motor output during hindlimb locomotion, future 
behavioural analyses of Pitx2-Cre;DTA animals will be important to determine whether 
the Pitx2+ IN system is also involved in additional, possibly more subtle modulation of 
motor control. 
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6. CONCLUDING REMARKS 
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The work described in this thesis explored how muscarinic receptors affect 
motor output and MN function in the lumbar region of the neonatal mouse spinal cord. 
Using electrophysiological recordings of MNs in isolated spinal cord preparations, 
along with ventral root recordings during drug-induced locomotion, it was possible to 
elucidate the cellular mechanisms underlying M2 and M3 muscarinic receptor 
modulation of spinal excitability and the involvement of these receptors in circuits 
responsible for the generation of rhythmic patterns of locomotor activity.  Several 
previous studies have described some of the roles of muscarinic receptors in the control 
of spinal motor function in different vertebrates such as the salamander (Alaburda et al., 
2002; Chevallier et al., 2006, 2008), turtle (Alaburda et al., 2002), rat (Kiehn et al., 
1996; Jordan et al., 2014; Anglister et al., 2017) and mouse (Jiang et al., 1999; Miles et 
al., 2007). Despite the shared commonalities between observations, there are often 
discrepancies, even when comparing close species such as rat and mice (Kiehn et al., 
1996; Jiang et al., 1999). The current study sought to clarify the role of cholinergic 
modulation in the neonatal mouse spinal cord. In addition, this study focussed on a 
particular subpopulation of cholinergic INs – Pitx2+ INs because they are best 
characterized and the only genetically traceable group of cholinergic INs in the spinal 
cord. Use of state-of-art genetic tools allowed detailed exploration of muscarinic 
modulation mediated by Pitx2+ INs.  
 This study demonstrated that M2 and M3 muscarinic receptors are solely 
responsible for muscarinic modulation of spinal locomotor output. A balance between 
M2 and M3 receptor activation is involved in sustained rhythmic fictive locomotion. 
M3 muscarinic receptors seem to be important for stabilizing the locomotor rhythm, 
whereas activation of M2 muscarinic receptors increases irregularity in the frequency of 
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locomotor bursts but also increases the strength of ventral root bursting by increasing 
MN output during locomotion. Experiments investigating the role of M2 and M3 
receptors in the modulation of MN function suggest that these receptors play opposing 
roles. Both M2 and M3 receptors are present at last-order synapses to MNs. M2 
muscarinic receptors decrease synaptic drive and hyperpolarize MNs due to the opening 
of leak K+ channels. M3 receptors on the other hand, increase synaptic inputs to MNs 
and elicit a depolarization which could be due to regulation of a ionic mechanisms such 
as the M-current (Alaburda et al., 2002; Bertrand and Cazalets, 2011; Lombardo and 
Harrington, 2016). M3 muscarinic receptor activation dominates in larger MNs, 
whereas M2 muscarinic receptor-mediated responses dominate in smaller MNs based 
on the capacitance values recorded. Interestingly both receptors are involved in the 
muscarine-elicited increase in MN output indicating that the disruption of the M2/M3 
receptor balance might have consequences for cholinergic modulation of motor output. 
The current work has demonstrated that M2 and M3 muscarinic receptors have 
complementing effects on the modulation of MN function and spinal networks involved 
in the control of mammalian hindlimb locomotion. 
 Experiments investigating the roles of specific subtypes of cholinergic INs, 
which focussed on Pitx2+ INs, defined cellular mechanisms involved in cholinergic 
control of motor output. In the lumbar spinal cord of the neonatal mouse, activation of 
Pitx2+ INs during locomotion causes release of ACh from C-boutons that activate 
postsynaptic M2 muscarinic receptors, which in turn regulate the activity of Kv2.1 
channels allowing for a faster repolarization phase during an action potential, resulting 
in increased MN firing and subsequent increased muscle contraction (figure 5). 
DREADD-mediated inhibition of Pitx2+ INs reduced motor output during locomotion, 
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while genetic ablation of cholinergic Pitx2+ INs removed any M2 muscarinic receptor-
mediated effects on the amplitude of locomotor bursts, proving that this population of 
cholinergic cells is important for the adjustment of the strength of motor activity. This 
information not only advances our understanding of the networks involved in hindlimb 
locomotion but also characterizes a group of important modulatory spinal INs that is 
severely affected in spinal cord injury and ALS.  
 In summary, this work has provided valuable novel information regarding 
cholinergic modulation of mammalian spinal locomotor circuitry. Receptors involved in 
muscarinic modulation have been pharmacologically characterized and their 
mechanisms of action explored. A particular subset of cholinergic neurons - Pitx2+ INs 
– has been found to contribute to this modulation by increasing MN output and 
therefore enhancing muscle contraction. In the future, anatomical and behavioural 
studies should be performed to fully address the anatomical distribution of M2 and M3 
receptor modulation and the impact that DREADD-mediated modulation of Pitx2+ INs 
might have in vivo.  
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Figure 5 – Suggested mechanism of Pitx2+ IN-mediated increase in motor output. 
Pitx2+ INs (red) form C-bouton synapses on MNs (green) and are known to received 
disynaptic inputs from sensory afferents (blue) as well as input from higher brain areas 
(purple) (Zagoraiou et al., 2009). Activation of Pitx2+ INs will activate postsynaptic M2 
muscarinic receptors at the C-bouton synapse that will positively regulate Kv2.1 
channels. This modulation leads to a decrease in action potential duration, allowing for 
increased MN firing output which will translate into more intense contraction of 
muscle; DRG – dorsal root ganglion.  
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